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Abstract 
The fact that non-communicable diseases (NCDs) have become the leading causes of death and disability 
over the past two decades globally warrants dedicated research and the implementation of prevention 
strategies. Global restrictions/bans have been placed on persistent organic pollutants (POPs) due to the 
links between early-life exposure to them and NCD risks that have been observed in epidemiological 
studies. Certain POP groups (such as polychlorinated biphenyls (PCBs), organochlorine pesticides 
(OCPs) and polybrominated diphenylethers (PBDEs)) are present/persistent in human breast milk at 
considerable levels several decades/years despite restrictions/bans. Increased understanding of exposure-
response relationship is now needed to confirm the significant pollutants exposures and their exposure 
windows. Individual data from early childhood biomonitoring POPs is, therefore, vital.   
Direct measurements of body burdens in early childhood have been a challenge, due to the reduced 
availability of invasive-biomonitoring (such as blood sampling) under ethical and practical 
considerations. Early-childhood biomonitoring studies typically rely on measurements of breast milk 
concentrations and/or modelling the body burden of POPs in infants/toddlers using intake estimates and 
growth data. Previously, concentrations of selected POPs in faeces of adults were reported to be largely 
independent of the dietary intake of chemicals, but dependent on the body burden. Thus, this thesis aimed 
to investigate the viability of using faeces as a non-invasive matrix for estimating the body burden of 
POPs in infant/toddlers.  
Faeces, as a biomonitoring matrix, was not well-documented for both the convenience and the practical 
scope previously. An effective analytical method, including sampling faeces and POPs extraction/clean-
up and quantification, was developed and had been modified throughout the study with recent advances 
in sample-preparation techniques. Based on the effective analytical method, the relationship between the 
POP concentrations in faeces and the body burden (assessed via breast milk and blood samples) in 
infants/toddlers was then investigated.  
The measured concentrations of POPs in the faeces of a group of 7 infants/toddlers were compared to 
existing pooled blood serum data from children (0-4 years) in Australia (Chapter 2). The similarity of 
POP profiles observed between the existing blood data and the collected faeces samples hold promise 
for the viability of faecal analysis as an early-exposure biomonitoring tool. Subsequently, matched breast 
milk and faecal samples from 10 mother-child pairs were obtained and analyzed with the distribution of 
individual exposure levels of infants/toddlers and the correlation between exposure and faecal 
concentrations being investigated for the first time (Chapter 3).  
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The monthly variation of POP concentrations in faeces over the first year of life of one infant was 
investigated and compared to modelled blood concentrations (Chapter 4). The results showed the POP 
concentrations in faecal samples decreased rapidly following weaning and the ratio of faecal:blood 
concentrations (Kfb) values changed over the first year of life. With no correlation found between the 
change in Kfb values and the change in chemical intake via the diet, the direct correlation between the 
concentrations in faeces and the body burden was again indicated. Changes in the partitioning properties 
of faeces occurring as the diet changed appeared to be the primary factor in the change in Kfb values 
observed over time in this infant. 
In Chapter 5, the concentrations of selected POPs were measured in matched plasma and faecal samples 
collected from 20 infants/toddlers (aged 13±4.8 months). We observed higher rates of POP detection in 
faeces (2 g dry weight) than in plasma (0.5 mL). Among the five chemicals that had detection frequencies 
over 50% in both matrices, p.p’-dichlorodiphenyldichloroethylene (p,p’-DDE) and 2,3’,4,4’,5-
pentachlorobiphenyl (PCB118), 2,2’,3,4,4’,5’-pentachlorobiphenyl (PCB138) and 2,2’,4,4’,5,5’-
pentachlorobiphenyl (PCB153) had Pearson’s correlation coefficients between log-transformed 
concentrations in plasma (Cb) and concentrations in faeces (Cf) that were greater than 0.74 (P<0.05). We 
determined faeces:plasma concentration ratios (Kfb), which can be used to estimate Cb from 
measurements of Cf for infants/toddlers. For a given chemical, the variation in Kfb was considerable 
(quotient of 95% percentile and 5% percentile from 5.2-11). Between 5% and 50% of this variation was 
attributed to short term variability between successive bowel movements. This variability could be 
reduced by pooling faeces samples over several days. Some of the remaining variability was attributed 
to longer term intra-individual variability.  
In conclusion, results from this thesis showed that faecal sampling can provide a non-invasive alternative 
and complementary method for characterizing infant/toddler exposure to POPs. This allows 
incorporation of direct biomonitoring without the limitations/difficulties of blood sampling in these 
populations and can complement estimates derived from toxicokinetic modelling.  Limitations of the 
current dataset, additional steps that could enhance the use of faecal biomonitoring in these populations, 
and the possibility of utilizing the method in the epidemiology are also discussed in the final Chapter of 
the thesis.  
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1.1 Early-life exposure to POPs may influence people’s health over a life-time 
Over the last two decades, the global health landscape has been found changing. The leading causes of 
death and disability have changed from communicable diseases in children to non-communicable 
diseases (NCDs) in adults (IHME, 2013; Vos et al., 2015). NCDs, also known as chronic diseases, 
generally progress slowly over an extended time period, which is increasingly recognized as an important 
issue in public health. The four main types of NCDs are cardiovascular diseases (such as heart attacks 
and stroke), cancers, chronic respiratory diseases (such as chronic obstructed pulmonary disease and 
asthma) and diabetes (Figure 1.1). The more frequent occurrence of other categories of NCDs (including 
mental illness, cognitive decline, and allergic diseases) has also contributed to the gradual rise of public 
concern (Gluckman and Hanson, 2006; Hanson and Gluckman, 2015).  
 
Figure 1.1: Global shifts in leading causes of DALYs, 1990-2010 (DALYs refers to the sum of years lost due to premature 
death and years lived with disability, and are also defined as years of healthy life lost) (source: (IHME, 2013)) 
 
The mechanisms implicated in the developmental programming of NCDs are poorly understood (Hanson 
and Gluckman, 2011). The time interval of the substantial increase observed in incidence of many NCDs 
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was much too short to be attributable to genetic change. The developmental origins of health and disease 
(DOHaD) concept has started to gain broad acceptance, proposing that a body’s development is plastic, 
and that it allows the organism to respond to the surrounding environment, especially during early 
development (Gluckman et al., 2008; Gluckman et al., 2009; Barouki et al., 2012; Hanson and Gluckman, 
2015). This concept is based on an increasing number of epidemiological studies that suggest that 
environmental factors, such as nutrients, environmental chemicals, drugs, infections and other stressors 
in early developmental period can lead to adverse chronic consequences later in the course of life 
(Nickerson, 2006b; Nagayama et al., 2007a; Kortenkamp et al., 2011; Barouki et al., 2012; Ochiai et al., 
2014; Vaiserman, 2015). 
 
POPs (such as polychlorinated biphenyls (PCBs), organochlorine pesticides (OCPs) and polybrominated 
diphenylethers (PBDEs)) are a group of environmental chemicals that are semi-volatile, resistant to 
degradation, bio-accumulate in human tissues and are potentially harmful to human health (Jones and de 
Voogt, 1999). Selected physicochemical properties of POPs and reported associations between early-life 
POP exposure and specific health outcomes are summarized in Table 1.1. It is noteworthy that a causal 
link between POP exposure and the development of NCDs is actually lacking and the early-life exposure 
here was referred to the POP concentrations measured in cord blood, maternal blood and/or breast milk. 
 
Table 1.1 Properties of selected POPs and examples of epidemiological associations between early-life exposure (POP 
concentrations in cord blood, maternal blood and/or milk) and health outcomes 
POPs Formula log Koa Log Kow1 
Half-lives 
(estimated in 
adult)  
Associations between early-life exposure and health 
outcomes 
p,p’-DDE C14H8Cl4 8.4015 6.51 
10 years2; 
26.81years3 
Increased thyroid volume, prevalence of thyroid 
antibodies and impaired fasting glucose level in young 
adults5, and overweight in children6 
HCB C6Cl6 6.8816 5.86 4.22 years3 
Increased thyroid volume, prevalence of thyroid 
antibodies and impaired fasting glucose in young 
adults5. Also associated with poor social competency 
scores7 
PCBs C12H10-xClx 7.93-10.1217 3.76-8.26 12~22 years 3.4 
Obesity and Type II diabetes in adults and children, 
and with low birth weight and increased “catch-up” 
growth8; effects on thyroid hormones homeostasis and 
motor development of infant.9 
PBDEs C14H(10-x)BrxO 
10.53-
11.8218 
5.7-8.27 0.1-7 years4 
Adverse effects on motor, cognitive and behavioural 
outcomes, endocrine disruption, disruption of thyroid 
homeostasis10; decreased birth weight, length and 
chest circumference11; cryptorchidism12; affects 
signalling pathways that are important for learning, 
memory13; and neural development14 
Reference:1: Connell et al., 2007;  2: Wolff and Anderson, 1999;  3: Mikes et al., 2012; 4: Ogura, 2004);  5: Langer et al., 2008;  6: Valvi et al., 2012;   
7:Ribas-Fito et al., 2007;  8:Jacobson and Jacobson, 1996;  9:Gladen et al., 2000;  10:Roze et al., 2009;  11:Chao et al., 2007;  12:Main et al., 2007;  
13:Eskenazi et al., 2013;  14:Herbstman et al., 2010; 15: Howard and Meylan, 1997; 16: Harner and Mackay, 1995;  17: Li et al., 2003; 18: Harner et al., 
2001 
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While the importance of developmental exposures has been documented, the quantitative role of 
individual environmental chemicals and their molecular mechanisms is not fully understood (Ruiz et al., 
2016). The area of epigenetics provides significant insights into these mechanisms (Hanson and 
Gluckman, 2015). It has been shown that chemicals can alter epigenetic marks and that the same or 
similar epigenetic alterations can be found in patients with the disease of concern or in diseased tissues 
(Hou et al., 2012). To illustrate this, findings linking pesticides (including OCPs) with epigenetic 
alterations are summarized in Table 1.2 (Hou et al., 2012). As this research area is still in a preliminary 
stage, future investigations are needed to determine whether low-level exposed subjects develop 
epigenetic alterations over time and whether such alterations increase the risk of disease (Baccarelli and 
Bollati, 2009; Wadhwa et al., 2009; Hou et al., 2012; Collotta et al., 2013; Stel and Legler, 2015).  
 
Table 1.2 Effects of pesticides (including organochlorine pesticides) on epigenetic changes  
           Epigenetic changes 
In vitro/in 
vivo 
Tissue/species 
Example of diseases 
potentially associated with the 
observed changes in epigenetic 
changes 
DNA methylation 
  P53 hypermethylation In vitro 
Human lung 
adenocarcinoma A549 cells1 
Breast cancer2 and 
hepatoblastoma3 
Alter DNA methylation in the 
germ line 
In vivo Rat tetis4-6 
Potential effects in the 
offspring 
Hypomethylation of c-jun andc-
myc 
In vivo Mouse liver7,8 
Gastric cancer9,10 colon 
cancer9 liver cancer11,12 kidney 
cancer11 and bladder cancer13 
Global hypomethylation (Alu) In vivo Human PBL14,15 
Various cancers16-19 and 
schizophrenia20 
Both hypomethylation and 
hypermethylation of VHL 
In vitro Human kidney cell21 Renal cell carcinoma21 
Histone 
modificatio
n 
↑ Ac of H3 and H4 
In vitro and 
in vivo 
Immortalized rat 
mesencephalic/dopaminergi
c cells (N27 cells)22 
Parkinson’s disease22 
References: 1: Mass and Wang, 1997   2:Radpour et al., 2010   3: Hanafusa et al., 2005   4: Anway et al., 2005    5:Guerrero-Bosagna et al., 2010     6: Anway 
and Skinner, 2006    7: Tao et al., 2000     8: Tao et al., 2000     9: Luo et al., 2010   10: Fang et al., 1996   11:  Pereira et al., 2001   12: Tsujiuchi et al., 1999   
13:Delsenno et al., 1989    14: Rusiecki et al., 2008   15: Kim et al., 2010  16: Smith et al., 2007    17: Roman-Gomez et al., 2006  18:(Deng et al., 2006  
19:Brothman et al., 2005   20: Shimabukuro et al., 2007  21:Zhong and Mass, 2001   22: Brothman et al., 2005  (Source: (Hou et al., 2012), Table 1) 
 
 
In recognition of the potential adverse health effects, the use of the most of POPs has been 
restricted/phased out in many countries after Stockholm Convention in year 2001. However, most POPs 
like PCBs and OCPs persist in the environment and humans without showing evident declining trends 
(Smith, 1999; Porta and Zumeta, 2002; Wilhelm et al., 2003; Toms and Mueller, 2014; Hung et al., 
2016). A steadily increasing trend of PBDEs has been detected in the environment, human serum and 
breast milk samples since the 1980s according to many studies worldwide (Noren and Meironyte, 2000; 
Akutsu et al., 2003; de Wit et al., 2006; Doucet et al., 2009). In addition, some POPs (such as PCBs, 
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HCB) are unintentional produced during industrial processes/biomass burning (WHO, 2002; Porta et al., 
2012; Carpenter, 2013). 
 
Infant/toddlers are readily exposed to POPs in utero via the placenta and during nursing via breast milk 
(McLachlan, 1993; Porpora et al., 2013; Faniband et al., 2014). Because reporting of POPs in breast milk 
differs greatly between the studies worldwide, it is difficult to conduct rigorous evaluations of temporal 
and spatial trends (Fång et al., 2015). Narrowing down the geographic scope, the past use/sources of 
selected POPs (a portion), information on restrictions or changes in use, and the available data of 
concentrations in breast milk in Australia in the last two decades are presented in Table 1.3.  
 
Table 1.3 Past use/sources of POPs (a portion), restricted information and the available data of concentration of selected POPs 
in breast milk in Australia 
Chemical 
(group) 
Past use/sources and restricted 
information 
 
 
Restricted information Concentrations in breast milk (ng/g 
lipid) mean (min-max)  
PCBs 
Industrial chemicals used as heat 
exchange fluids in electric transformers 
and capacitors; additives in paint, 
carbonless copy paper and paint. 
Dioxin-like PCBs are also formed in 
combustion.  
 
Large quantities of PCBs have been removed 
from use and destroyed in accordance with the 
PCB Management Plan which was published in 
1996. The plan requires that the removal from 
service of all equipment containing scheduled 
PCB material at >50 mg/kg should be 
completed no later than 1 January 2009. 
 Hexa-CB:  
60 (22-230) (year 1995)1  
 
 PCB153: 7.2 (year 
2008/09)1  
DDT(DDE) 
 
Used as an insecticide to control a broad 
range of insects in food crops, cotton and 
tobacco, in cattle/ sheep and in domestic 
premises and gardens/  
 
 
 
 
DDT was banned in 1987.  
 
p,p’-DDT:  
11 (8.5-12) (year 1993)3                                      
8.8(3.6-30)(year 2002/03) 3 
 
 
p,p’-DDE: 
310 (280-360) (year 1993)3                             
310(150-870)(year 2002/03) 3 
540 (year 2008/09) 2 
 
HCB 
 
Used as a fungicide. Also a by-product 
from 23 industries manufacturing 
solvents, chlorine containing 
compounds and pesticides. HCB can be 
generated unintentionally by 
combustion facilities. 
 
 
Production at the Orica plant, Sydney ceased in 
1991. De-registered as a pesticide by 1987 and 
use as an industrial chemical was phased out by 
1997. 
HCB:  
30(18-53) (year 1993) 3 
18(6.6-76) (year 2002/03) 3 
 6.1 (year 2008/09) 2 
 
PBDEs 
 
Polyurethane foam products such as 
furniture and upholstery in domestic 
furnishing, and in the automotive and 
aviation industries and plastic products, 
such as housings for computers, 
automobile trimmings, telephone 
handsets and kitchen appliance casings. 
 
 
 
Penta-BDE and octa-BDE are not 
manufactured in Australia. Importation ceased 
in mid-2005 and is forbidden since 2007. 
 
BDE47:  
5.4(4.1-7.0) (year 1993) 3 
5.6(2.8-9.6) (year 2002/03) 3 
 
BDE153:   
1.0(0.9-1.2) (year 1993) 3 
1.1 (0.59-1.6) (year 2002/03) 3 
 
 1: Reference: Quinsey et al., 1995    2: document was submitted to Department of Environment    3: Reference: Harden et al., 2005     
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Avoiding maternal transfer of PCBs and dioxins to the next generation by some means has been 
suggested (Patandin et al., 1999). In some countries regulatory bodies have issued dietary consumption 
advise to control the accumulation of POPs in human bodies, especially for expectant, pregnant and 
nursing mothers (Ontario Ministry of the Environment, 2011). A particular focus has been put on fish 
consumption, since fish is a major route of exposure to bio-accumulating contaminants; the consumption 
of fish has been suggested to be controlled and replaced by other food such as beef 
(European Commission, 2006; Sweden National Food Administration, 2008). However, modelled 
results have shown that this measure unlikely effectively reduces prenatal, postnatal, and childhood 
exposures to compounds that have long elimination half-lives in human bodies such as POPs (Pluim et 
al., 1994; Binnington et al., 2014).  
 
It is of concern that whether more effective preventative measures are needed in recognition of the 
developmental plasticity of health and diseases, as not intervening early will probably represent a missed 
opportunity (Adeyi et al., 2007). The associations found between early-life exposure to POPs via certain 
pathways and adverse health outcomes (Table 1.1) do not necessarily imply causality. An increased 
understanding of the exposure-response relationship can assist in defining the most important chemicals 
and exposure windows. This would be the most efficient way to help inform policy making and therefore 
improve population health. 
 
 
1.2 Challenges in exposure-response analysis of POPs 
For the ultimate goal of revealing exposure-response relationship of POPs, clarifying the relationship 
among the exposure dose, the absorbed dose and the biologically effective dose of POPs is essential 
(Barr et al., 2005). It is surrounded by huge challenges. Firstly, after initial intrauterine exposure, POPs 
can get into infants and toddlers’ bodies through several routes (including inhalation, dermal and oral 
exposure) at different rates due to different behaviors (Geraets et al., 2014). Secondly, the processes of 
Absorption, Distribution, Metabolic biotransformation and Excretion (ADME), also termed 
toxicokinetics, modify the concentration of POPs in body tissues (Clewell and Clewell, 2008; Ashauer 
et al., 2012). Thirdly, it is important to consider variation in an individual’s response to POP exposure, 
so that individual-specific assessment over a long duration of time is preferred in order to capture possible 
exposure windows.  
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In confronting these challenges, various studies have been done regarding this topic and several most-
influential factors have been identified for further exploration. PCBs, OCPs and PBDEs are focused in 
this study because they are commonly detected in the environment and human tissues.  
 
1.2.1 Exposure routes 
Dietary exposure primarily via consumption of animal fats (including dairy products) is the main 
exposure pathways for many traditional POPs such as PCBs and OCPs.   Following their release into the 
environment they typically accumulate either along the atmosphere – plant – animal or from the 
water/sediment along the aquatic food chains (Patandin et al., 1999; Moser and McLachlan, 2002; 
Frederiksen et al., 2009; Bosch de Basea et al., 2011). For infants and toddlers that are breast fed, 
ingestion of breastmilk is a key intake route (Patandin et al., 1999; Toms et al., 2016). In contrast, the 
exposure modes of PBDEs in humans are relatively less well defined and may be congener specific. 
While breast feeding still presents an important exposure pathway for infants (Toms et al., 2008), dust 
seem to be another important source for toddlers regarding PBDEs (Frederiksen et al., 2009). 
 
1.2.2 Absorption 
Oral exposure to POPs results in preferential absorption by the intestinal lymphatic system, i.e. exchange 
of POPs between the lumen content and the wall of the digestive tract. It was postulated that the intake 
of POPs occurs primarily by co-absorption with dietary lipids. The exchange of POPs between the 
digestive tract and the blood stream has been modelled using the two film theory involving diffusion 
through a lipid-like medium and an aqueous medium in series (Moser and McLachlan, 2002). 
 
The absorption of PCBs, HCB and dioxins from breast milk in infants in several studies was measured 
by comparing the estimated total intake and the excretion in faeces (Jodicke et al., 1992; Korner et al., 
1993; McLachlan, 1993; Dahl et al., 1995; Abraham et al., 1996). Consistently, highly absorbed fractions 
were reported, except for hepta-and octachlorinated dioxins. In adults, Moser and McLachlan (2001) 
further reported the “real” absorption (also called maximum dietary absorption) that was calculated by 
subtracting the component of the faecal flux originating from the body. As a result, > 95% maximum 
dietary absorption for most of the PCBs and dioxins were found, decreasing to a minimum of 50-60% 
for the octachlorinated dioxins and furans. Also in that study, log Kow values of 7.5 was found as a 
dividing point, as the maximum dietary absorption stayed high between 0.9 and 1 for chemicals with 
lower log Kow values and decreased with increasing Kow values. This seems to be consistent with the two 
film theory (Moser and McLachlan, 2001).  
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Knowledge of ADME of PBDEs is still restricted largely to experimental rodents (rats and mice) in vitro 
and in vivo (Hakk and Letcher, 2003; Gill et al., 2004). Similar observations as found for PCBs were 
found from these studies that the absorption of individual PBDE congeners varies depending on the 
degree of bromination of the compounds. With the findings regarding PCBs as mentioned above, high 
absorption efficiency (especially with breast milk) in humans can be assumed for other POPs that have 
a structural resemblance and similar range of Kow values, such as PBDEs and p,p’-DDE.  
 
Of note, the bio-accessibilities (the fraction mobilized from the matrix to the gastrointestinal tract) of 
POPs in food are also influenced by food constituents as indicated in several studies where in vitro 
digestion methods were used (Xing et al., 2008; Yu et al., 2011). The bio-accessibility of PBDEs in dust 
is also investigated via in-vitro experiments. Fang and Stapleton (2014) found that the bio-accessible 
fraction was over ~60% for the lower molecular weight PBDEs (such as tri- to penta-BDE congeners) 
and it decreased to ~20% for higher molecular weight compounds (such as BDE209). They also 
witnessed a reverse relationship between absorption and log Kow values for chemicals with log Kow values 
> 5, suggesting that overall the log Kow values was a good predictor of the bio-accessibility of PBDEs. 
However, inconsistent observations regarding this relationship were observed by other studies (Ruby et 
al., 2002; Lepom et al., 2013), hence there seems to be some uncertainty associated with measuring bio-
accessibility.  
 
1.2.3 Distribution 
POPs are readily absorbed into the blood through intestine after ingestion (Kelly et al., 2004). After 
absorption, their concentrations in blood initially decays relatively rapidly, representing the alpha decay 
period (Flesch-Janys et al., 1996). During the alpha decay, the POP is distributed into the fatty portions 
of tissues, mainly adipose tissue, liver, and other tissues (including intestinal lumen content). Factors 
such as physicochemical properties of the chemicals, blood flow rate, and tissue lipid volume which 
influence the distribution of the chemicals into different tissues (Thomaseth and Salvan, 1998).   
 
The distribution process has been described as two types: “flow-limited” and “diffusion-limited (also 
called permeability limited)”. In the former scenario, the distribution of chemicals contained in blood 
across the well-stirred tissue compartment is fast and homogenous and the blood flow to the tissue is 
rate-limiting on itself. In the latter case, the distribution of the chemicals is slower and may be incomplete 
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with the rate-limiting process of the distribution the trans-membrane movement (La Merrill et al., 2013). 
The physical basis of this diffusion limitation is found to be related to Kow, i.e. the diffusion becomes 
rate limiting if Kow is large enough. Levitt (2010) investigated the quantitative relationship between the 
diffusion limitation and the Kow value using data from rats, and found that chemicals become diffusion 
limited at values of log Kow greater than about 5.6. To my knowledge, no related data is available to date 
for humans.   
 
As for those chemicals that have concentrations at equilibrium between tissues and blood, the adipose 
tissue:blood partition coefficient (PCat:b) is the numerical value representing the relative distribution of 
chemicals between tissue and blood. Haddad et al. (2000) concluded that PCat:b can be predicted solely 
from tissue and blood lipid composition data, regardless of n-octanol:water partition coefficient (PCo:w) 
(i.e. Kow) of chemicals. They further suggest that this finding was not only validated for adipose tissue 
but also for other tissues unless macromolecular binding occurs.  
 
Intestinal lumen content (as a tissue) exchanging POPs with blood via a bidirectional diffusion process 
has been indicated. It is found that the amount of a range of POPs (including PCB and PCDD/F 
congeners) in faeces (the lumen content at the exit of the digestive tract) exceeds dietary intake when 
tissue levels are high. This contradicted suggestions that POPs in faeces are mainly from the POPs in 
undigested food. Further, it has been observed that the ingestion of non-absorbable dietary fat substitutes 
increases the faecal excretion of PCBs and PCDD/Fs in humans and the degree of this increase varies 
with the physical-chemical properties of the chemical (which can exceed a factor of 10). It is not easily 
reconcilable with the argument that the digestive tract elimination is due to the biliary excretion (Moser 
and McLachlan, 2002). Moreover, the authors found that 1-octanol is not an ideal model for the sorption 
properties of the faeces via comparing faeces/gas equilibrium partition coefficient and the octanol/air 
partition coefficient of PCBs and HCB. 1-octanol was found behaving as a more polar partitioning 
medium than faeces (Moser and McLachlan, 2002).  
 
1.2.4 Metabolic biotransformation, Excretion 
Metabolic bio-transformation and excretion are two clearance or elimination pathways of POPs. 
Hydroxyl and methyl sulfone metabolites (MeSO2-CBs) of PCBs have been identified in humans 
(Letcher et al., 2000). Methyl sulfone derivatives (MeSO2-DDE) are known to represent primary 
metabolic products of DDE in human tissues (Weistrand and Norén, 1997). Various hydroxylated BDE 
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(OH-PBDE) congeners (such as 4’-OH-BDE 49 and 6-OH-BDE 47) were detected in human blood 
samples (Athanasiadou et al., 2008; Qiu et al., 2009; Stapleton et al., 2009; Stapleton et al., 2011). Certain 
P450 enzymes, especially those of the CYP2B family are known to be involved with the formation of 
these metabolites (Letcher et al., 2000; Marchesini et al., 2008; Feo et al., 2013).   
 
It is believed that metabolism takes place primarily in the liver (Barr et al., 2005). Although CYPs can 
be found in virtually all organs including the liver, intestine, skin and lung, it is the liver that is the 
predominant site of P450-mediated elimination (Dong et al., 2010). One Swedish study found that the 
ratios of the sum of MeSO2-CBs to the sum of chlorinated biphenyls were 1:250 and 1:28 in adipose 
tissue and the liver, respectively; the ratios of the sum of MeSO2-DDEs to p,p’-DDE were 1:455 and 
1:61 in adipose tissue and liver, respectively (all calculated from the median values) (Weistrand and 
Norén, 1997). Adipose tissue constitutes a continual source of internal exposure to POPs, and the 
accumulated POPs are slowly released into the bloodstream and further into tissues where metabolism 
may take place (ie. liver).  Accordingly chemicals may also partition from the bloodstream back through 
the intestinal wall into the digestive tract into the faeces and are then excreted (La Merrill et al., 2013). 
The toxicockinetics of environmental chemicals in humans may be influence by gut microbiota, though 
the specific factors are not well understood (Snedeker and Hay, 2012).  
 
However, their long half-lives (Table 1.1) indicate that most POPs are poorly metabolized. The amount 
of POPs distributed into intestinal lumen content (i.e. faeces) may account for a considerable portion of 
total elimination of unchanged chemicals. Since the high lipophilic POPs would be expected to be 
associated with lipid including excretion, they are expected to be excreted via the most important 
pathway for physical loss of body lipid which actually excretion with the faeces. Daily lipid loss via 
faeces amounts to 5-7 g, whereas the excretion with skin lipid is only 0.5-1 g (Rohde et al., 1999). Ogura 
(2004) calculated half-lives due to faecal excretion from several studies, and found that although the half-
lives due to faecal excretion are generally longer than the overall half-lives, faecal excretion seems to be 
responsible for a large part of the overall elimination of most of the congeners of PCDD/Fs and PCBs.  
 
1.2.5 Toxicokinetic models 
Information regarding the toxicokinetics of POPs can then be integrated into mathematical equations and 
put into a broader context to simulate the chemical kinetics in the entire lifetime of humans. Toxicokinetic 
modelling is a hypothesis-testing tool in toxicology and it ranges from statistical regression models to 
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physiologically based toxicokinetic (PBPK) modellings (Thomaseth and Salvan, 1998; Council, 2006). 
Statistical regression models focus on one-compartment first-order kinetics for POPs aiming at providing 
a black-box description of the variables that influence POPs kinetics (Pirkle et al., 1989). PBTK models 
include the physiology and antomy of the animal or human body as well as the biochemistry of the 
chemical/chemicals of interest incorporated into the conceptual model for computer simulation (Belfiore, 
2005) (Figure 1.2).  
 
Figure 1.2. Simplified flow chart illustrating processes involved in PBTK models. Source: (Andersen, 1987) 
 
PBTK models can provide important predictions of relevance to risk assessment that are difficult to 
measure such as the biochemical and biophysical process related to POPs  (Andersen et al., 1993; Kohn 
et al., 1993; Chiu et al., 2007). However, few studies of PBTK models in humans have been established 
for POPs, especially for infants and toddlers: only two related studies have been reported to date to my 
knowledge (Verner et al., 2009b; Verner et al., 2010).  One reason for this is that data regarding the 
toxicokinetics of POPs in humans are typically limited to information derived from cases of accidental 
ingestion of food contaminated with POPs, occupational exposure and animal experiment. In addition to 
this, there is always an amount of uncertainty and variability involved in modelling due to differences 
between individuals and/or potential inconsistencies in generalized assumptions.  
 
For instance, the “apparent” elimination half-life of one chemical that is calculated from concentration 
declines in longitudinal data for particular individuals are more easily obtained than the “intrinsic” half-
life. The former is actually not suitable for a toxicokinetic model because it describes the observed 
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decline in concentration under specific conditions of ongoing exposure and changes in body size and 
composition (Ritter et al., 2011). Gathering more biomonitoring data and the validation of model outputs 
are both therefore vital for the development of the PBTK models in humans.  
 
Human biomonitoring is based on sampling and analysis of the individual’s tissues and fluids. This 
technique takes advantage of the knowledge that environmental agents that have entered the human body 
leave markers reflecting this exposure. The marker may be the agent itself or a breakdown product, and 
it may also be some change in the body resulting from the interaction of the agent or its breakdown 
product(s) with the individual. The target organ is often not known and, even if known, is frequently not 
available for sampling. Thus, POPs in accessible matrices are measured to gauge the doses in relevant 
tissues based on empirical data. In conjunction with available biomonitoring data, the toxicokinetic 
models have been used to simulate the concentration-time profiles of POPs in individual tissue/organ, so 
as to assist in risk assessment (Andersen, 1995; Chiu et al., 2007). 
 
 
1.3 Assessing concentrations of POPs in the blood (Cb) of infants/toddlers is an issue 
POPs concentrations in human blood/serum/plasma (Cb) is always the variable that is chosen for 
validating PBTK models, since blood is the matrix that is responsible for circulation in almost all the 
PBTK models. Therefore concentrations of POPs in human blood/serum/plasma (Cb) has always been 
an important variable to be simulated in PBTK models.  
 
Cb, itself, also serve as an important indicator of human body burden of POPs (Price et al., 1972; Iida et 
al., 1992; Rohde et al., 1999; Wolff and Anderson, 1999; Park et al., 2007; Stapleton et al., 2009). As 
outlined above, it is typically assumed that POPs are in passive pharmacokinetics equilibrium between 
different lipid compartments such as those of blood and adipose reservoir of the individuals. The 
concentrations of POPs in the fatty portions of tissues is subsequently in equilibrium with the 
concentrations in the lipid portion of blood. Hence, Cb is one essential variable for the exposure-response 
analyses of POPs.  
 
While concentrations of POPs in blood samples of adults are relatively well-documented, concentrations 
in infants/toddlers and children have only occasionally been determined and are seldom reported due to 
the related logistical and ethical constraints (Needham et al., 2005). Background concentrations of some 
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specific POPs of interest reported in the human population range from ng/g lipid to pg/g lipid 
concentrations. Even with the most sensitive available analytical techniques such as a high resolution 
mass spectrometry (HRMS), ~0.1 g of blood lipid (6 – 10 mL of whole blood) is required to cover most 
of the key analytes among the PCBs, PBDEs and OCPs with substantial higher volumes being needed 
when measuring PCDD/Fs in blood from background populations. Consequently, assessing body 
burdens of infants and/or small children, where maximum blood volumes that can be collected are 
typically much less than 5 to 10 ml, is ethically, logistically and analytically difficult and typically only 
done for chemicals or individuals potentially with higher body burden.  
 
With respect to infants/toddlers, the levels of the chemicals in other biological samples are then measured 
to gauge the blood doses and body burden of POPs. Epidemiologic studies to date, to investigate 
relationships between early-life exposure to POPs and various outcomes pertaining to health and 
development,  have mainly relied on diverse biological samples drawn prenatally (maternal blood), at 
birth (cord blood), or postnatally (breast milk) (for references, see Table 1.1). Some other approaches 
were proposed, such as multiplying breast milk concentration by the duration of breastfeeding (Jacobson 
and Jacobson, 1996; Koopman-Esseboom et al., 1996; Grandjean et al., 2003).  
 
Simplified PBPK models have recently been developed to simulate blood POP levels for the early-life 
stage (Verner et al., 2013a; Gyalpo et al., 2015; Jusko et al., 2016). The first one is the toxicokinetic 
model that was developed by Verner et al (2013) to simulate blood POP levels in children from two 
longitudinal birth cohorts was validated against blood levels measured at 6, 16 and 45 months of age. 
Simulated levels explained between 10% and 83% of measured blood levels, depending on the cohort, 
the compound, the sample used to simulate children’ blood levels. The Verner model is an important step 
forward in increasing the capacity to adequately estimate Cb during windows of susceptibility. However, 
the causes for divergence in the accuracy of toxicokinetic model remain unresolved. 
 
Other promising alternatives for estimating Cb are worth exploration which has instigated the present 
study. Alternative matrices obtained from infants/toddlers, are always more available than blood and 
could provide potentially useful information either provide some insight to toxicokinetic models or 
allowing for comparison of data among matrices.  
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1.4 Potential biomarker for concentrations of POPs in blood (Cb) in infants/toddlers 
In the present study, a major goal was to find alternative, but still minimally to non-invasive, ways to 
estimate Cb for infants and toddlers. For monitoring human exposure to POPs, hair and 
fingernails/toenails are the two matrices that have been increasingly investigated in addition to blood and 
breast milk. Compared to other matrices, hair and nails can be easily, cheaply and entirely non-invasively 
collected as well as easily transported and stored for analysis. As moderate correlations between PBDEs 
and PCBs in hair and nails and PBDEs and PCBs in serum were observed, hair and nails were suggested 
as biomarkers to assess human exposure in recent studies (Liu et al., 2016; Zheng et al., 2016). However, 
levels in blood were found to be only a small proportion of levels of POPs in hair (Zheng et al., 2016), 
and levels in nails were suggested to be reflective of an integrated exposure to both internal and external 
sources (Liu et al., 2016).  
 
Faeces is another matrix that is easily accessible for infants/toddlers. A range of POPs has been found in 
faeces in previous studies dating back to the 1990s from Yusho patients (Iida et al., 1992). Following 
that, faecal POPs have been mainly measured in breast-fed infants where selected POPs were analysed 
in their faeces for calculating chemical absorption percentages against the ingested amount of POPs via 
breast milk (Jödicke et al., 1992; Korner et al., 1993; McLachlan, 1993; Abraham et al., 1996b). In these 
studies, over 90% of the ingested chemicals (log Kow < 7.5) associated with breast milk was found to be 
absorbed by infants. However, faeces has not been considered as a biomarker of POPs and has not 
received wide attention for biomonitoring due to the conception that POPs in faeces are mainly from the 
POPs in undigested food. As mentioned above, chemicals end up in faeces along with undigested food 
as well as body reservoir, and the main source of POPs in faeces is the body reservoir rather than 
undigested food. Thus, examining the correlation between the body burden and the excretion may be 
another approach to quantify the body burden. 
 
 
1.5 Uncertainty of using faeces as a biomarker of POPs in blood (Cb) in infants/toddlers 
Focusing on dioxins, the key findings from studies that carried out faeces analysis in adults include (1) 
the maximum net absorption of a chemical remained constant at about 95-100% until a log Kow of about 
7.5 and then began to decrease; (2) the faeces flux is independent of the dietary intake and proportional 
to the body tissue concentration; (3) the faecal excretion are affected when the sorption properties of the 
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faeces are modified. Based on all these findings, Moser and McLachlan (2002) formulated a model of 
the absorption and desorption of POPs in the human gastrointestinal tract.  
 
The model concept is that, gastrointestinal exchange can be viewed as two processes operating 
simultaneously: absorption of contaminant form the diet, and excretion of contaminant from the body’s 
reservoirs via the faeces. Additionally, it is assumed that the human body (excluding the lumen of the 
digestive tract) as a single well-mixed compartment and that exchange with the digestive tract is the only 
significant fate process. A “fat-flush” theory implicated in the correlation observed between body burden 
and faecal concentrations of most POPs was postulated. This model is adapted here in my thesis as the 
theory prerequisite for correlating the Cb with concentrations of POP in faeces (Cf). The following 
explanation is mainly based on Moser and McLachlan’s paper on this model (Moser and McLachlan, 
2002).  
 
It is suggested that gastrointestinal exchange of POPs can be viewed as two processes that are operating 
simultaneously: absorption of the contaminants from the diet, and excretion of the contaminants from 
the body’s reservoirs via the faeces (Schlummer et al., 1998; Moser and McLachlan, 1999; Rohde et al., 
1999). As summarized in Figure 1.3, it is hypothesized that it is not correct to consider the concentration 
in the gut tissue to be constant. Rather, during dietary lipid absorption, the lipid absorbed into the gut 
tissue increases the lipid content of the tissue, diluting the POPs reservoir and resulting in a temporary 
reduction of the lipid-based concentrations of the POPs in the gut wall (shown as the process form a to c 
in Figure 1.3). The lipid content eventually returns to its original state when the absorbed lipids have 
been transported into the lymph and blood, reversing the gradient from the gut contents to the gut wall 
(shown as the process form c to d in Figure 1.3).  
 
The intestine-digesta partition coefficient (KIG) at the point of equilibrium of chemical absorption and 
desorption in the upper gastrointestinal tract is a critical dynamic parameter of the “fat-flush” theory. It 
would largely be dependent on the respective volumes and sorption capacities of those compartments 
(i.e. intestinal wall and gut content). Currently, the relative partitioning capacities and contaminant 
kinetics at the intestinal tissue-digesta interface are not fully understood (Kelly et al., 2004). 
Nevertheless, the quotient of the faeces and blood concentration KFB (units [g blood-fat]/[g dry-faeces]) 
for a large range of POPs in volunteers with background contamination and for contaminated workers 
were found in remarkable agreement and are presented in Table 1.4. 
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Figure 1.3: Schematic illustration of the gastrointestinal exchange of POPs in human body (LBCQ means lipid-based 
concentration quotient. When the value above 1 indicate a positive diffusion gradient resulting in absorption). Stage a: POPs 
together with lipid food just arrived in small intestine; stage b and c: the process of lipid/POPs absorption firstly into gut tissue 
and secondly into body reservoir; stage d: the process of faeces generation and POPs desorption from body reservoir into 
faeces (Modified from Figure 4 (Schlummer et al., 1998)) 
 
The KFB is not necessarily an equilibrium partition coefficient and will be influenced by the last stages 
of the digestion process that determine the chemical/physical properties of faeces. There could be several 
possible factors influencing KFB, such as age, intestinal transit time, composition of the diet, and 
absorption rate of intestinal fat and water. Of note, in Table 1.4, there is some indication of higher KFB
 
values for compounds with very high Kow, such as 1,2,3,7,8,9-Cl6DD, 1,2,3,4,6,7,8-Cl7DD, Cl8DD, and 
1,2,3,4,6,7,8-Cl7DF. One possible reason is an enhanced sorption capacity of the gut contents for very 
lipophilic compounds (Moser and McLachlan, 2001). Also, many chemicals that are also POPs, other 
than PCDD/Fs and PCBs, had not been studied for the feasibility of using faecal analysis. The chemicals 
include pesticides (aldrin, chlordane, dieldrin, endrin, mirex, toxaphene, DDT, a-HCH, ß-HCH, 
endosulfansheptachlor, chlordecone, lindane, and PeCB), those used as flame retardant (HexaBDE, 
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tetraBDE and HBCD) and PFOS used as fabric protector. While all these chemicals are inclined to 
accumulate in human tissues, the chemical-specific factors in toxicokinetics (particularly absorption, 
distribution and excretion in the body) are not clear yet.  
 
Table 1.4 Quotient of the faeces and blood concentration KFB (units (g blood fat)/(g dry faeces)) for volunteers with 
background contamination (this study) and for contaminated workers (source:  (Moser and McLachlan, 2001))  
 
 
  
Many factors could then influence the KFB values between adults and infants, including a different 
composition of diet, an immature digestive tract (Abraham et al., 2012) and different microbial flora in 
the digestive tract of infants (Ellis Pegler et al., 1975; Stephen and Cummings, 1980). In addition, the 
development of the infant as well as the ongoing changes in diet and activity patterns could lead to larger 
variations in the KFB values. 
 
 
Objectives of thesis 
The importance and the challenges in early-childhood biomonitoring of POPs warrant efforts to develop 
any potential tools for exposure characterization and verify the practical scope and convenience of those 
tools. While KFB
 is a parameter of considerable practicality for predicting body burden of  a range of 
POPs in adults, the reliability of utilizing KFB
 in infants and toddlers needs investigation. The aim of this 
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thesis was therefore to examine the effectiveness of the approach that uses faeces as a non-invasive 
matrix for assessing the body burden of POPs in infants and toddlers. The objectives set forth in this 
study were to: 
 
 Develop a novel analytical method for analysis of POPs in faeces that is more cost-effective 
compared to traditional methods (Chapter 2 and 4); 
 Quantify exposure of Australian infants to POPs via analysis of POPs in breast milk samples 
(Chapter 3); 
 Investigate the potential association of POP concentrations in matched breast milk and faecal 
samples, so as to investigate the possibility of using faecal concentrations as an indicator of body 
burden (Chapter 3);  
 Investigate both the intra- and inter-individual variability of KFB values of selected POPs for 
infants/toddlers in order to assess the practical scope and convenience of utilizing faeces as a 
matrix for POP biomonitoring (Chapter 4 and 5).  
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Chapter 2: A preliminary study on assessing body burden of persistent 
organic pollutants (POPs) in infants/toddlers through analysis of faeces 
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Abstract 
Exposure that cause chronic diseases usually take place years, perhaps decades, before disease is 
diagnosed. Increasing studies indicates the links between early-life exposure to POPs and chronic disease 
risks. However, the exact exposure-response relationship are not clear and of substantial challenges. One 
challenge is accurate measurement of day-to-day body burden of POP in early childhood individually. 
Direct measurements of body burdens in early childhood is stymied by ethical and practical 
considerations regarding invasive-biomonitoring (such as blood sampling). POP concentrations in 
maternal tissues (cord blood and breast milk) were usually used directly as indications of the body burden 
of the infants/toddlers; increased confidence of body-burden prediction was achieved when 
physiologically based pharmacokinetic (PBPK) models were involved. Accuracy of any PBPK model is, 
however, dependent on the accuracy of its parameter information (mainly including toxicokinetic 
information and exposure information). The utility of PBPK model is also subject to the availability of 
major exposure sources and the toxicokinetic information of participants. The paucity of existing data 
on exposure of POPs in early childhood and validation of the method for measuring POPs in faeces were 
addressed in preliminary studies. 
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Introduction  
Most persistent organic pollutants (POPs) like polychlorinated biphenyls (PCBs), a range of 
polybrominated diphenyl ethers (PBDEs) and organochlorine pesticides (OCPs) are readily absorbed 
(via the ingestion and inhalation) and accumulate in fatty tissue, including adipose tissue and human milk 
(Connell et al., 2007). Health effects related to exposure to these chemicals may include neurological 
effects, altered functioning of the nervous system and/or endocrine disruption (Siyali, 1972; Stacey and 
Thomas, 1975; Matthew and Walter, 1997). The chronic disease (that manifest later in life and may be 
attributed to early life exposure to POPs) has become the leading cause of death and disability in adults 
(IHME, 2013; Vos et al., 2015). There is increased concern regarding the environmental impact on the 
health of children who have been disproportionately affected by environmental problems. For example 
they may be subjected to relatively higher exposure, have greater physiological susceptibility and/or 
suffer more extreme consequences due to growth (Dales et al., 2004; WHO, 2008; Gavidia et al., 2009; 
Clark et al., 2010). It is therefore worthwhile to assess the correlation between burden of disease and 
exposure to xenobiotic chemical pollutants like POPs. Such assessment may provide guidance for 
legislative changes regarding chemical bans and give reliable advice to parents including lactating 
mothers. 
The conventional technique of measuring body burden for POPs is via collection and analysis of serum. 
However with children, collection of sufficient serum for analysis of trace organic pollutants remains 
typically ‘too difficult’ with respect to ethics, consent/participation and feasibility (i.e. requirement for 
multiple sampling to get sufficient volume) (Toms et al., 2008). This problem with sample volume has 
been overcome in some studies by pooling samples from groups of individuals, however, this approach 
is not suitable for longitudinal assessments of body burden during infancy and early childhood when 
exposure is least understood.  
For a range of persistent lipophilic organic pollutants, it has been shown that desorption from the body 
into the lumen of the digestive tract followed by fecal excretion is one of the major mechanisms for 
physical elimination (Kissel and Robarge, 1988; Rohde et al., 1999). Early evidence came from studies 
on breast fed children which showed that faecal excretion of polychlorinated dibenzodioxins and furans 
(PCDD/Fs) did not change/decrease over the weaning period despite the fact that exposure/uptake via 
breast milk was estimated to be much higher than in the substituted diet (Abraham et al., 1996). Moser 
and McLachlan further suggested that the fecal levels of a range of POPs are determined by their 
concentration in the body, not in the diet (Moser and McLachlan, 2001). A feces/blood distribution 
coefficient KFB was defined as the quotient of the dry weight-based concentration in feces and the lipid-
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based concentration in blood demonstrating that the dry weight-based faeces concentration can be 
linearly related to the lipid-based blood concentration over a very wide range. Therefore, with the use of 
KFB, fecal POPs have the potential to make a reliable biomarker for the body burden of POPs. McLachlan 
and team undertook a range of systematic studies expanding the concept with the aim to increase 
clearance of POPs using non-digestible fat, however the focus of their work was primarily on 
parameterizing a model for the uptake and clearance of POPs in humans and not on applying the approach 
to estimating body burden. 
With the present study we aim to quantify POPs in faeces of infants/toddlers. Furthermore, in this 
preliminary study we aim to compare the measured concentrations of POPs in the faeces to recent 
Australian data from pooled children (0-4 years in age) blood serum (Toms et al., 2012).  
 
Materials and methods  
Sample Collection and Storage 
For this study, we recruited 5 infants and 2 toddlers from families of at least two years’ residence in 
Brisbane, Australia, who originate from several countries (Table 2.1).  
 
Table 2.1 Demographics of infants/toddlers including national background of parents, year of birth, age of mother and child 
at sample collection and feeding status 
Subject Gender 
Parents’ 
nationality/Residence years 
in Australia 
The 
year 
of 
birth 
Mother’s 
age at the 
year of 
birth 
Primipara 
or other 
Age at the time 
of sampling 
Feeding component at 
the time of sampling 
Infant 1 Male Canada/2 years 2012 34 Primipara 
6 month-11 
months 
Breast milk/formula 
milk/solid food 
Infant 2 Male New Zealand/3 years 2012 33 Primipara 5-6 months Breast milk/solid food 
Infant3* Female Malaysia & Chinese/4 years 2012 36 Second 5-6 months 
Breast milk/formula 
milk 
Infant 4 Female Australia 2012 32 Primipara 7 months 
Breast milk/formula 
milk/solid food 
Infant 5 Female Australia 2012 40 Primipara 7months 
Breast milk/formula 
milk/solid food 
Toddler 1 Female Australia 2010 33 Primipara 2 years Solid food 
Toddler2* Male Malaysia & Chinese/4 years 2010 34 Primipara 2 years  and half 
Formula milk/solid 
food 
*Toddler 2 and Infant 3 are from a vegetarian family. 
 
 
Parents collected faecal samples twice a week for one month for each individual child. Sample collections 
were done by directly taking a portion of the faeces that was not in contact with the nappy (or from a 
liner applied on top of the nappy which can help retain a dry portion of the faeces). Nappy and liner 
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materials were also analyzed as QA/QC samples with very low concentration of POPS observed. 
Samples were freeze-dried and stored at -80 oC in clean amber jars covered by PTFE-lined screw lid until 
extraction. 
 
 Sample extraction and clean-up 
3 gram aliquots of the dried faeces samples as well as a blank consisting of bovine calf serum were placed 
in a diodonium cell with 3 grams of hydromatirx. The samples were then spiked with internal standards 
and extracted using n-hexane in an Accelerated Solvent Extractor (ASE), at 100 oC, 1500 psi using 3 
static cycles of 7 minutes. The extracts were cleaned up on a multilayered column (30 cm ×1 cm i.d.), 
having Na2SO4, KOH silica, neutral silica, 44% acid silica, 22% acid silica, neutral silica and Na2SO4 
from bottom to top. PCBs, OCPs and PBDEs were eluted with 80 ml of Hexane. The hexane extractable 
‘lipid content’ of the samples was determined in a separate extraction in the ASE using the above 
conditions where the hexane was evaporated to dryness and the ‘lipid content’ was determined 
gravimetrically. 
  
Sample analysis 
All samples were analyzed for indicator PCBs, OCPs and PBDEs using a GCMS-QP2010 Plus operated 
in negative chemical ionization (NCI) mode. An Rxi®-XLB columns (fused silica) 0.28mm (i.d.)×25m 
fused silica capillary column was used.  The injection port and transfer line temperatures were maintained 
at 270 oC and 280 oC, respectively, and the oven temperature program was 80 oC for 3 min, then 20 oC 
min-1 to 320 oC and finally 320 oC for 6 min; total run-time 25 min. The mass spectrometer operating 
conditions were as follows: ion source 280 oC; ionization energy 38 eV; electron multiplier voltage set 
to 300 V. Selective Ion Monitoring (SIM) experiments were performed for each homolog. 
 
Results and Discussion 
7 PCBs, 10 PBDEs as well as a series of OCPs could be detected in the two faeces samples analyzed to 
date (Table 2.2). The mean CV for analyzing replicates of a pool of multiple samples collected from the 
infant was 34 % for the 24 compounds detected, where 15 of the 24 compounds had a CV < 28 % (ie. 
replicates deviate by less than a factor 1.5).  Consistently good reproducibility was found for the PCBs 
whereas reproducibility was lowest for a range of the BDEs as well as chlordanes and HCH. 
Overall the concentrations of POPs in the faeces from these one infant and one toddler were relatively 
similar and dominated by few PCBs (ie PCB 153, 138 and 118), BDE 47, 99, 100 and DDE which were 
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found in the range of 1 to 5 pg/g lipid. This profile in faeces is similar of that observed in blood of 
children from Australia. In detail, on a lipid weight basis, concentration in the faeces of the main PCBs 
and BDEs in the infant range from about one third (BDE 47) to nearly equal (BDE 99) when compared 
to pooled blood collected in 2009 from 0 – 4 year old children. In contrast concentrations of OCPs were 
found at much lower levels than in the pooled blood (i.e. 1 – 10% for DDTs and HCB respectively).    
The data also suggest that the levels of selected POPs were slightly higher in the faeces of the toddler 
compared with those from the infant. This is in agreement with other data comparing levels of PBDEs 
in pooled blood from surplus blood specimens using infants and small children (Toms et al. 2009). A 
common explanation for this is that one major exposure pathway for PBDEs in children is the ingestion 
of house dust and higher accumulation of PBDEs in serum may reflect higher mobility and associated 
exposure (Frederiksen et al., 2009). However, this explanation may not be applicable for other studied 
chemicals. It indicates that the partitioning behaviors of POPs from body reservoir into faeces may be 
source specific and/or age specific.  
Overall our study showed that POPs can be identified using faecal samples collected from small children.  
The future goal is to assess whether we can use the concentration of POPs in faeces for estimating the 
concentration in blood lipid and therefore the body burden of POPs in the children.  More work is 
underway to calibrate the underlying model where ideally we plan to obtain matched faeces and blood 
samples from same children. 
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Table 2.2 Concentration of indicator PCBs, PBDEs and OCPs in faeces from one infant (duplicate) and one toddler. And the 
ratios of them to the concentration in a pooled blood sample analyzed at 2008/9 
Compound 
 
Concentration in 
Infant faeces * 
(ng/g lipid) 
CFi1 +SD  (CV) 
Concentration in 
Toddler faeces 
(ng/g lipid) 
CFi2 
Concentration in 
Pooled Infants 
Blood# 
(ng/g lipid) CBP 
Infant faeces* to 
Pooled Blood#   
ratio CFi1/CBP 
Toddler faeces to 
Pooled Blood# 
ratio  CFi2/CBp 
PCB 
28 0.30 ± 0.06 (20) 0.59 1.2 0.25 0.49 
52 0.17 ± 0.01 (5.9) 0.35 n.d.(0.5) - - 
101 0.25 ± 0.02 (8.0) 0.30 n.d.(0.5) - - 
118 0.78 ± 0.06 (7.7) 1.8 1.4 0.55 1.3 
153 1.7 ± 0.10 (5.9) 1.7 3.4 0.51 0.49 
138 1.3 ± 0.23 (18) 2.2 2 0.65 1.1 
180 0.83 ± 0.01 (1.2) 0.60 2.3 0.36 0.26 
PBDE 
28 0.94 ± 0.93 (99) 0.19 0.5 1.9 0.38 
47 4.4 ± 0.31 (7.0) 5.0 13 0.33 0.38 
49 0.15 ± 0.01 (6.7) 0.15 n.d.(0.5) - - 
66 0.04 ± 0.01 (25) 0.04 n.d.(0.5) - - 
85 0.44 ± 0.40 (91) 0.62 0.50 0.88 1.2 
99 2.3 ± 1.3 (57) 3.9 4.8 0.90 0.81 
100 1.9 ± 0.35 (18) 3.4 3.4 0.54 1.00 
153 0.45 ± 0.23 (51) 1.0 3.2 0.14 0.31 
154 0.11 ± 0.08 (73) 0.32 0.50 0.21 0.64 
183 0.32 ± 0.39 (122) 0.04 0.50 0.63 0.08 
DDT 0.70 ± 0.11 (16) 0.89 12 0.06 0.07 
DDE 2.2 ± 0.24 (11) 3.1 280 0.01 0.01 
HCB 0.52 ± 0.10 (19) 0.58 5.4 0.10 0.11 
(ϒ-HCH) 
Lindan 
0.40 ± 0.17 (43) 0.20 
n.d. (2.4) - - 
Heptachlor 0.70 ± 0.02 (2.9) 0.79 n.a. - - 
t-chlordane 0.19 ± 0.08 (42) 0.37 n.a. - - 
c-chlordane 0.24 ± 0.17 (71) 0.19 n.a. - - 
 *: Based on 2 replicate of a split sample 
#:  Concentration of p (ng/g lipid) for age group of 0-4 years in Australia for 2008/09 (Source:  Chemical Monitoring Initiative: Australian human blood 
sample collection and chemical testing—Final Report 
n.d. : not detected followed by the value in brackets which is the limit of detection;        n.a.: not analysed 
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Abstract 
Assessing blood concentration of persistent organic pollutants (POPs) in infants is difficult due to the 
ethical and practical difficulties in obtaining sufficient quantities of blood. To determine whether 
measuring POPs in faeces might reflect blood concentration during infancy, we measured the 
concentrations of a range of POPs (i.e. polychlorinated biphenyls (PCBs), polybrominated diphenyl 
ethers (PBDEs) and organochlorine pesticides (OCPs)) in a pilot study using matched breast milk and 
infant faecal samples obtained from ten mother-child pairs. All infants were breast fed, with 8 of them 
also receiving solid food at the time of faecal sampling. In this small dataset faecal concentrations (range 
0.01 - 41ng/g lipid) are strongly associated with milk concentrations (range 0.02 - 230 ng/g lipid). 
Associations with other factors generally could not be detected in this dataset, with the exception of a 
small effect of age or growth. Different sources (external or internal) of exposure appeared to directly 
influence faecal concentrations of different chemicals based on different inter-individual variability in 
the faeces-to-milk concentration ratio Rfm. Overall, the matrix of faeces as an external measure of internal 
exposure in infants looks promising for some chemicals and is worth assessing further in larger datasets.  
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Introduction  
The link between exposure to some persistent organic pollutants (POPs) and endocrine disrupting/ 
carcinogenic effects seems to be clear from laboratory studies on a range of biota (Tanabe, 2002; Li et 
al., 2006; Alonso-Magdalena et al., 2011; Bergman et al., 2013), and there is increasing evidence that 
exposure in early life is an important determinant of long-term disease risk (Nagayama et al., 2007b; 
Ochiai et al., 2014). However, more large-scale epidemiological studies are needed for understanding 
the exposure window that can elicit effects and the extent of the contribution of lipophilic pollutants to 
the increased risk of incommunicable diseases in humans (Nickerson, 2006a; Jorissen, 2007). Infancy is 
a critical stage of development and is associated with unique exposure pathways that can increase 
exposure to lipophilic pollutants (Solomon and Weiss, 2002). Nevertheless, exposure assessment in early 
life is challenging and complicated by reluctance of parents and investigators to take blood samples from 
infants. In addition, the small volume sample that may be obtained poses technical challenges for 
measuring analytes.  
To avoid sampling blood, physiologically based pharmacokinetic (PBPK) models have been used to 
generate individualized toxicokinetic profiles of lipophilic pollutants in infants. Such models usually 
contain many variables, such as: the initial value (e.g., the concentration in meconium or umbilical cord 
blood), ongoing exposure values (e.g., concentrations in mother’s breast milk), intrinsic elimination 
values (estimated from assembled data from longitudinal monitoring data or estimated via measuring 
excretion rate) and infants’ growth rate (Lorber and Phillips, 2002; Verner et al., 2013b). Each of these 
variables is uncertain, and consequently the modelled exposure of the infant can also be associated with 
considerable uncertainty. In this context, finding a non-invasive matrix that has a direct relationship with 
the blood concentration and can be measured repeatedly throughout infancy would improve exposure 
assessment of lipophilic pollutants in infants. 
 
Evidence in adults suggests that the faecal concentration of some lipophilic pollutants (polychlorinated 
dibenzo-p-dioxins and dibenzofurans (PCDD/Fs), polychlorinated biphenyls (PCBs) and 
hexachlorobenzene (HCB)) is directly related to the blood concentration. Schrey et al. (1998) reported 
that faecal excretion of most PCDD/Fs examined exceeded the daily intakes from food (Schrey et al., 
1998). Moser and McLachlan also found that altering dietary exposure did not influence faecal excretion 
of PCDD/Fs, HCB, and PCBs (Moser and McLachlan, 2001), which means faecal concentration was not 
affected by the concentration of POPs in diet. Further, Rohde et al. found a correlation between levels in 
blood and levels in faeces for PCDD/Fs over a very broad concentration range (Rohde et al., 1999). To-
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Figueras and his team pointed out a strong correlation between HCB levels in faeces and in serum (To-
Figueras et al., 2000a).  
 
In two breast fed children, faecal excretion of PCDD/Fs was found not to decrease during the weaning 
period to the same extent as the estimated decrease in exposure/uptake resulting from substituting breast 
milk with a solid diet (Abraham et al., 1996a), implying that the faecal concentration in these two infants 
was at least partially determined by the blood concentration.  
 
Maternal breast milk is considered the most accessible matrix that provides reliable information related 
to the intake of lipophilic pollutants in the corresponding infant (Verner et al., 2013b) for those chemicals 
for which uptake via food is the primary exposure pathway for the infant (although dust is acknowledged 
as another important source for some POPs) (Toms et al., 2009b; Lee et al., 2014). In addition, after a 
decline during the first month of lactation, concentrations of lipophilic pollutants in breast milk have 
been found to remain steady throughout the breastfeeding period, and to be close to the initial infant 
blood concentrations (Abraham et al., 1994; Lee et al., 2013; Verner et al., 2013b; Vigh et al., 2013).  
 
The key aims of this study were: to assess the concentration of a range of POPs (PCBs, polybrominated 
diphenyl ethers (PBDEs) and organochlorine pesticides (OCPs)) in matched infant faeces and breast milk 
samples with reproducible results; to evaluate whether concentrations in the two media are correlated; 
and to evaluate whether faecal concentrations can potentially be used as biomarkers of the blood 
concentration of POPs in infants.  
 
Materials and methods  
Chemicals 
Standard solutions of native PCBs, PBDEs and OCPs were purchased from AccuStandard Inc.. Isotopic 
carbon-labelled PCB standard solutions and PBDE standard solutions were purchased from Wellington 
Laboratories Inc., and isotopic carbon-labelled OCP standards were ordered from Cambridge Isotope 
Laboratories Inc.. n-Hexane (SupraSolv®), dichloromethane (DCM, SupraSolv®), granulated anhydrous 
sodium sulphate (Scharlau Chemie S.A.), silica (Davisil Grade 633, Sigma-Aldrich®) and Florisil® 
(Fluka, Sigma-Aldrich®) were used for extraction and clean-up. Silica and Florisil were activated at 140 
°C for at least 12 hours before use. Sodium sulphate was baked at 400 °C for at least 12 hours before 
use. 
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Recruitment and sample collection 
This project received ethics approval by The University of Queensland Ethics Committee (approval 
number H/308 NRCET). Ten mothers were recruited opportunistically when they were pregnant, from 
Sydney (7) and Brisbane (3), Australia. Breast milk samples were collected in August, 2013. A minimum 
of 50 ml of breast milk was collected from each mother over multiple collections over a one-month 
period into a clean glass jar that was provided. These mothers then collected faecal samples from their 
infants twice a week for two weeks, beginning 12-20 weeks after breast milk sampling. Only faecal 
material that had not been in contact with the inner liner of the diaper was collected (Supporting 
Information Instruction for Sampling Faeces). Questionnaires requesting demographic information 
about each mother /infant pair were completed by the mothers (Supporting Information Tables S1, S2). 
Breast milk and faecal samples were stored in a freezer at the participants’ homes until transportation 
(on ice, in a cool bag) to the laboratory. In the laboratory, samples were stored at -20 °C until analysis. 
 
Sample analysis 
Lipid content in milk samples was determined gravimetrically in an aliquot based on a liquid-liquid 
extraction protocol. Approximately 1 g of homogenized milk sample was weighed in a 15 ml centrifuge 
tube. Then 2 ml of methanol, 1 ml of methyl tert-butyl ether (MTBE) and 1 ml of hexane were added 
consecutively. The centrifuge tube was shaken vigorously (10 min), sonicated (10 min) and centrifuged 
at 2000 rpm (10 min). The upper layer was transferred to a pre-weighed tube. Again 1 ml TBME and 1 
ml hexane were added to the original tube which then was shaken (10 min), sonicated (20 min) and 
centrifuged at 4000 rpm (10 min). The upper layers were combined and blown down to dryness. The 
tube was put into a 103 °C oven and weighed periodically until a stable reading was obtained.  
For contaminant analysis, the homogenized milk sample (~6 g) was transferred to a centrifuge tube and 
spiked with labeled standard solution (see Table S3 in the Supporting Information). The milk was 
extracted as described above for lipid content measurement. After concentrating the extract to about 1 
ml, it was applied onto the top of a glass column (30 cm × 1.0 cm i.d.) containing 1 cm of anhydrous 
NaSO4, 14 cm of alumina, 14 cm of florisil and 1 cm of NaSO4 from top to bottom. The sample was then 
eluted with 100 ml of a mixture of hexane and DCM (1:1 V:V). The eluate was concentrated to 0.5 ml 
and applied onto the top of another column (17 cm × 0.8 cm i.d.) containing 0.5 cm of NaSO4 and 15 cm 
of silica gel from top to bottom. The second column was then eluted with 30 ml of a mixture of hexane 
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and DCM (1:1 V:V). The eluate was concentrated to 25 µl and 25 µl isooctane containing 200 pg 13C-
PCB141 was added as the recovery standard right before instrumental analysis.   
The homogenized, freeze-dried faecal samples (~3 g) from each infant were placed into 100 ml ASE 
cells with 10 g silica gel, spiked with internal standards and then extracted using hexane and DCM (1:1 
V:V) on a Thermo Scientific™ Dionex™ ASE™ 350 Accelerated Solvent Extractor system. The 
program was: 100 °C, 1500 psi, 3 static cycles of 7 minutes and purge time of 120 seconds. The extracts 
were transferred to a column (1.2 cm i.d.) containing 20 cm silica, and eluted with 100 ml of a 
hexane/DCM mixture (1:1 V:V). The extract was concentrated and transferred to another column (1.2 
cm i.d.) containing 20 cm florisil, and eluted with 80 ml hexane/DCM (1:1 V:V). The hexane and DCM 
(1:1 V:V) extractable lipid content of the samples was determined in a separate extraction employing 
ASE with the same conditions as above, followed by evaporation to dryness and gravimetric 
determination of the lipid content. 
 
Instrumentation, Analysis and Quantification 
All samples were analysed for indicator PCBs (PCB 28, 52, 101, 118, 138, 153 and 180), PBDEs (PBDE 
47, 99, 100, 153 and 154) and OCPs (pentachlorobenzene (PeCB), hexachlorobenzene (HCB), 
heptachlor, heptachlor epoxide B, heptachlor epoxide A, mirex and p,p’-DDE) using a Thermo Fisher 
GC 1310-HRMS DFS operated in EI-MID mode. A DB-5MS column (30 m × 0.25 mm × 0.25 μm, J&W 
Scientific) was used. All the samples were analysed at a resolution ≥5000. The internal standard 
quantification method was used. The signal/ noise (S/N) ratio was above 10 for all quantified peaks. 
 
Quality control 
For every 5 samples analysed, a blank sample was included to check laboratory contamination. Cow’s 
milk was used as the blank for breast milk, while diatomaceous earth was used as the blank for faeces. 
The method limit of quantification (mLOQ) of one compound was defined as the mean value of its 
concentration in blank samples plus 10 times its standard deviation, while the limit of detection was set 
at the mean plus 3 times the standard deviation. The data were blank-corrected by subtracting the mean 
concentrations of target compounds observed in the blanks. Diaper liners were also analysed as quality 
control samples, and low concentrations of target compounds were observed (Supporting Information 
Table S4). To minimize contamination, liners with the faecal samples were taken out of the diaper right 
after the infants’ bowel movement and the faecal samples were then tipped into a pre-cleaned aluminium 
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foil sheet (faecal material that had been in contact with the inner liner of the diaper was carefully 
retained), folded up, and put into the freezer immediately.  
The average recoveries of the 13C-labelled standards ranged from 30-110% (in breast milk samples) and 
32-112% (in faeces samples) (Supporting Information Table S3). Replication of lipid analysis showed 
good reproducibility with a coefficient of variation (CV) of 4.5% for breast milk and 6.9% for faeces. 
Two replicates (i.e. subsamples of a common sample) were analyzed for three of the breast milk and all 
10 faeces samples. Average coefficients of variation (CV) of the concentrations were 13% and 19% for 
breast milk and faeces, respectively; larger differences (20% - 40%) were observed for chemicals that 
were measured at relatively low concentrations (Supporting Information Table S5, S6). Where replicates 
were analyzed the mean concentration of the two replicates was used for further statistical analysis of 
association.  
 
Statistical analysis 
Multiple linear regression analyses examining potential associations between log10-transformed faecal 
concentrations and factors including log10-transformed milk concentration (data log10-transformed for 
normal distributions), other feeding characteristics, and age were performed using STATA IC 12 
(College Station, TX, USA). For regression analyses, measures below limit of detection (LOD) were 
imputed as LOD/2; measures between LOD and the mLOQ were imputed using the average of two 
determinations.   
 
Results and discussion  
Concentration of POPs in breast milk and infant faeces 
A range of PCB congeners, BDE congeners and OCPs were detected in both faeces and breast milk 
samples (Table 3.1; detailed information for individual samples is presented in the Supporting 
Information Table S5, S6). PCB 52, 101, PBDE 154, heptachlor and heptachlor epoxide A were detected 
above the mLOQ in less than half of the breast milk samples, and PBDE 154 and heptachlor epoxide A 
were detected above the mLOQ in less than half of the faeces samples, as indicated by the shaded rows 
in Table 3.1. For this reason, these 5 compounds are not discussed further. This is the first time that 
concentrations of these three groups of POPs in faeces have been reported in one study.  
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Table 3.1 Concentration (ng/g lipid1) of indicator PCBs, BDEs, and OCPs in breast milk and infant faeces collected from 10 
pairs of mothers and infants from Sydney and Brisbane, Australia (mean ± standard deviation (median) minimum-maximum 
(variability factor2)) 
Congener 
% >LOQ 
Breast milk        Infant faeces 
Breast milk  Infant faeces  
 
Ratio of faeces to milk 
concentrations 
PCB 28 60 70 
1.0 ± 0.49 (0.91) 
0.53-2.1 
0.86 ± 0.73 (0.58) 
0.11- 2.4 
1.7 ± 1.4 (0.98) 
0.28-4.2 (15) 
PCB 52 40 70 
0.31 ± 0.15(0.38) 
0.03-0.46 
0.66 ± 1.2 (0.18) 
0.09- 3.5 
-- 
PCB 101 40 50 
0.18 ± 0.11 (0.16) 
0.02-0.36 
0.67 ± 0.92 (0.23) 
0.12- 2.5 
-- 
PCB118 100 80 
1.4 ± 1.6 (0.64) 
0.12-5.9 
0.83 ± 1.0 (0.45) 
0.16- 3.5 
1.1± 1.0 (0.62) 
0.12-2.8 (23) 
PCB 138 100 100 
7.0 ± 6.6 (4.8) 
0.77-26 
2.1 ± 2.4 (1.5) 
0.26-8.7 
0.32 ± 0.16 (0.31) 
0.052-0.56 (11) 
PCB 153 100 100 
8.7 ± 6.2 (6.4) 
1.3-24 
2.4 ± 3.3 (0.83) 
0.44-12 
0.23 ± 0.13 (0.20) 
0.069 – 0.48 (7.0) 
PCB 180 100 100 
5.9 ± 5.7 (3.5) 
0.56-21 
2.0 ± 2.9 (0.48) 
0.18-10 
0.31 ± 0.24 (0.23) 
0.044 – 0.71 (16) 
PBDE 47 100 100 
3.3 ± 3.0 (1.8) 
0.27- 8.7 
3.9 ± 4.6 (1.9) 
0.34- 15 
1.1 ± 0.30 (1.1) 
0.76- 1.8 (2.4) 
PBDE 99 90 70 
0.66 ± 0.62 (0.33) 
0.09- 2.2 
0.96 ± 1.2 (0.38) 
0.08 – 3.7 
1.0 ± 0.51 (0.79) 
0.13- 1.7 (13) 
PBDE 100 80 90 
0.70 ± 0.53 (0.57) 
0.09- 1.8 
0.88 ± 1.7 (0.23) 
0.08- 5.8 
1.1 ± 0.83 (0.96) 
0.29- 3.2(11) 
PBDE 153 100 80 
1.5 ± 1.1 (1.5) 
0.1- 3.9 
1.4 ± 0.81 (1.4) 
0.25- 2.6  
0.87 ± 0.27 (0.80) 
0.43- 1.4 (3.3) 
PBDE 154 0 0 -- -- -- 
PeCB 80 80 
0.48 ± 0.18 (0.42) 
0.28- 0.91 
0.85 ± 0.65 (0.47) 
0.27- 2.0 
1.8 ± 1.3 (0.93) 
0.64- 4.0(9.5) 
HCB 100 100 
4.8 ± 2.1 (4.5) 
2-8.9 
1.3 ± 0.99 (0.86) 
0.36-3.5 
0.33 ± 0.35 (0.20) 
0.084 – 1.4 (17) 
Heptachlor 10 60 0.25 
0.16 ± 0.05 (0.12) 
0.11- 0.25 
-- 
Heptachlor epoxide B 80 100 
1.5 ± 1.1 (0.69) 
0.4- 3.7 
0.43 ± 0.60 (0.12) 
0.038- 1.7 
0.23 ± 0.25 (0.15) 
0.025-0.78(32.5) 
Heptachlor epoxide A 0 0 -- -- -- 
Mirex 60 60 
0.54 ± 0.68 (0.12) 
0.03- 2 
0.16 ± 0.23 (0.05) 
0.025- 0.69 
0.67 ± 0.45 (0.5) 
0.13- 1.3 (10) 
p,p’-DDE 100 100 
92 ± 73 (71)  
9.0- 230 
18± 12 (18) 
4.0- 41 
0.30 ± 0.2 (0.24) 
0.044 – 0.63 (14) 
1: average lipid content is 3.1% and 19% for breast milk (fresh weight) and faeces (dry weight), respectively 
2: for each individual compound, it is the result of the highest value divided by the lowest value among all pairs that have data above mLOQ 
 
 
The highest concentration in breast milk was measured for PCB 153 (1.3 - 24 ng/g lipid) among PCBs, 
BDE 47 (0.27 - 8.5 ng/g lipid) among PBDEs and p,p’-DDE (9.0 - 230 ng/g lipid) among OCPs. 
Concentrations of individual chemicals varied typically between 1 and 2 orders of magnitude among all 
mothers (Table S5). This range is much greater than the uncertainty in the measurement of the 
concentrations (as indicated by the replicate analyses, see above), indicating that the dataset provides a 
good basis for assessing possible relationships between concentrations in breast milk and concentrations 
in faeces. One potential reason for this relatively large variation in concentrations in breast milk is that 
the study included mothers with a range of different ethnicities/origins including mothers who had lived 
abroad for most of their lives. Chemical specific differences in exposure between different 
countries/continents have been demonstrated in many studies (Solomon and Weiss, 2002). Other reasons 
may include differences in age and diet (Supporting Information Table S1).  
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This variation was reflected in the concentrations in faeces (Table S6), which ranged from 0.44 - 12 ng/g 
lipid for PCB 153, 0.34 - 15 ng/g lipid for BDE 47, and 4.0 - 41 ng/g lipid for p,p’-DDE. For PCB 153 
the lowest concentrations in both breast milk and faeces were observed in Pair 4, while the highest 
concentrations in both matrices were observed in Pair 6. For BDE 47, the lowest concentrations in both 
matrices were from Pair 7 and the highest concentrations in both matrices were from Pairs 10 and 6. The 
highest levels of DDE occurred in Pairs 6 and 9 for both matrices. The relationship between concentration 
of POPs in breast milk and in infant faeces is explored in more detail below.  
 
Relationship between the log-transformed faecal concentration of POPs and a variety of factors 
In this study, we examined the relationship between the log-transformed faecal concentration of all 14 
compounds from Table 3.1 and a variety of factors including: log- transformed milk concentrations; 
infant age in months; adjusted months of breastfeeding; fraction of total feeding due to breastfeeding 
(adjusted breastfeeding months/age); adjusted months of solid food; total weight gain; and rate of weight 
gain (Table S2, S7). A variety of possible interrelationships among these variables were also examined 
in order to identify potential co-variation that could affect the regressions. 
Measured faecal concentrations for all analytes together are correlated with milk concentrations (Figure. 
3.1; 14 analytes, 10 paired measurements for each; Pearson corr. Coeff. =0.72).  
 
 
Figure. 3.1 Faecal and milk concentrations of 14 target compounds from 10 paired samples. 
 
Adding other factors related to milk concentration in general did not result in significant independent 
contribution to the observed relationship. There was no significant relationship with months of 
breastfeeding, fraction of life breastfed, or conversely, months of solid food intake.  However, because 
of the small number of pairs, no definite conclusions can be drawn regarding these factors based on this 
dataset. 
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Age was an independent, inverse predictor of faecal concentration (p=0.017) when added into the model 
with milk concentrations, but the relationship was very slight, and adding age resulted in only a small 
improvement in the adjusted R-squared (0.54 vs. 0.52 for milk concentration alone) (Table 3.2). 
Similarly, absolute change in weight (but not rate of weight change) was also borderline significant when 
added to milk concentrations in the model (p= 0.092), with the findings again in the inverse direction – 
greater weight gain results in slightly lower faecal concentrations (R2 of 0.53). However, those two 
parameters, age and change in weight, are highly correlated (Pearson corr. coeff. = 0.95), so it is not 
possible to determine which of the two contributed more to faecal concentrations.  In summary, in this 
small dataset faecal concentrations are highly predicted by milk concentrations, and other factors cannot 
be detected in this dataset, with the exception of a small effect of age or growth.  
Table 3.2 Multiple linear regression results for Log10(faecal concentration, ng/g lipid) for 14 compounds from 10 paired 
maternal milk and infant faecal samples (R2 for model, 0.54) 
Parameter Regression Coefficient (95% CI) p value 
Log10 Milk concentration, ng/g lipid 0.63 (0.53 to 0.73) <0.001 
Age, months -0.052 (-0.095 to -0.009) 0.017 
Intercept 0.058 (-0.22 to 0.33) 0.674 
 
 
Two possible mechanisms are postulated for a monotonic correlation between human milk and infant 
faeces. The first mechanism is that some portion of the ingested chemical is excreted in the faeces without 
having been absorbed systemically, and that the concentration in the milk is a good surrogate for the 
infant’s ingestion of the chemical. The second mechanism is that the chemical concentration in the faeces 
is controlled by the chemical concentration in the body, and that the concentration in the milk is a good 
surrogate for the concentration in the body of the infant during the time of breastfeeding. A mixture of 
these two mechanisms may also operate depending upon the specific chemical and the exposure matrix 
(food, dust, or other matrix).  Further elucidation of these two mechanisms will likely require additional 
datasets, in particular, datasets with blood concentration data and including infants or small children that 
are not being currently breastfed as well as those that are. 
 
Chemical-specific observations  
This dataset can neither confirm nor refute the hypothesis that faecal concentration reflects blood 
concentration. However, we can use the ratio of concentrations of POPs in faeces samples (Cf, in ng/g 
lipid) to that in milk samples (Cm, in ng/g lipid): 
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 Rfm = Cf / Cm  
to explore which of the two explanations for the monotonic correlation between Cf and Cm might apply 
to the different compounds. The Rfm values for each compound in each pair of samples (only the pairs 
that have data above mLOQ) are presented in the Supporting Information Table S8.  A compound 
specific summary of the data is presented in Table 3.1. The Rfm for individual samples ranged from 0.044 
for DDE and PCB 180 to 4.2 for PCB 28, and the median Rfm ranged from 0.20 for PCB 153 and HCB 
to 1.1 for BDE 47.   
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Figure. 3.2 Rfm values for each individual chemicals (the height of bar represents the median value; each dot is for each pair 
of participants) 
 
For a given chemical, Rfm varied among mother/infant pairs by as little as a factor < 2.5 for BDE 47 up 
to a factor >32 for Heptachlor epoxide B (Figure. 3.2, Table S8,  Figure. S1). The different variability 
in Rfm between chemicals indicated that different factors were involved for different chemicals in 
determining the relationship between Cf and Cm. If the hypothesis that faecal concentration reflects 
concentration in the infant’s body (i.e., the second mechanism outlined above) is true, one would expect 
high variability of Rfm. This is because pharmacokinetic modeling has shown that the relationship 
between Cm and concentrations in the infant’s body is strongly influenced by e.g., age and length of 
breastfeeding (Verner et al., 2013b). On the other hand, if the faecal concentration reflects the amount of 
chemical ingested (the first mechanism outlined above), one would expect low variability of Rfm under 
certain conditions. This would be the case if the mother’s milk was the dominant source of ingested 
chemical and the chemical’s absorption efficiency did not vary widely between individuals. It would also 
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be the case if another source besides mother’s milk dominated the infant’s ingestion, and if the same 
source also dominated the mother’s exposure. 
The variability of Rfm between pairs for the major BDEs, i.e. BDE47 and BDE153 is comparatively very 
small (Table 3.1, Figure 3.2). This would speak for the faecal concentrations reflecting the amount of 
these chemicals ingested. Dust is considered one of the primary vectors of the exposure of the mother 
and the infant for BDEs (Trudel et al., 2011) and it is reasonable to assume that the levels of these 
chemicals in mother’s milk and in food/dust are correlated for mothers that are living in the same (dust) 
environment. The relatively large molar mass of BDEs could also resort in restricted absorption in the 
digestive tract (Kelly et al., 2004), which would favor this mechanism. 
For remaining compounds, it is noteworthy the lowest Rfm values for PCB118, 138, 153,180, DDE and 
mirex all occur with Pair 1. Besides Pair 1, other two pairs, i.e. Pair 9 and Pair 2, have the biggest numbers 
of compounds (5 and 3, respectively) with the lowest Rfm values among all pairs. Those mother/infant 
pairs with the lowest Rfm values are pairs that have older children and the longest periods of solid food 
being introduced before faecal samples were collected (see Table S8). The combination of these factors 
would be expected to lower Rfm. In addition, PCBs and HCB have been proved to have very high 
absorption efficiency in gut both adults and infants (McLachlan, 1993; Abraham et al., 1994; Moser and 
McLachlan, 2002a). This would speak more for the faecal concentrations reflecting the concentrations 
in the infant’s body.  
The analyses of correlation between Kow and Rfm was conducted as well. As shown in Figure 3.3, the 
slope of the regression line of the relationship between Rfm and Log Kow is 0.028 and is not significantly 
different from zero (P=0.89). Similarly, the slope of the regression line of the relationship between Rfm 
and Log Koa is 0.064 and is not significantly different from zero either (P=0.52). 
The primary purpose of this pilot study was to demonstrate that a large range of compounds could be 
measured in feces with reproducible results. The strong correlations between maternal milk and faecal 
concentrations, whether due to faeces levels directly reflecting milk levels, indirectly reflecting another 
common exposure pathway for mother and infant, or reflecting levels in the infant’s body, suggest that 
faeces is a promising matrix for biomonitoring infant exposure to POPs. Additional data, including blood 
concentration data paired to faecal data, are being generated to further evaluate the use of faecal 
concentrations as a marker for internal exposure of infants and children.  In future work it is important 
that a broad spectrum of chemicals be studied as the faeces concentrations of different chemicals are 
69 
 
clearly influenced by different factors. Longitudinal studies will also be important to see how the 
concentrations in faeces change over time in the same infant as a result of changes in concentrations in 
blood and changes in exposure vectors such as diet and dust ingestion.  
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Figure 3.3. Rfm values for chemicals (PCB28, 118, 138, 153, 180, PBDE47, 99, 100, 153, p,p’-DDE, HCB, mirex and 
heptachlor epoxide B) that have different Kow and Koa values. (Kow and Koa values for PCBs are from (Li et al., 2003); Kow 
for PBDEs are from (Braekevelt et al., 2003); Koa values for PBDEs are from (Harner et al., 2001); Kow and Koa values for 
mirex are from (Tinsley, 2004); Kow and Koa values for PeCB are from (Malcolm; et al., 2004); Kow and Koa values for HCB 
are from (Harner and Mackay, 1995); Kow and Koa values for p, p’- DDE are from (Howard and Meylan, 1997)). 
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Abstract 
Previous studies have found that the concentrations of a range of persistent organic pollutants (POPs) in 
faeces is linearly proportional to the POP concentrations in blood of human adults irrespective of age 
and gender. In order to investigate the correlation between POP concentrations in faeces and blood in 
infants, the monthly variation of POP concentrations in faeces over the first year of life of one infant was 
investigated in this study and compared to modeled blood concentrations. Faecal samples were collected 
from one male infant daily. The samples were pooled by month and analyzed for three selected POPs 
(2,2’,4,4’,5,5’-Hexachlorobiphenyl (PCB153), p,p′-dichlorodiphenyldichloroethylene (p,p′-DDE) and 
2,2’,4,4’-tetrabromodiphenyl ether (BDE47)). The POP concentrations in faecal samples increased for 
the first four months by a factor of 2.9, 4.9 and 1.4 for PCB153, BDE47, and p,p′-DDE, respectively. 
The faecal concentrations of all POPs decreased rapidly following the introduction of formula and solid 
food to the diet and subsequent weaning of the infant. Further, a one-compartment model was developed 
to estimate the daily POP concentrations in the blood of the infant. The POP concentrations in blood 
were predicted to vary much less over the first year than those observed in faeces. The faeces:blood 
concentration ratio of selected POPs (Kfb) differed significantly (P<0.0001) between the period before 
and after weaning, and observed changes in Kfb are far greater than the uncertainty in the estimated Kfb. 
A more stable Kfb after weaning indicates the possibility of applying the stable Kfb values for non-
invasive assessment of internal exposure in infants after weaning. The intra-individual variation in Kfb 
in infants is worthy of further investigation.  
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Introduction 
Polychlorinated biphenyls (PCBs), the organochlorine pesticide metabolite p,p’-DDE, and 
polybrominated diphenylethers (BDEs) are examples of persistent organic pollutants (POPs) that 
accumulate in lipid tissues of biota including blood. Evidence is mounting that early life exposure to 
POPs (via placenta and breast milk) contributes to burden of disease in later life (Jacobson et al., 1990; 
Jacobson and Jacobson, 1996; Schantz et al., 2003; Iszatt et al., 2015). Data on the internal exposure (i.e. 
the concentration of such chemicals in the body/body tissues) during early life would aid the investigation 
of these links, but such data remain scarce. Collecting and analyzing blood samples is a widely used tool 
for assessing internal exposure of POPs in adults, but is regarded as invasive for infants and young 
children. Therefore, non-invasive approaches are needed for estimating internal exposure to POPs during 
early life.  
Faeces, as the primary excretive matrix of POPs except for breast milk (Rohde et al., 1999; To-Figueras 
et al., 2000b), could be analyzed as one potential noninvasive approach for assessing internal exposure 
(Chen et al., 2015). Previous studies have found that for adults the concentrations of POPs in faeces are 
largely independent of the dietary intake of the chemicals, but are dependent on the concentrations in 
blood. (Schlummer et al., 1998; Moser and McLachlan, 1999; Rohde et al., 1999; Moser and McLachlan, 
2001).  Furthermore, these papers suggested that gastrointestinal exchange of POPs can be viewed as 
two processes that are operating simultaneously: absorption of the contaminants from the diet, and 
excretion of the contaminants from the body’s reservoirs via the faeces.    
One concern with using faecal concentrations as an indicator of blood concentration is the intra- and 
inter- individual variability of the faeces:blood concentration ratio (Kfb). As Abraham et al. (1996) noted, 
there are probably many factors influencing Kfb, such as age, intestinal transit time, composition of the 
diet, and absorption rate of intestinal fat and water. Nevertheless, in adults, the variability of Kfb for 
polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) with a large range of Kow values has 
been found to be reasonably small (Moser and McLachlan, 2001). In toddlers, a feasibility study with 
faeces as a non-invasive biomonitoring matrix for brominated flame retardants (BFRs) was reported 
recently (Sahlstrom et al., 2015). Although that study did not focus on the variability of Kfb,, linear 
regression models developed using concentrations of four BDE congeners in faeces to predict blood 
concentrations of tetra- to decaBDEs yielded range-normalized root-mean-squared-errors of 4.9 – 20%. 
For infants, the intra- and inter-individual variability of Kfb still needs to be investigated. Factors that 
could result in different Kfb values between adults and infants include a different composition of diet, an 
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immature digestive tract (Abrahamse et al., 2012) and different microbial flora in the digestive tract of 
infants (Ellis Pegler et al., 1975; Stephen and Cummings, 1980). In addition, dust can be an important 
source of BDEs for infants due to behaviors like mouthing of hands and objects, and crawling (Toms et 
al., 2009a; Johnson et al., 2010).  
The objective of this study was to investigate the intra-individual variability of the faeces:blood 
concentration ratio Kfb of 2,2
’,4,4’,5,5’-hexachlorobiphenyl (PCB153), p,p’-dichlorodiphenyl (p,p’-DDE) 
and 2,2’,4,4’-tetrabromodiphenyl ether (BDE47) in one male infant over his first year of life. The three 
selected compounds were the most abundant POPs observed in a previous study of POPs concentrations 
in matched breast milk and infant faecal samples (Chen et al., 2015). Faecal samples were collected from 
one male infant daily, pooled by month, and analyzed for the three target compounds. Further, a one-
compartment model was developed to estimate the variability of the POP concentrations in the blood 
lipid of the infant during the study period. 
 
 Experiment 
 Study design 
Infant faecal samples (collected daily and pooled monthly over the first year of the infant’s life) as well 
as the mother’s breast milk sample (collected cumulatively over 4 weeks during the third month of 
lactation) were analyzed for PCB153, BDE47 and p,p’-DDE. A simple one-compartment model was 
developed to predict the concentrations of POPs in the blood of the infant, taking into consideration 
intake of POPs via food and dust, elimination via faeces and diffusion via body lipid. The model was 
then evaluated using measured concentrations of three POPs in the diet and faeces of two babies in a 
previous study (Abraham et al., 1996b). The model was subsequently parameterized with our measured 
concentrations in breast milk and faecal samples, infant growth information, and recorded diet together 
with related food exposure data derived from literature. The model was then used to predict blood 
concentrations and in turn used to assess potential variation of Kfb values of the infant throughout its first 
year (Section 2.5.2).  
 
Study subject 
This study received ethics approval by the University of Queensland Ethics Committee (approval number 
H/308 NRCET). One male infant born in Brisbane, Australia in 2012 was recruited. Basic information 
about the infant and his mother is presented in Table 4.1. The infant was healthy over the 1st year of life 
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and had weight gains between the 50th and 75th percentile, as well as height gains between the 25th and 
90th percentile (The WHO Child Growth Standards) according to developmental milestone reports 
recorded by the infant’s doctor. 
Table 4.1 Basic data of the infant and mother 
Mother  
       Age at birth (y) 39 
       BMI1 before pregnancy 19 
 Infant  
       Gestational age (wk) 39 
       Birth weight (kg) 3.4 
       Birth height (cm) 51 
Nutrition   
       Full breast-feeding for (wk) 17 
       Weaning at (wk) 26 
       Equivalent full breast-feeding (wk)2 21 
       Solid food started at (wk) 23 
Child care started from (day) 122 
Weight at one year of age (kg) 11 
Height at one year of age (cm) 78 
1: BMI= mass (kg)/ height (m)2. Normal BMI is 18.5 – 24.9. 
2: Estimated equivalent full breast-feeding time: full breast-feeding days corresponds to the total amount of breast-feeding.  
 
 
 
Sampling 
Breast milk was collected by the mother before each feeding from Week 14 to 18 after birth. Small 
aliquots were pooled to produce one sample of approximately 100-150 ml. Infant faecal samples were 
collected from Day 8 to Day 373 in the first year of life, except for a one-month interruption from Day 
189 to Day 220 when the family went on an overseas trip. At each sampling point, only faecal material 
that had not been in contact with the inner liner of the diaper was collected into a sheet of aluminium 
foil. The folded aluminium foil sheet was then sealed inside a plastic re-sealable bag and stored in a 
freezer at the participant’s home until transportation to the laboratory (on ice, in a cool bag). A detailed 
description of sample collection and transportation is given in a previous study (Chen et al., 2015). Pools 
of faeces were based on 7 samples evenly obtained from faeces collected in each week of a given month 
(in this study one ‘month’ is defined as one calendar month. As the infant was born on 22nd December; 
for example, Month 1 refers to days from January 1 to January 31). Faecal samples were stored at -20°C 
until analysis. 
 
Analysis and quality control 
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POPs were measured in breast milk using a previously described method (Chen et al., 2015). Briefly, the 
homogenized milk sample was transferred to a centrifuge tube and spiked with a solution of labeled 
standards (13C12-PCB153, 
13C12-BDE47 and 
13C12-p,p’-DDE). A mixture of methanol, methyl tert-butyl 
ether and hexane (2:1:1, v/v/v ratio) was added and the sample was shaken vigorously for 10 minutes. 
Following separation the upper layer was collected and the extraction was repeated. The two extracts 
were combined, evaporated to about 1 ml, and subjected to purification using adsorption chromatography 
on alumina and florisil packed in an open glass column. Target analytes were eluted with 100 ml of 
hexane: dichloromethane (1:1, v/v ratio). The eluant was concentrated to 0.5 ml in hexane and transferred 
to a column containing silica gel. The column was then eluted with 30 ml of a hexane: dichloromethane 
mixture (1:1, v/v ratio). The eluate was concentrated to 25 µl in hexane. 25 µl of isooctane containing 
200 pg of 13C12-PCB141 was added as the recovery standard immediately prior to HRGC/HRMS 
analysis. Instrument methods are provided in the Supplementary Information (SI).  
 
The freeze-dried, homogenized faecal samples were extracted and purified in a single step using methods 
modified from Abdallah et al., (2013). A 100 ml DioniumTM PLE cell was filled from the bottom upwards 
with 20 g of activated florisil, 20 g of sulfuric acid (40%) impregnated silica, 10 g of activated silica and 
approximately 1 g of homogenized faeces sample pre-mixed with 2 g of activated silica (see Figure S1). 
Extraction was carried out on an ASE 350 (Dionex, Sunnyvale, CA, USA) using a solvent mixture of 
hexane: dichloromethane (1:1, v/v ratio) at 100 °C, under a pressure of 1500 psi. The heating time, static 
time, and purge time was 5 min, 7 min and 120 s, respectively.  A flush volume of 60% was used. Two 
static cycles were used to achieve maximum recovery of target compounds. The extract was concentrated 
to 25 µl using N2 evaporation and transferred to an autosampler vial. 25 µl (200 pg) of 
13C12 -PCB141 in 
iso-octane was added as the recovery standard immediately prior to HRGC/HRMS analysis. The lipid 
content of breast milk and faeces samples was determined in separate extractions with the same methods 
mentioned above (however without adsorbent in ASE cells), followed by evaporation to dryness and 
gravimetric determination of the lipid content (Chen et al., 2015). 
 
In every batch of samples, bovine milk and diatomaceous earth were included as blanks and pooled 
faeces samples were included for quality assurance and quality control (QA/QC) of the analysis. The 
QA/QC results are summarized in Table S1. Briefly, the average recoveries of the labelled standards 
were 60-69% in breast milk and 77-92 % in faecal samples. Replication of lipid analysis had a coefficient 
of variation (CV) of 4.5% for breast milk and 7.1% for faeces samples. For the chemical analysis, the 
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average CV between duplicate samples was 13% for breast milk samples and 11% for faecal samples; 
larger differences (20-35%) were observed for BDE47 in faecal samples that were measured at relatively 
low concentrations. Where replicates were analyzed, the mean concentration of the two replicates was 
used for further statistical analysis and discussion.  
 
Model  
Assumptions 
The following assumptions were made in the model developed to predict blood concentration (Cblood t; 
ng/g lipid): (i) POP exposure occurs primarily from the ingestion of contaminated food and dust, and the 
data on concentrations in food (other than breast milk) and dust from other geographic regions give 
reasonable estimates of the concentrations the infant was exposed to; the primary exposure source of 
DDE is the dietary ingestion of p,p’-DDE itself, not the metabolism of DDT (Kannan et al., 1994; Harden 
et al., 2005); (ii) the body of the infant is considered as a single well-mixed compartment where the 
chemicals of interest accumulate solely in lipids; (iii) POPs and lipid in diet are completely absorbed 
(consistent with McLachlan (1993)) and are then distributed homogeneously in the body lipids including 
the blood lipid (Haddad et al., 2000; Verner et al., 2013c); (iv) POP concentrations in breast milk 
remained the same over the whole breast feeding period (LaKind et al., 2009), and the measured POP 
concentrations are representative of the concentrations throughout this period; (v) infant weight, body 
lipid fraction of infant, faecal excretion rate for the first 113 days and POP concentrations were 
approximated by linear interpolation between measurement time points; (vi) faecal excretion is the only 
elimination pathway for the selected chemicals (Price et al., 1972; Rohde et al., 1999; Park et al., 2007); 
(vii) as a starting point of the model, Cblood t  at t = 8 d, the initial POP concentrations (lipid normalized) 
in the infant, were assumed equal to the lipid-normalized concentration in the breast milk of the mother  
(Mazdai et al., 2003; Wu et al., 2007; Watkins et al., 2011; Verner et al., 2013c).  
 
Conceptual representation 
The change in the mass of the chemical in the body was calculated by subtracting the mass of the 
chemical eliminated through faecal excretion from the daily intake (through dust, breast milk, formula 
and/or solid food). We used (i) the measured concentrations in the breast milk and the faeces, (ii) POP 
concentrations in formula and solid food from the literature; and (iii) body weight-dependent breast milk 
intake and faeces excretion mass (Sievers et al., 1993; Arcus-Arth et al., 2005; Verner et al., 2009a) 
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(conceptual representation in Figure S2). With this information, the lipid normalized concentrations of 
the three chemicals of interest in blood on Day t, i.e., Cblood t (ng/g lipid), can be determined by: 
 
(1)                   
where Mt is the body lipid mass on Day t (g). Intaket and Eliminationt are the intake and elimination of 
selected POPs on Day t, respectively (ng/d). Intake and Elimination can be further described by equations 
(2) and (3): 
                                 (2) 
 
                                                                                                      (3) 
where Cmilk, and Csolid food, are the POP concentrations in breast milk and solid food (ng/g lipid), 
respectively, and Qmilk  and Qsolid food, are the breast milk and solid food fat intake (g lipid/d), respectively. 
Similarly, Cdust is the concentration in dust (ng/g) and Qdust is the dust intake (g/d). Qfaeces, is the faeces 
excretion (g lipid/d). Equation (1) can then be expressed as: 
    
                                                                                                                                                                 (4)                        
After calculating Ct with Equation 4, Kfb the faeces:blood partition coefficient can be calculated as:                                                                                                                                                   
                                                               (5) 
 
 
Evaluation 
To evaluate the model that was developed for the infant in our study, the model was first applied to 
predict blood concentrations in the infants described by Abraham and colleagues. Abraham et al. (1996) 
studied the dietary transfer of several PCDDs in two infants. They made several measurements of the 
concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 1,2,3,7,8-pentachlorodibenzo-p-dioxin 
(PeCDD) and 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) in the infants’ diet and faeces and 
collected information on their breastfeeding history and weight gain. Additionally, PCDD concentrations 
were measured in blood from the two infants at the age of 11 months. This data was entered into the 
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model developed in our study (2,3,7,8-TCDD, 1,2,3,7,8-PeCDD and 1,2,3,4,6,7,8-HpCDD). The 
predicted concentrations of these three chemicals in the infants’ blood at age of 11 months were then 
compared to the observations in the study by Abraham et al (1996).  
 
 
Parameterization 
The variables Cmilk and Cfaeces were measured in this study. Qsolid food was calculated based on the diet 
diary recorded by the parents and lipid contents of food items taken from the literature (Fernandes et al., 
2012) (Table 4.2). Body weight was measured by doctors. All other parameters were taken or deduced 
from the literature: Qmilk and the corresponding lipid contents were determined with equations from the 
literature (Arcus-Arth et al., 2005).  Csolid food was calculated based on studies of exposure to POPs via 
food (Kannan et al., 1994; Bocio et al., 2003; FSANZ, 2007; Loran et al., 2009; Pandelova et al., 2010; 
Ali et al., 2014). Cdust was calculated utilizing a correlation between blood/breast milk and dust 
concentration (Ali et al., 2014). Qdust  and Qfaeces were calculated based on empirical data (Sievers et al., 
1993; Koo, 2000; Wu et al., 2007; Watkins et al., 2011). Further details regarding parameterization are 
provided in the SI. 
 
 
Statistical analysis 
The model was implemented in Microsoft Excel 2013 (Microsoft, Redmond, WA, USA) and is provided 
in the SI. Uncertainty analysis (see SI, Uncertainty Analysis) and the T-test for testing the significance 
of temporal change were carried out using GraphPad Prism 6 (GraphPad Software, Inc., USA). 
 
 
Results 
Concentrations of POPs in maternal breast milk and infant faecal samples  
The concentrations of PCB153, BDE47 and p,p’-DDE in the maternal breast milk sample were 13, 1.4 
and 96 ng/g lipid, respectively.  Concentrations in monthly pooled faecal samples ranged from 2.6-23 
ng/g lipid for PCB153, 1.1-7.3 ng/g lipid for BDE47 and 26-130 ng/g lipid for p,p’-DDE. The measured 
lipid content of faeces ranged from 8.7%-28% (Table 4.3). Both the lipid-based chemical concentrations 
in faeces as well as the faecal lipid content increased up until Month 4.  
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Table 4.2 Diet diary of the infant (Month 1 – 12). Intake sources including breast milk, food (different categories of food 
consumed (per day) at different age (month) of the infant) and dust. Columns on the right provide typical concentrations of 
chemicals of interest in the foods and dust. 
Category 
(/%lipid 
content 
(g/ml)1) 
Month  
1 
Month  
2 
Month  
3 
Month  
4 
Month  
5-6 
Month  
7-8 
Month  
9-10 
Month  
11-12 
PCB 
1536 
BDE 
477 
p,p’-
DDE8 
ng/g lipid  
Breast milk2 
(~3.73) 
~600ml ~650ml ~700ml ~750ml (600 – 100 ml) (100 – 0 ml) -- -- 13 1.4 96 
Formula4 
(2) 
~30ml -- -- -- (150 - 450 ml) 
(450 – 600 
ml) 
(700 – 800 ml) (600 – 800 ml) 0.26 0.091 0.058 
Cereals & 
grains 
(4.1) 
-- -- -- -- 
Rice, barley, 
oat 
(1/4 cup5) 
Rice, barley, 
oat 
(1/3 cup) 
Multi-grain 
crackers, wheat 
(1/2 cup) 
Pastas, bagels 
(1/2 cup) 
0.080 0.13 0.24 
Fruits 
(0.21) 
-- -- -- -- 
Apple, 
bananas, pear 
(1/4 cup) 
Avocados, 
peaches 
(1/4 cup) 
Cherries, mango, 
kiwi, papaya, 
blueberries 
(1/4 cup) 
Berries, citrus 
(1/3 cup) 
0.59 0.58 0.13 
Vegetables 
(0.29) 
-- -- -- -- 
Green beans, 
potatoes 
(1/4 cup) 
Carrot, peas, 
pumpkin 
(1/4 cup) 
broccoli, 
cauliflower, 
onions, 
mushrooms 
(1/4 cup) 
corn, cucumbers, 
spinach, 
tomatoes 
(1/3 cup) 
0.42 0.53 11 
Protein 
(7.3 for 
poultry;9.3 for 
fish) 
-- -- -- -- -- -- 
chicken, tuna 
(1/4 cup) 
(1/3 cup) 
0.090/
9.39 
0.073/1.49 0.34/159 
Dairy 
(23) 
-- -- -- -- -- 
yogurt  
(1/4 cup) 
Cream cheese 
(1/4 cup) 
Cheddar 
(1/3 cup) 
0.36 0.099 0.058 
Dust10   0.030g 0.030g 0.030g 0.030g 0.030g 0.030g -- 7011ng/g -- 
1. Reference: (Fernandes et al., 2012) 
2: Only showing approximate range of the amount. Exact values for every day were calculated in the model. 
3: Although the breast milk collected for analysis had a lipid content of 3%, the samples were collected at the beginning of each particular feeding and at one particular month. 
Exact values for every day were calculated in the model 
4: The value of first month was calculated as the whole consumed formula amount in this first month divided by 30 days. Values for other days are measured via bottle when fed.  
5: one cup = 237 ml 
6, 7: Reference: (Fernandes et al., 2012) 
8: References: (Kannan et al., 1994; Defra, 2012; FDA, 2012) 
9: 0.09 (in column PCB153), 0.073 (in column BDE47) and 0.34 (in column DDE) are for poultry; 9.3 (in column PCB153), 1.4 (in column BDE47) and 15 (in column DDE) are 
for fish.  
10: References: (EPA, 2011; Swartjes, 2011) 
11: References: (Wu et al., 2007; Watkins et al., 2011; Ali et al., 2014) 
 
 
After Month 4 the concentrations decreased. This coincided with the beginning of the weaning period 
(when the infant was fed less breast milk and infant formula), which lasted to the middle of Month 7.  
Solid food was introduced at the end of Month 5 (Day 125). At the end of the weaning period (Day 190), 
the lipid weight-normalized faecal concentrations of chemicals were 0.52 (PCB153), 0.82 (BDE47), and 
0.36 (p,p’-DDE) times the highest concentration observed at Month 4, respectively. Similarly, the lipid 
content of faecal samples decreased to 0.39 times the Month 4 content.  
 
Intake rates and faecal excretion rates (monthly averaged) of lipid and contaminants are also presented 
in Table 4.3. The ratio of excreted lipid to the consumed lipid ranged from 1.8% (Month 1) to 6.1% 
(Month 6). Subsequently, there is a dramatic increase in the ratio of excreted contaminants to the 
consumed contaminants from 14% to 230% (PCB153), 66% to 370% (BDE47) and 14% to 3200% (p,p’-
DDE) between Month 6 and Month 7,  when the infant was weaned from breast milk.  This change 
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reflects the strong decrease in intake rates of these compounds following weaning compared to the 
exclusively breast-fed period. Overall, from Months 7-12 the ratios of excreted contaminants to ingested 
contaminants was roughly ten times higher than that during the first 6 months. 
 
Table 4.3 Lipid content and concentration of POPs in monthly pooled faecal samples and one breast milk sample (mean ± SD 
(RSD)), and percent change of each month compared to Month 1; Excretion rate and intake rate of lipids and contaminants1; 
Modeled POP concentrations in blood (monthly average)  
 
 
Faecal lipid content 
 
 
PCB153 in faeces 
 
BDE47 in faeces 
 
p,p'-DDE in faeces 
 
Excreted/ Consumed 
(percentage of intake found in faeces) 
Predicted concentration in blood 
PCB153 BDE47 p,p'-
DDE  
 
g/g dry 
weight 
 
 
Percent  
change 
(%) 
 
 ng/g  
lipid 
 
   
Percent  
change  
(%) 
 
ng/g  
lipid 
 
Percent  
change  
(%) 
 
ng/g 
lipid 
 
Percent  
change 
(%) 
 
Lipid 
(g/kg 
(bw)/d) 
PCB153 
(ng/kg 
(bw)/d) 
BDE47 
(ng/kg 
(bw)/d) 
p,p'-DDE 
 (ng/kg 
(bw)/d) 
 
 
ng/g 
lipid 
 
 
ng/g 
lipid 
 
 
ng/g 
lipid 
Month 
1 
0.15 ± 
0.025 
(17%) 
-- 
8.0 ± 
0.26 
(3%) 
    -- 
1.5 ± 
0.22 
(15%) 
-- 
95 ± 
9.2 
(10%) 
-- 
0.093/5.1 
(1.8 %) 
0.76/62 
(1.2 %) 
0.14/6.7 
(2.1 %) 
8.2/460 
(1.8 %) 
 
15 
 
1.6 
 
110 
Month 
2 
0.21 ± 
0.010 
(4.8%) 
↑ 40 
8.8 ± 1.2 
(14%) 
↑ 10 
1.4 ± 
0.36 
(26%) 
↓  6.7 
65 ± 
5.7 
(9%) 
↓  31 
0.047/4.9 
(0.95 %) 
0.41/64 
(0.64 %) 
0.08/6.9 
(1.1 %) 
3.4/470 
(0.72 %) 
 
16 
 
1.8 
 
120 
Month 
3 
0.24 ± 
0.015 
(6.3%) 
↑ 60 
11 ± 0.92 
(8%) 
↑ 38 
3.5 ± 
0.69 
(19%) 
↑  130 
110 ± 
13 
(11%) 
↑  16 
0.037/4.8 
(0.77 %) 
0.48/62 
(0.76 %) 
0.15/6.7 
(2.3 %) 
4.0/460 
(0.88 %) 
 
19 
 
2.0 
 
140 
Month 
4 
0.28 ± 
0.020 
(7.1%) 
↑ 87 
23 ± 0.99 
(4%) 
↑ 90 
7.3 ± 
0.29 
(4%) 
↑  390 
130 ± 
7.9 
(6%) 
↑  37 
0.089/4.4 
(2.1 %) 
1.9/57 
(3.3 %) 
0.59/6.1 
(9.6 %) 
11/420 
(2.6 %) 
 
20 
 
2.1 
 
150 
Month 
5 
0.24 ± 
0.015 
(6.4%) 
↑ 60 
18 ± 0.75 
(4%) 
↑130 
5.2 ± 
0.67 
(13%) 
↑  250 
110 ± 
10 (9%) 
↑  16 
0.15/2.7 
(5.4 %) 
2.5/30 
(8.5 %) 
0.84/3.2 
(26 %) 
16/220 
(7.2 %) 
 
21 
 
2.2 
 
150 
Month 
6 
0.16 ± 
0.0050 
(3.2%) 
↑ 6.7 
11 ± 0.53 
(5%) 
↑ 38 
6.9 ± 
0.72 
(10%) 
↑  360 
91 ± 
6.1 
(7%) 
↓  4.2 
0.15/2.4 
(6.1 %) 
1.8/13 
(14 %) 
0.98/1.5 
(66 %) 
13/91 
(14 %) 
 
22 
 
2.2 
 
160 
Month 
72 
0.14   17 12 44 6.5 330 69 46 
0.15/2.5 
(5.8 %) 
1.7/0.74 
(230 %) 
0.94/0.25 
(370 %) 
9.8/0.30 
(3200 %) 
 
22 
 
2.1 
 
160 
Month 
8 
0.11 ± 
0.010 
(9.1%) 
↓ 27 
12 ± 1.2 
(10%) 
↑50 
6.0 ± 
0.19 
(3%) 
↑  300 
47 ± 
2.8 
(6%) 
↓  49 
0.15/3.3 
(4.4 %) 
1.5/1.0 
(150 %) 
0.820.34 
(240 %) 
6.6/0.52 
(1300 %) 
 
22 
 
2.1 
 
160 
Month 
9 
0.091 ± 
0.0020 
(2.1%) 
↓ 39 
3.3 ± 
0.63 
(19%) 
↓ 59 
3.9 ± 
0.70 
(18%) 
↑  160 
30 ± 
0.82 
(3%) 
↓  68 
0.15/3.9 
(3.9 %) 
0.58/3.5 
(17 %) 
0.52/0.79 
(66 %) 
4.6/4.7 
(96 %) 
 
22 
 
2.1 
 
160 
Month 
10 
0.10 ± 
0.0095 
(9.5%) 
↓ 33 
3.0 ± 
0.54 
(18%) 
↓ 63 
1.4 ± 
0.11 
(7%) 
↓  6.7 
26 ± 
4.1 
(16%) 
↓  73 
0.17/4.2 
(3.9 %) 
0.49/3.7 
(13 %) 
0.25/0.85 
(29 %) 
4.5/5.1 
(89 %) 
 
21 
 
2.0 
 
150 
Month 
11 
0.093 ± 
0.0075 
(8.1%) 
↓ 38 
2.6 ± 
0.40 
(16%) 
↓ 68 
1.1 ± 
0.13 
(12%) 
↓  27 
31 ± 
4.5 
(14%) 
↓  67 
0.15/4.3 
(3.5 %) 
0.41/4.3 
(9.6 %) 
0.19/0.9 
(21 %) 
4.5/6.0 
(74 %) 
 
21 
 
2.0 
 
150 
Month 
12 
0.087 ± 
0.0055 
(6.4%) 
↓ 42 
3.0 ± 
0.43 
(14%) 
↓ 63 
1.7 ± 
0.54 
(32%) 
↑  13 
26 ± 
4.2 
(16%) 
↓  73 
0.14/4.4 
(3.3 %) 
0.40/4.4 
(9.2 %) 
0.21/0.91 
(23 %) 
3.3/6.1 
(55 %) 
 
21 
 
2.0 
 
140 
Breast 
milk 
(fore 
milk)3 
0.031 ± 
0.0010 
(3.2%) 
 
-- 
 
13 ± 2.5 
(20%) 
 
-- 
 
1.4 ± 
0.30 
(21%) 
 
-- 
 
96 ± 
4.5 
(4.7%) 
-- --       -- -- 
 
-- 
 
 
 
-- 
 
 
-- 
 
 
-- 
1: Calculations based on the model (SI). Monthly average data were used   
2: Data for Month 7 in this study were calculated as the average of the data from Month 6 and 8.      3: Analysed breast milk was collect at the beginning of each particular 
feedings 
 
 
Model evaluation using literature data 
Based on the data for dietary concentrations, faecal concentrations, and breastfeeding history of the two 
infants from the Abraham et al. (1996) study, our model predicted concentrations at 11 months of age in 
reasonable agreement with the measured concentrations in blood with a relative error of <20% for all but 
one chemical (1,2,3,4,6,7,8-HpCDD) (Figure 4.1). Incomplete dietary absorption of chemicals of higher 
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Kow (i.e. 1,2,3,4,6,7,8-HpCDD) was observed in the studies by Abraham et al. (1996) and Moser and 
McLachlan (2001), which may be the reason for the poorer prediction by our model for this chemical 
(i.e., assumption (iii) for the model was violated). No data were available to evaluate the model 
predictions of concentrations in the infant at other time points during the first year of life. This model 
evaluation provides confidence in the use of the model for predicting POP levels in infants.  
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Figure 4.1. Comparison between predicted concentrations of 2,3,7,8-TCDD, 1,2,3,7,8-PeCDD and 1,2,3,4,6,7,8-HpCDD in 
blood at Month 11 obtained from applying our model to the data of two infants from the study of Abraham et al. (1996) and 
the corresponding measured values at Month 11 from the study by Abraham et al. (1996). (B1, B2 refers to the baby 1 and 
baby 2 in the study by Abraham et al (1996), respectively) 
 
 
Predicted concentrations of chemicals in infant blood lipid using the model 
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The predicted blood lipid concentrations of the three contaminants in the infant over the first year are 
shown in Figures 4.2 a-c. For PCB153, the concentration in blood was predicted to increase gradually 
until Month 10 and appeared to stabilize afterwards, ranging from ~15 to ~20 ng/g lipid on average. This 
pattern of temporal variation was also observed for the predicted concentration of p,p’-DDE in blood, 
ranging from ~100 to ~150 ng/g lipid. For BDE47, the concentration in blood was predicted to remain 
fairly consistent at around 1.5 ng/g lipid over the first year. For all three chemicals, the predicted 
concentrations in blood increased up to Month 6 while the concentration during the final six months 
appeared to be stable (Table 4.3).  
As a means to evaluate the influence of uncertainty in model input variables on the predicted infant 
concentrations and subsequent calculations of Kfb, we estimated the uncertainty of each variable and 
performed an uncertainty analysis of our model prediction (details in Table S2). The uncertainty analysis 
was conducted by changing one variable (i.e. to (mean + SD) and (mean – SD), respectively) at a time 
while other variables remained unchanged, and then rerunning the model for the range of model 
predictions (Table S3). 
The uncertainty analysis (Figure S3) shows that the predicted infant blood concentrations of the three 
POP chemicals are all mostly influenced by two variables. The first is the daily intake of contaminants 
via breast milk. This is determined as the product of lipid based concentrations in breast milk (Cmilk); the 
fresh weight of breast milk consumed (BM (fresh weight)), and the lipid content of breast milk (lipid 
content of BM). The second variable is the body lipid mass (Mt). The intake via breast milk has a positive 
influence on the model prediction while Mt
 has a negative influence. In contrast, other variables (Csolid 
food, Qsolid food, Cdust, Qdust, Cfaeces and Qfaeces) contribute little to the uncertainty, mainly due to the fact that 
the breast milk is the dominant source of the target compounds in the scenario of the present study.   
For this reason, analysis of a possible range of variation of the predicted POP concentrations in blood 
was performed by running the model with the (mean + SD) for intake of breast milk combined with 
(mean –SD) for Mt (and then vice versa). It was assumed that all possible outcomes were located within 
these two scenarios (Figure 4.2).  
 
Calculation of Kfb 
Faeces:blood concentration ratios, Kfb, were calculated over the first year of life for each of the POPs. 
Two different ratios were calculated, one using the lipid weight-based concentrations in faeces (Kfb, (ng/g 
faecal lipid)/(ng/g blood lipid)) and one using the dry weight-based concentrations in faeces (Kfb(d), (ng/g 
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faecal dry weight)/(ng/g blood lipid)) (Figure 4.2, d-f). Overall, the trends of Kfb and Kfb(d) for each 
chemical are similar with the most noticeable differences occurring during the first four months after 
birth when the infant was exclusively breastfed. 
Kfb and Kfb(d) for PCB153 and p,p’–DDE are initially approximately 1 and  0.1 at Month 1, respectively. 
By Month 12 they are approximately 0.1 (Kfb) and 0.01 (Kfb(d)). More specifically, for PCB153, both Kfb 
and Kfb(d) increase marginally until Month 5 and decrease back to the original value by Month 7. Kfb and 
Kfb(d) then level off during the following two months and decline by one order of magnitude by the end 
of Month 9 before plateauing. The trend in Kfb and Kfb(d) for p,p’-DDE is similar to that of PCB153, 
except that the changes in PCB153 are slightly sharper.  
Kfb and Kfb(d) for BDE47 fluctuate over the first year of life, starting and ending at approximately 1 (Kfb) 
and 0.1 (Kfb(d)).  During the first 4 months, Kfb and Kfb(d) for BDE47 increased more rapidly than observed 
for the other two chemicals. After Month 4 the pattern for Kfb is similar to that of PCB153, while the 
pattern for Kfb(d) is similar to that of p,p’-DDE.  
Kfb and Kfb(d) differed significantly between the period before and after weaning for all three POPs 
(P<0.0001). These differences are far greater than the uncertainty in Kfb that arises from the uncertainty 
in the modeled concentration in blood (see Figure 4.2 d-f). 
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Figure 4.2. Model-predicted concentrations of PCB153 (a), BDE47 (b), and p,p’-DDE (c) in blood plotted together with the 
measured concentrations in faecal samples.  The model-predicted concentrations include upper and lower uncertainty bounds 
(see text for uncertainty analysis description). Calculated Kfb ((g lipid)/ (g lipid)) and Kfb(d) ((g lipid)/ (g dw)) values are 
presented, including the uncertainty bounds based on the uncertainty bounds on the predicted concentrations in infants, for 
PCB153 (d), BDE47 (e) and p,p’-DDE (f). (Ct is the concentration in blood on day t; Kfb is the faeces:blood partition 
coefficient).  
 
 
Discussion 
Comparison between previous studies and the present study  
The measured lipid content of faeces from the infant in the present study (15-21% of dry weight) is higher 
than that from two breast-fed infants studied by Korner et al. (1993) (6-10% of dry weight faeces), but 
similar to that from 10 breast-fed infants studied by Quinlan et al. (1995) (average 16% of dry weight 
faeces). The levels of the target compounds in the mother’s milk were typical for mothers residing in 
Australia (Chen et al., 2015).  
The increase in POP concentrations in faeces during the first few months after birth followed by a 
decrease after weaning was also observed by Abraham et al (1996). In their study, faecal excretion of 
dioxin-like chemicals in two breast-fed infants and a formula fed infant was studied with samples 
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collected in Month 1 and 5 before weaning and Month 11, approximately 2 months after weaning. Similar 
to our results for PCB153, BDE47 and p,p’-DDE, PCDD/F concentrations in their breast-fed infants 
were highest during Month 5.  
Our model’s prediction of the time trend in Ct during the first year of the infant’s life is similar to the 
predictions by the physiologically based pharmacokinetic (PBPK) model from Verner et al. (2009, 2013). 
A notable difference was that our model predicted an increase in Ct between birth and weaning of about 
a factor of 1.5, while Ct doubled before weaning (in an infant breast-fed for about 3 months) in the studies 
by Verner et al. (2009). The initial condition (Ct equals the concentration in the breast milk) and the 
infant’s intake of POPs were the same in the two models, so they cannot explain the difference. However, 
Verner’s model had a smaller increase in the volume of distribution of the POPs in the infant (i.e., the 
infant’s lipid weight) during the first 3 months of life. This explains why the initial increase in Ct was 
greater. Verner et al. (2013) also predicted a decrease to the original concentration (nascent level) for 
PCB153 and p,p’-DDE during the second half of the year, which was not seen in our model. However, 
Verner et al. (2013) employed a shorter breastfeeding period (3 months). When the breast-feeding period 
was shortened to three months in our model, the concentrations of PCB153 also returned to 
approximately the nascent level by the end of the first year.  
Few studies are available to compare to our Kfb values, and to our knowledge no data are available on 
Kfb in infants or on temporal variance of Kfb. Moser and McLachlan (2001) reported Kfb ((ng/g faecal 
dry weight)/(ng/g blood lipid)) for dioxins and PCBs in five adults. Their results (0.01-0.02 for PCBs) 
were very similar to the value that we observed in the infant after the weaning period (i.e. Months 9-11) 
with a dry-weight based Kfb of 0.013 for PCB153 and p,p’-DDE. While Moser and McLachlan identified 
a higher Kfb for planar chemicals (0.03-0.12 for dioxins, 0.01-0.02 for non-planar PCBs), the highest Kfb 
observed in our present study was for BDE47 (0.086), which has a non-planar structure similar to 
PCB153. BDE47 has the highest molecular weight among the analytes investigated. The chemical to 
chemical variability in Kfb cannot be explained by molecular planarity alone, and our data suggests that 
molecular size may also be a factor.   
 
Implication of our findings 
In this study evidence is provided that partitioning from the body to the faeces, as reflected by Kfb and 
Kfb(d), changes during infancy. Two possible explanations are presented below.  
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The first hypothesis is that the level of POPs in the faeces of the infant is, in contrast to adults, directly 
governed by the level in the diet. This would mean that the changes in Kfb (Figure 4.2) were not a 
reflection of changes in how the chemical moves between the baby’s tissue and faeces, but rather the 
result of chemical intake with the diet. The decrease of POP concentrations in the diet lipid coincided 
with the decrease of POP concentrations in the faecal lipid, which could be interpreted as evidence in 
support of this hypothesis. However, comparing dietary intake and faecal excretion on a mass basis gives 
a different picture. Around the time of weaning, faecal excretion gradually increased while dietary intake 
decreased substantially (Figure S4). After weaning, dietary intake increased again while faecal excretion 
gradually declined. This is in clear contradiction with the hypothesis, indicating that the faecal excretion 
is not primarily governed by the dietary intake. A small contribution of dietary intake to faecal excretion 
cannot be ruled out, but the overall pattern does not support this as the predominant factor.  
This gives rise to the second hypothesis, which is that Kfb changes because the properties of the faeces, 
in particular their partitioning properties, change during the first year of life. The decrease in Kfb after 
weaning (Figure 4.2) cannot be explained by changes in the lipid content of the faeces; the mass of 
chemical excreted daily decreased, while the mass of faecal lipid excreted daily increased (Figure S4). 
Changes associated with the physiological development of the gastrointestinal system might contribute 
to changes in the partitioning properties of the faeces, as might changes in the bacterial flora (Wall et al., 
2009).  The bacterial floral initially change over the first few months of breastfeeding and subsequently 
with the introduction of solid foods (Wall et al., 2009; Nejrup et al., 2015). Another possible explanation 
is the digestibility of the food. In our study solid foods were gradually introduced with increasing 
frequency and variety. It is widely accepted that fibre and certain other constituents (such as animal oil) 
of solid food contribute to the development of the digestive ability of the infant. Our results suggest that 
these changes decrease the sorption capacity of the faeces for the chemicals studied.  
The sampling size of one infant is an inherent limitation of our study. A single infant cannot be considered 
to be “representative” of any population. However, there was nothing unusual about this infant with 
respect to growth, nutrition pattern, or other characteristics. The detailed data on diet, infant growth, and 
the serial collection and analysis of faecal samples over the first year of life constitutes a rich dataset. In 
combination with the simple physiologically based toxicokinetic model, these data provide a testable set 
of predictions regarding the relationship between faecal concentrations of highly lipophilic POPs and 
blood lipid concentrations in infants during the developmentally critical period of the first year of life. 
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In summary, it is crucial to take Kfb variability into consideration when applying biomonitoring 
techniques that utilize faecal samples from infants. Understanding the dynamic nature of factors affecting 
chemical excretion and the associated changes in Kfb is essential to the successful application of faecal 
monitoring to assess internal exposure.  The much more stable Kfb values after weaning indicates the 
possibility of applying the technique to infants after weaning. The intra-individual variation in Kfb in 
infants before weaning requires further investigation with other infants, ideally through parallel 
collection of blood and faecal samples from the same individuals.  
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Abstract 
Early-childhood biomonitoring of persistent organic pollutants (POPs) is challenging due to the 
logistical and ethical limitations associated with blood sampling. This study investigated using faeces 
as a non-invasive matrix to estimate internal exposure to POPs. The concentrations of selected POPs 
were measured in matched plasma and faecal samples collected from 20 infants/toddlers (aged 13±4.8 
months). We observed higher rates of POP detection in faeces (2 g dry weight) than in plasma (0.5 
mL). Among the five chemicals that had detection frequencies over 50% in both matrices, log 
concentration in faces and blood were highly correlated (r>0.74, P<0.05) for p.p’-
dichlorodiphenyldichloroethylene (p,p’-DDE), 2,3’,4,4’,5-pentachlorobiphenyl (PCB118), 
2,2’,3,4,4’,5’-pentachlorobiphenyl (PCB138) and 2,2’,4,4’,5,5’-pentachlorobiphenyl (PCB153). We 
determined faeces:plasma concentration ratios (Kfb), which can be used to estimate Cb from 
measurements of Cf for infants/toddlers. For a given chemical, the variation in Kfb was considerable 
(quotient of 95% percentile and 5% percentile from 5.2-11). Between 5% and 50% of this variation 
was attributed to short term variability between successive bowel movements. This variability could 
be reduced by pooling faeces samples over several days. Some of the remaining variability was 
attributed to longer term intra-individual variability, which was consistent with previously reported 
observations of a decrease in Kfb during weaning. The strong correlations between Cf and Cb 
demonstrate the promise of using faeces for biomonitoring. Future research on the causes of the 
variability in Kfb could improve the precision of this technique.  
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5.1 Introduction 
Persistent organic pollutants (POPs), including certain organochlorine pesticides (OCPs) and 
numerous industrial chemicals (e.g. polychlorinated biphenyls (PCBs) and polybrominated 
diphenylethers (PBDEs)), are a class of ubiquitous xenobiotics that persist in the environment, 
bioaccumulate via the food chain, and pose a risk of causing adverse effects to human health 
(Nickerson, 2006; Chao et al., 2007; Langer et al., 2008; Herbstman et al., 2010; Valvi et al., 2012; 
Eskenazi et al., 2013).  Till now, PCBs, some OCPs and PBDEs have been banned or substantially 
restricted in use by many countries due to their physicochemical properties and risk profiles, and a 
decrease in exposure and associated body burden has been observed in some parts of the world (Law 
et al. 2014; Mikeš et al. 2012). Nonetheless, exposure and body burden is anticipated to continue for 
decades to come (Hung et al. 2016; Ryan and Rawn 2014; Sharma et al. 2014; Toms et al. 2012). 
Meanwhile, the knowledge gap in POP toxicology has precluded identifying both the most harmful 
compounds at current levels of exposure and safer alternatives (Chen et al. 2016; Taylor et al. 2013). 
Therefore it remains a need for the scientific community to continue to monitor and evaluate the risk 
of current and emerging POPs in our environment (Li et al. 2006) .   
Concentrations of POPs in lipid portion of blood (Cb) serves as an important indicator of human body 
burden of POPs. After entering human bodies, POPs are highly attracted to lipids and accumulate in 
adipose tissue (La Merrill et al. 2013).  It is typically assumed that POPs are in passive toxicokinetic 
equilibrium between different lipid compartments such as those of blood and adipose reservoir of the 
individuals (Haddad et al. 2000). Hence, Cb is one essential variable for the exposure-response 
analyses of POPs in toxicological studies (Price et al., 1972; Iida et al., 1992; Rohde et al., 1999; 
Wolff and Anderson, 1999; Park et al., 2007; Stapleton et al., 2009). However, there is a lack of 
adequate Cb data during potentially vulnerable developmental windows, including infancy, mainly 
due to the logistical and ethical constraints regarding sampling blood in infants and toddlers 
(Needham et al., 2005).  
For infants and toddlers, individual and longitudinal data on POP concentrations in blood samples 
are scarce due to the logistical and ethical constraints regarding sampling blood in these age groups 
(Needham et al., 2005). POP concentrations in maternal tissues (cord blood and breast milk) have 
been used instead as an indication of the body burden of the infants/toddlers. When toxicokinetic 
(TK) models are used, the confidence of body-burden prediction in infants and toddlers from POPs 
concentrations in maternal tissues is greater (Verner et al., 2009; Verner et al., 2013). Of note, the 
accuracy of any TK model is dependent on the accuracy of its parameter information (both 
toxicokinetic variables and exposure information) (Caldwell et al., 2012). For instance, half-lives of 
POPs used in a TK model for infants were derived from experiments with adults, and this 
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extrapolation might have contributed to the unexplained deviation of model-predicted POP 
concentrations in children’s blood from measurements (Verner et al., 2013).  
Faeces, a matrix that can be obtained from infants/toddlers less invasively and more conveniently, 
has been suggested to be useful for early-life biomonitoring. In toddlers, significant correlations 
between congener-specific concentrations in faeces and serum were found for 7 of 9 PBDE congeners 
studied (Sahlstrom et al., 2015). Concentrations of p,p’ DDE and PCB153 in faeces collected from 
one infant over a period of one year were recently reported to be largely independent of the dietary 
intake (Chen et al., 2016). Those results are in accordance with findings from studies on adults 
(Schlummer et al., 1998; Moser and McLachlan, 1999; Rohde et al., 1999; To-Figueras et al., 2000; 
Moser and McLachlan, 2001). Moser and McLachlan (2001) suggested that the ratio of POP 
concentrations in faeces to blood (Kfb) is a parameter of considerable practical value for describing 
the excretion of POPs from the body. However, variation in Kfb still needs to be explored and 
characterized in infants and toddlers, as variations have been observed both between individuals 
(Sahlstrom et al., 2015) and between chemicals in the same individual (Chen et al., 2016).  
The objective of this study was therefore to further assess the reliability of using faecal samples as a 
non-invasive matrix to determine body burden of a range of POPs. The concentrations of several 
OCPs, PCB congeners and PBDE congeners were measured in matched plasma and faecal samples 
from 20 infants/toddlers. The relationship between the concentrations in plasma (Cb) and the 
concentrations in faeces (Cf) was then assessed via both linear regression and analysing values of Kfb.   
 
5.2. Methods 
Study Participants 
The participants (infants/toddlers [n=20]) in this study were recruited from the ongoing study “A 
phase 2, single-centre, double blind, randomized, placebo-controlled study testing the primary 
prevention of persistent asthma in high risk children by protection against acute respiratory infections 
during early childhood using OM-85” (OMPAC). The inclusion/exclusion criteria for the OMPAC 
study are shown in Table S1. Participants were asked to donate samples twice for the present study. 
The first sampling occurred in April 2014 while the second occurred in September 2014. At each 
sampling time, one plasma sample of ~0.5 ml and faecal samples from 1-2 bowel movements (~2 g 
dry weight [dw])) were collected from each participant, and a questionnaire regarding living and 
eating habits was completed by their parents. Participants were not required to fast before the blood 
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samples were conducted. 13 participants completed two sampling periods. Four participants 
participated only in the first sampling while 3 participated only in the second.  
If a faeces sample was smaller than 1 g dw, then it was combined with the other faeces sample from 
the same sampling day prior to extraction. Otherwise the two faeces samples from the same sampling 
day were analysed separately (participant No. 5, 20 and 22 from the first sampling, and 2, 3, 8, 10, 
15 and 16 from the second sampling).   
This study received ethics approval by the University of Queensland Ethics Committee and 
Children’s Health Services Queensland Human Research Ethics Committee (approval number H/308 
NRCET; HREC reference number: HREC/12/QRCH/119). The Centers for Disease Control and 
Prevention (CDC) were determined not to be engaged in human subject research since no personally 
identifiable information was made available to CDC researchers. 
 
Sampling  
Blood was collected into a polypropylene tube with 100 units of preservative free heparin. It was then 
processed as follows to obtain plasma: (i) centrifuging at 700 x g for 10 min at room temperature; (ii) 
collecting the plasma layer down to within 0.5-1.0 cm of the top of the red cell layer (avoiding 
disturbance of white cells) using a sterile transfer pipette; (iii) centrifuging the plasma again at 700 x 
g for 10 mins to remove platelets; (iv) transferring the plasma sample into a brown Eppendorf tube 
and storing at -80°C.  
Faecal samples for each participant were collected from 1-2 defecation events right before and after 
the blood sampling. At each sampling point, only faecal material that had not been in contact with 
the inner liner of the diaper was transferred to a sheet of aluminium foil. The folded aluminium foil 
sheet was then sealed inside a plastic re-sealable bag and stored in a freezer at the participant’s home 
until transportation to the laboratory (on ice, in a cool bag). A detailed description of faecal sample 
collection and transportation is given in a previous study (Chen et al., 2015). Faecal samples were 
stored at -20°C until analysis. 
 
Analysis  
Analysis included four chlorinated pesticides (p,p’ DDE, HCB, β-HCH, γ-HCH), five PCB congeners 
(PCB 28, 118, 138, 153 and 180) and five PBDE congeners (PBDE 47, 99, 100, 153 and 154) in 
plasma and faecal samples.  
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All brown Eppendorf tubes containing plasma samples were sent to the Centers for Disease Control 
and Prevention (CDC), USA, on dry ice for analysis. POPs were measured in individual plasma 
samples using a methodology published previously (Jones et al. 2012; Sjodin et al. 2004). Briefly, 
the method includes automatic fortification of the samples with internal standard using a Gilson 215 
liquid handler (Gilson Inc.; Middleton, WI). The samples were thereafter extracted by automated 
liquid-liquid extraction (LLE) using the liquid handler. Removal of co-extracted lipids was performed 
on a silica: silica/sulfuric acid column using Rapid Trace equipment (Biotage; Uppsala, Sweden) for 
automation. Final analytical determination of the target analytes was performed by gas 
chromatography isotope dilution high resolution mass spectrometry (GC-IDHRMS) employing a 
DFS instrument (Thermo DFS, Bremen, Germany). The plasma lipid concentrations were determined 
using a commercially available test kit from Roche Diagnostics Corp. (Indianapolis, IN) for the 
quantitative determination of total triglycerides and total cholesterol. Final determinations were made 
on a Hitachi 912 Chemistry Analyzer (Hitachi; Tokyo, Japan).  
POPs were measured in faeces using a previously described method (Chen et al., 2015). In short, the 
freeze-dried, homogenized faecal samples were extracted and purified in a single step using methods 
modified from Abdallah et al. (2013). A 100 ml DioniumTM PLE cell was filled from the bottom 
upwards with 20 g of activated florisil, 20 g of sulfuric acid (40%) impregnated silica, 10 g of 
activated silica and approximately 1 g of homogenized faeces sample pre-mixed with 2 g of activated 
silica. Extraction was carried out on an ASE 350 (Dionex, Sunnyvale, CA, USA) using a solvent 
mixture of hexane:DCM (1:1, v/v ratio) at 100 °C, under a pressure of 1500 psi. The heating time, 
static time, and purge time were 5 min, 7 min and 120 s, respectively.  A flush volume of 60% was 
used. Two static cycles were used to achieve acceptable recovery (>50%) of target compounds. The 
extract was concentrated to 25 µl under a gentle N2 stream and transferred to an autosampler vial. 25 
µl (200 pg) of 13C12 -PCB141 in iso-octane was added as the recovery standard immediately prior to 
HRGC/HRMS analysis. The lipid content of the faeces sample was determined in a separate 
extraction using the same extraction method, except that no sorbents were included in the ASE cell. 
The resulting extract was then evaporated to dryness and the lipid content was determined 
gravimetrically.  
 
Quality control 
In every batch of 24 plasma samples, 3 method blank and 3 spiked sample quality control samples 
were included. The analyte quantity in the sample was blank-corrected using the median analyte 
quantity in the blanks. The method limit of qualificaiton (mLOQ) was defined as three times the 
standard deviation of blank samples or the instrumental detection limit (lowest standard confirmed to 
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have a signal to noise ratio greater than three), whichever was larger. The instrumental limit of 
detection was 0.5 pg/uL for each of the PBDEs except PBDE-209 (5 pg/uL), 0.5 pg/uL for the PCBs, 
and 5 pg/uL for the OCPs. The limit of qualification (LOQ) for each plasma sample was then 
calculated by dividing the mLOQ by the sample amount.  
 
In every batch of eight faecal samples, one diatomaceous earth sample was included as a blank and 
one pooled faeces sample was included to monitor the repeatability of the faecal sample analysis. All 
concentrations reported were blank-corrected using the median analyte amount in the blank samples. 
The mLOD was defined as three times the standard deviation (STD) of blank samples, while the 
method limit of qualification (mLOQ) was defined as 10 times the STD of blank samples. All 
chromatographic peaks were confirmed to have a signal-to-noise ratio greater than 3. The LOD and 
LOQ for each faecal sample were then calculated by dividing the mLOD and mLOQ with the sample 
amount.  
 
The average recoveries of the labelled standards ranged from 61% - 93% for all chemicals (Table 
S2). Only results that were above the LOQ were used in the regression analysis. A more conservative 
criterion was used for faecal samples because the variability in matrix properties contributes to a 
higher uncertainty in the measured concentrations. For summarizing data, results for plasma below 
the LOQ were imputed as LOQ/(2)1/2; results for faeces below the LOD were imputed as LOD/(2)1/2  
and for faeces between the LOD and the LOQ were imputed as the average of LOD and LOQ.  
 
Concentrations of target POPs in faeces were determined on both a dry-weight and lipid-weight basis. 
In those cases where two samples from the same day were analysed (Table S3), the dry-weight based 
concentrations of POPs in a given individual were more consistent than lipid-weight based 
concentrations (paired t test done on percent differences of both lipid-based and dry-weight based 
data, P= 0.005, n=38). Therefore the dry-weight based concentrations were used for the data analysis.  
 
Statistical Analysis 
Linear-regression analysis of the relationship between Cb and Cf, and ANOVA of Kfb among 
chemicals were performed using GraphPad Prism 6 (GraphPad Software, Inc., USA). Intra-individual 
variance in Kfb was measured by calculating the percent difference (% difference) of two values for 
each participant. Intraclass correlation (ICC) was used for comparing the influences of intra-
individual and inter-individual variance on the whole variance observed for a certain group, whereby 
single measurements of The Two-Way Random Absolute Agreement ICC values were usedvia SPSS 
 102 
 
23 (Chicago, USA).  Other statistical evaluation of the analytical and demographical data was 
performed using Microsoft Excel 2013 (Microsoft, Redmond, WA, USA). 
 
 
5.3. Results 
The chemical-specific analytical results are shown in Tables S4 and S5. Eight chemicals (β-HCH, γ-
HCH, PCB28, PCB180, BDE99, BDE100, BDE153 and BDE154) were not included for regression 
analysis due to low detection frequencies in both plasma and faecal samples. The detection frequency 
of BDE47 was 88% in faeces but only 12% in plasma and hence it was not included in the regression 
analysis either. The faeces:blood concentration ratios (Kfb) values for all plasma-faeces sample pairs 
are shown in Table S6. For convenience, Cb is used to represent the lipid-weight normalized 
concentration in plasma and Cf is used for the dry-weight normalized concentration in faeces in the 
following text. Due to the varying number of samples that were collected from each participant, one 
pair of plasma and faecal samples from every individual was randomly chosen to form a cross-
sectional dataset. The cross-sectional dataset is summarized in Table S7.  
 
5.3.1 Cohort information 
Basic information regarding the infants/toddlers is compiled in Table 1 (more details are shown in 
Tables S8 and S9). The participants were evenly distributed in terms of sex and delivery type. The 
average age of the participants was 13 months (ranging from 5.6 months to 24 months). The majority 
of participants (60%) were weaned before the first sampling time point. One participant took 
antibiotics within a week before or after sampling, and one participant took antibiotics on the 
sampling day. No bowel complaints were reported for any participant on the sampling days. 
Table 5.1. General information about recruitment in this study.  
Participants (n=20) 
 
Number 
(% of all recruits) 
Gender   
        Male  8(40%) 
        Female 12(60%) 
Delivery type   
        Normal vaginal delivery (NVD)  9(45%) 
        Caesarean Section (CS)  11(55%) 
Participants’ ages (months) at sampling time (average ± standard deviation (median)) 13±4.8 (14) 
Nutrition   
       fully breast-fed  0(0%) 
       weaning (partially breast-fed) 5(25%) 
       weaned in between two sampling points 3(15%) 
       weaned before the first sampling time point 12(60%) 
Antibiotic taken within a week before or after sampling 1(5%)(Participant No.23) 
Antibiotic taken on the sampling day 1(5%)(Participant No.15) 
Bowel complaints (within 3 days before and after sampling) 0 
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5.3.2 Concentrations of POPs in Plasma (Cb) 
The Cb of four chlorinated pesticides (p,p’-DDE, HCB, β-HCH and γ-HCH), five PCB congeners 
(PCB28, 118, 138, 153 and 180) and five PBDE congeners (BDE 47, 99, 100, 153 and 154) from 20 
infants/toddlers are summarized in Table 2. Results from pooled serum samples collected in 2006-
07 from infants in Australia aged 0.5-1.5 years old (Toms et al., 2009) are also included in Table 2 
for comparison.  
In the cross-sectional cohort, p,p’ DDE was detected in all the plasma samples. HCB, PCB118, 138, 
153 and 180 were qualified in 55-75% of the samples. Other analysed chemicals were qualified in 
<50% of the samples.  p,p’ DDE had the highest Cb, with a mean of 290 ng/g lipid, followed by HCB 
(10) and then the PCB congeners (1.1-6.8). Mean values of Cb were similar to mean lipid-normalized 
concentrations in the pooled serum sample collected in 2006-2007 from Australian infants, except 
for the BDEs 47, 99 and 100, which had lower concentrations in our data set (Figure S1).  
Cb was not normally distributed at either sampling period for any of the chemicals (D
’Agostino & 
Person normality test). The Cb of p,p
’-DDE ranged by more than two orders of magnitude (9.6 - 3400 
ng/g lipid) among participants. The geometric means of Cb of PCB 138, 153, 180 and HCB were 2.7, 
3.3, 2.0, and 8.8 ng/g lipid, respectively. Concentrations of DDE, HCB, PCB118, 138 and 153 in 
plasma are plotted against participant age in Figure S2. 
Table 5.2. Lipid content and POP concentrations1 (ng/g lipid) in infants’ and toddlers’ plasma in the current study and 
the averaged concentrations in pooled samples collected from 2006-07. 
 
Current study (n=20) 
Australian pooled 
samples (age 0.5 – 
1.5 years; male and 
female combined) 
 Chemical concentration Chemical LOD  
 
DF%2 
mean 
(STD) 
GM3 (95% CI) median min max 
mean 
(STD) 
min max mean 
Lipid content 
(%) 
-- 0.52 (0.078) 0.52 (0.48-0.55) 0.53 0.39 0.68 -- -- -- -- 
p,p’-DDE 100 290 (750) 100 (55,180) 96 9.6 3400 6.4 (1.9) 3.3 11 210 
HCB 65 10 (6.1) 8.8 (6.7, 12) 8.8 <LOD 28 6.4 (1.9) 3.3 11 6.8 
β-HCH 30 5.9 (2.9) 5.4 (4.5, 6.5) 5.3 <LOD 15 6.4 (1.9) 3.3 11 11 
γ-HCH 0 4.5 (1.3) 4.3 (3.8,5.0) 4 <LOD <LOD 6.4 (1.9) 3.3 11 NA4 
PCB28 20 1.1 (0.47) 1.0 (0.85, 1.3) 1.1 <LOD 2.2 1.3 (0.38) 0.66 2.2 1.2 
PCB118 55 2.6 (2.6) 1.8( 1.3, 2.7) 1.6 <LOD 12 1.3 (0.38) 0.66 2.2 1.9 
PCB138 70 5.5 (8.4) 2.7 (1.7, 4.7) 2.7 <LOD 31 1.3 (0.38) 0.66 2.2 2.8 
PCB153 75 6.8 (11) 3.3 (2.0, 5.7) 3.3 <LOD 42 1.3 (0.38) 0.66 2.2 4.8 
PCB180 55 3.2 (4.4) 2.0 (1.3, 3.0) 1.7 <LOD 20 1.3 (0.38) 0.66 2.2 4.3 
BDE47 20 2.7 (1.3) 2.5 (2.1,3.0) 2.6 <LOD 7.1 3.1 (0.93) 1.6 5.4 20 
BDE99 0 0.91 (0.28) 0.87 (0.75, 1.0) 0.82 <LOD <LOD 1.3 (0.38) 0.66 2.2 7.7 
BDE100 20 1.1 (0.44) 0.99 (0.83, 1.2) 1.0 <LOD 2.3 1.3 (0.38) 0.66 2.2 4.5 
BDE153 40 2.4 (2.1) 1.9 (1.4, 2.5) 1.6 <LOD 9.4 1.7 (0.72) 0.66 3.4 3.1 
BDE154 0 0.91 (0.28) 0.87 (0.75, 1.0) 0.82 <LOD <LOD 1.3 (0.38) 0.66 2.2 0.4 
1POPs concentration: LOD/(2)1/2 was used for the concentration under detection limit when the mean and GM were calculated.     
2DF%, detection frequency.   
3GM: geometric mean  
4NA: not analysed. 
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5.3.3 Concentrations of POPs in faeces (Cf) 
The Cf of four chlorinated pesticides (p,p’-DDE, HCB, β-HCH and γ-HCH), five PCB congeners 
(PCB28, 118, 138, 153 and 180) and five PBDE congeners (BDE 47, 99, 100, 153 and 154)  in faecal 
samples from 20 infants/toddlers are summarized in Table 3.  p,p’-DDE, HCB and BDE47 were 
qualified above LOQ in 90% of faecal samples, followed by PCB118 (80%), PCB138 and PCB153 
(both 75%). Other analysed chemicals were qualified in <50% of the samples. p,p’-DDE had the 
highest concentration in faeces  (mean 1.7 ng/g dw), followed by BDE47 (0.37 ng/g dw) and then 
PCB 153, HCB and other PCB congeners (0.084 - 0.20 ng/g dw).  
 
Similarly to the results for plasma, Cf was not normally distributed at either sampling period for any 
of the chemicals (D’Agostino & Person normality test). The geometric mean Cf of p,p
’ DDE was 0.61 
ng/g dw, while for the PCBs it ranged from 0.019 - 0.068. The geometric mean Cf of HCB was 0.069, 
while for the PBDEs it ranged from 0.0019 – 0.20. The concentrations of DDE, HCB, PCB118, 138 
and 153 in faecal samples are plotted for every participant along with their ages in Figure S3. 
 
Table 5.3. POP concentrations1 (ng/g dw) in infants’ and toddlers’ faecal samples.  
   Chemical concentration Chemical LOD Chemical LOQ 
 
  
DF%2 
mean 
(STD) 
GM3 (95% CI) median min max 
mean 
(STD) 
min max 
mean 
(STD) 
min max 
Lipid 
content 
(%) 
  
-- 
12 
(5.0) 
11 (9.4, 14) 11 6.0 23 -- -- -- -- -- -- 
p,p’-
DDE 
  
90 
1.7 
(3.3) 
0.61 
(0.31,1.2) 
0.75 <LOD 14 
0.014 
(0.012) 
0.0061 0.061 
0.038 
(0.017) 
0.02 0.084 
HCB 
  
90 
0.090 
(0.056) 
0.069 (0.045, 
0.11) 
0.092 <LOD 0.21 
0.011 
(0.0063) 
0.005 0.032 
0.036 
(0.021) 
0.016 0.11 
β-HCH 
  
40 
0.055 
(0.1) 
0.01 (0.0042, 
0.026) 
0.0062 <LOD 0.36 
0.0035 
(0.0021) 
0.0015 0.010 
0.012 
(0.0071) 
0.005 0.035 
γ-HCH 
  
20 
0.014 
(0.010) 
0.011 
(0.0079, 
0.016) 
0.0097 <LOD 0.035 
0.0092 
(0.0074) 
0.002 0.036 
0.031 
(0.025) 
0.008 0.12 
PCB28 
  
30 
0.051 
(0.089) 
0.026 (0.016, 
0.043) 
0.022 <LOD 0.41 
0.022 
(0.010) 
0.011 0.05 
0.073 
(0.035) 
0.037 0.17 
PCB118 
  
80 
0.084 
(0.093) 
0.042 (0.023, 
0.078) 
0.044 <LOD 0.28 
0.0068 
(0.0051) 
0.002 0.021 
0.02 
(0.017) 
0.005 0.071 
PCB138 
  
75 
0.14 
(0.31) 
0.046 (0.023, 
0.078) 
0.041 <LOD 1.4 
0.0076 
(0.0057) 
0.002 0.024 
0.024 
(0.019) 
0.007 0.08 
PCB153 
  
75 
0.20 
(0.41) 
0.068 (0.035, 
0.13) 
0.059 <LOD 2.1 
0.013 
(0.0070) 
0.005 0.035 
0.04 
(0.023) 
0.017 0.12 
PCB180 
  
20 
0.069 
(0.19) 
0.019 (0.010, 
0.034) 
0.013 <LOD 0.83 
0.013 
(0.0063) 
0.007 0.03 
0.044 
(0.021) 
0.023 0.1 
BDE47 
  
90 
0.37 
(0.42) 
0.20 (0.11, 
0.36) 
0.27 <LOD 1.9 
0.015 
(0.0081) 
0.005 0.037 
0.050 
(0.027) 
0.016 0.12 
BDE99 
  
45 
0.034 
(0.054) 
0.014 
(0.0073, 
0.028) 
0.018 <LOD 0.24 
0.0048 
(0.0038) 
0.0015 0.017 
0.016 
(0.013) 
0.005 0.056 
BDE100 
  
15 
0.023 
(0.030) 
0.015 
(0.010,0.022) 
0.015 <LOD 0.14 
0.017 
(0.0099) 
0.004 0.044 
0.057 
(0.033) 
0.015 0.15 
BDE153 
  
20 
0.051 
(0.14) 
0.0092 
(0.004, 
0.019) 
0.0049 <LOD 0.56 
0.0072 
(0.0038) 
0.0035 0.02 
0.024 
(0.013) 
0.012 0.067 
BDE154 
  
0 
0.0020 
(0.001) 
0.0019 
(0.0015, 
0.0022) 
0.0019 <LOD <LOD 
0.0028 
(0.0013) 
0.0015 0.0069 
0.0092 
(0.0044) 
0.005 0.023 
1POP concentrations: LOD/(2)1/2 was used for the concentrations <LOD when the mean and GM were calculated..  The average of LOD and LOQ was 
used for results between LOD and LOQ when the mean and GM were calculated.     2DF%, detection frequency (>LOD).    3GM: geometric mean  
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5.3.4 Concentrations in faeces in relation to concentrations in matched plasma samples  
The association between log10 Cb and log10 Cf was assessed for DDE, HCB, PCB118, 138 and 153 
using linear regression (see Tables S10 and S11). The regressions were significant with values of r2 
ranging from 0.55-0.77, except for HCB (r2 of 0.022). These relationships are illustrated in Figure 1.  
The faeces:blood concentration ratios (Kfb) determined from the cross-sectional data set are shown in 
Table 4. The Kfb values were normally distributed for p,p’-DDE, HCB and PCB138 (D’Agostino & 
Person normality test). The mean Kfb values for p,p’-DDE, HCB and PCB138  were 0.0081, 0.024 
and 0.018, respectively. The coefficient of variance (CV) of Kfb was 47%, 66% and 57% for p,p’-
DDE, HCB, and PCB138, respectively. The Kfb values for PCB 118 and PCB 153 ranged from 0.010-
0.11 and 0.0072-0.073, respectively.  
 
 
Figure 5.1. Linear regression for five chemicals between the log10 transformed (dry-weight based) faecal concentration 
and (lipid-weight based) plasma concentration. Mean LOD for plasma concentrations and mean LOQ for faecal 
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concentrations are shown in the figures. The 95% confidence intervals are shown with dashed lines (Details are in Table 
S11). 
 
5.3.5 Sources of variability in Kfb 
The influence of short-term (i.e. two-bowel-movement) variation in Kfb was assessed using a sub-
group of participants (participant No. 3, 8, 10, 15, 16, 20, and 22) who provided two faeces samples 
collected successively within a day. These samples were analysed separately. The percentage 
difference in Cf between successively collected samples was as high as 48% (Table S3). These Cf 
data were used to calculate two Kfb values for each individual, whereby Cb was assumed to be the 
same for the two successively collected faecal samples (see lower right part of Table 4). Two-Way 
Random Absolute Agreement ICC coefficients were calculated for the paired Kfb values for the 7 
individuals in this sub-group. For HCB and the PCBs the ICC coefficients ranged from 0.70-0.95, 
indicating that most of the observed variability in Kfb was due to inter-individual differences, while 
5-30% was due to short term variability between bowel-movements. A lower value of 0.50 was 
obtained for p,p’-DDE, indicating that half of the observed variability in Kfb was due to short term 
variability between bowel-movements. 
 
A second sub-group of the participants (No. 3, 8, 10, 12, 15, 17, 20, 22, 23 and 25) provided samples 
collected ~5 months apart, which allowed investigation of the long-term intra-individual variation in 
Kfb. The percentage difference (% difference) between the two Kfb values varied from 18 to 112% 
for p,p’-DDE, 39 to 100% for HCB, 19 to 59% for PCB118, 13 to 82% for PCB138, and 0 to 75% 
for PCB153 (see upper right part of Table 4). The Two-Way Random Absolute Agreement ICC 
values were above 0.84 and 0.85 for PCB 118 and 153, respectively, indicating that ~15% of the 
observed variability in Kfb was due to intra-individual variability. The ICC values for DDE, HCB and 
PCB 138 were 0.32, 0.50 and 0.47, respectively, indicating the 50% or more of the total variability 
was due to intra-individual variability for these chemicals.  
 
 
5.4 Discussion 
Compared to blood, using faeces for POP biomonitoring in infants/toddlers has the benefit of easier 
access to sufficient sample to quantify the contaminants. The 2 g of faeces in our study contained 6 
times more p,p’-DDE than 1 mL of blood (equivalent to about 0.5 mL of plasmas used in this study). 
Since a larger effective sample size can be achieved for faecal samples, it allows for better detection 
frequencies for analytes present at low concentrations.  
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Table 4. Kfb ([g lipid]/ [g dw]) of the cross-sectional dataset for selected POPs (left columns), of the sub-group of 10 
participants with two Kfb values 5 months apart (right top columns), and of the subgroup of 7 participants with two Kfb 
values estimated from two successive bowel movements (right bottom columns).  
Participantsa DDE HCB 
PCB 
118 
PCB 
138 
PCB 
153 
Participants DDE HCB 
PCB 
118 
PCB 
138 
PCB 
153 
1 -- -- -- -- -- 3-1 0.012 -- 0.040 0.037 0.027 
2 -- -- -- -- -- 3-2 0.0072 -- 0.033 0.028 0.021 
3 0.0072 0.0055 0.033 0.028 0.021 8-1 0.0041 -- 0.020 0.008 0.012 
5 0.0079 -- -- -- -- 8-2 0.0025 -- 0.015 0.013 0.012 
8 0.0041 0.0070 0.020 0.0080 0.012 10-1 0.006 -- -- -- -- 
9 0.0089 -- -- -- -- 10-2 0.0076 -- -- -- -- 
10 0.0076 -- -- 0.0076 0.0072 12-1 0.0094 0.049 0.050 -- 0.023 
11 0.016 -- -- 0.018 0.020 12-2 0.017 0.016 0.040 -- 0.030 
12 0.017 0.016 0.0400 0.025 0.030 15-1 0.0033 -- 0.040 0.022 0.020 
15 0.0033 0.0030 0.040 0.022 0.020 15-2 0.0018 -- 0.053 0.025 0.024 
16 0.0061 0.0065 0.033 0.025 0.031 17-1 0.0092 -- -- -- -- 
17 0.0063 -- -- -- -- 17-2 0.0063 -- -- -- -- 
18 0.0095 0.023 -- -- -- 20-1 0.017 -- -- -- -- 
20 0.0048 0.011 0.11 0.041 0.073 20-2 0.0048 -- -- -- -- 
22 0.0073 0.0080 0.010 0.013 0.011 22-1 0.0073 -- 0.010 0.013 0.011 
23 0.0097 -- -- -- -- 22-2 0.005 -- 0.0060 0.0060 0.0050 
24 0.0033 0.020 -- -- -- 23-1 0.016 -- -- -- -- 
25 0.010 0.0029 0.039 0.023 0.038 23-2 0.0097 -- -- -- -- 
26 0.0079 0.0098 0.021 0.0095 0.0130 25-1 0.010 0.0029 0.039 0.023 0.038 
27 0.011 0.0059 0.048 0.051 0.050 25-2 0.012 0.0043 0.053 0.055 0.052 
Mean 0.0081 0.0099 0.039 0.023 0.027  Intra-individual variability (% difference)
c  
 
 
 
Std. Deviation 0.0038 0.0065 0.027 0.013 0.019 Min 18 39 19 13 0 
CV 46% 66% 69% 58% 70% Mean 49 70 31 49 29 
Passed normality test 
(a=0.05) 
YES YES NO YES 
NO 
 
 
Max 112 100 59 82 75 
5% percentile (P5) 0.0033 0.0029 0.01 0.0076 0.0072 ICCd (n) 0.32(10) 0.50(2) 0.84(6) 0.47(5) 0.85(6) 
median 0.0078 0.0075 0.036 0.022 0.021 Participants DDE HCB PCB 
118 
PCB 
138 
PCB 
153 
95% percentile (P95) 
percentile 
0.017 0.023 0.11 0.051 0.073 3-2-1 0.0045 0.0039 0.034 0.025 0.020 
P95/P5 5.2 7.9 11 6.7 10 
3-2-2 0.0076 0.0075 0.034 0.031 0.022 
8-1-1 0.0035 0.0083 0.027 0.0063 0.013 
Results in adultsb  (n) -- 4 4 5 5 8-1-2 0.0047 0.0058 0.013 0.0096 0.011 
Mean -- 0.024 0.023 0.018 0.016 10-2-1 0.0072 -- -- 0.014 0.0088 
Std. Deviation -- 0.005 0.013 0.008 0.007 10-2-2 0.0081 -- -- 0.00047 0.006 
CV -- 21% 57% 44% 44% 15-1-1 0.0023 0.0040 0.051 0.021 0.02 
a The code in column “participants” indicates the participant number (first 
number), the sampling occasion number (second number) and the order of two 
bowel movements (third number). 
b Reference: (Moser and McLachlan, 2001) 
c %difference =
|𝑉𝑎𝑙𝑢𝑒 1−𝑉𝑎𝑙𝑢𝑒 2|
(value 1+value 2)
2
 × 100 
d: Two-Way Random absolute agreement ICC was used (single measures are 
presented here) 
--:not calculated or not reported due to lack of data .  
 
15-1-2 0.0013 0.0017 0.053 0.029 0.028 
16-2-1 -- 0.0061 0.043 0.026 0.041 
16-2-2 -- 0.0068 0.022 0.025 0.021 
20-2-1 0.011 -- -- -- -- 
20-2-2 0.025 -- -- -- -- 
22-1-1 0.01 0.0079 0.014 0.018 0.016 
22-1-2 0.0047 0.0093 0.0065 0.0083 0.0058 
                             Intra-individual variability (% difference)b  
 
 
Min 12 11 0.74 3.9 10 
Mean 45 42 42 44 42 
Max 79 81 74 97 91 
 ICCc (n) 0.50 (7) 0.82(5) 0.70(5) 0.89(6) 0.95(6) 
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5.4.1 The relationship between Cf and Cb 
As outlined in the results for the cross-sectional group of participants, the log-transformed Cb and Cf 
were significantly and linearly correlated for p,p’-DDE, PCB118, 138, and 153. The relationship 
between Cb and Cf is given by: 
 
𝑙𝑜𝑔𝐶𝑓 = 𝑘𝑙𝑜𝑔𝐶𝑏 + 𝑏                         (1) 
 
where k is the slope of the regression line, and the b is the y-intercept. Values for k and b are provided 
in Table S11. Equation 1 can be transformed into:  
 
   𝐶𝑓 = 10
𝑏𝐶𝑏
𝑘
                                      (2) 
 
A k of 1 reflects a linear relationship between Cf and Cb.  k was slightly less than 1 for p,p
’-DDE, and 
slightly larger than 1 for PCB138 and PCB153, while the 95% confidence intervals of all chemicals 
included 1. Hence the data overall show a near linear relationship between Cf and Cb, and a linear 
relationship could not be excluded. 
 
Among the five chemicals that had high detection frequencies (>55%) in both matrices, only for HCB 
was the correlation between log transformed Cf and Cb neither linear nor significant. This can be 
attributed to the fact that HCB had the narrowest ranges in Cb and Cf and all of the data were close to 
the LOD/LOQ (Figure 1). 
 
The relationship between Cf and Cb was chemical specific. The Kfb value for p,p’-DDE was 
significantly different from the Kfb values for the three PCB congeners (one-way ANOVA, Friedman 
test,  P<0.001). This indicates that chemical specific Kfb values are needed for biomonitoring 
purposes.  
 
5.4.2 Sources of intra-individual variability in Kfb 
The use of faeces as a biomonitoring tool is dependent on having an accurate and precise measure of 
Kfb. In this study the variability in Kfb was high; the variation of Kfb in the cross-sectional dataset 
ranged from a factor of 5.2 to 11 in terms of the quotient of 95% percentile and 5% percentile. ICC 
assessment shows that both short term and long-term intra-individual variability contribute 
significantly to the overall variability in Kfb.  The low variation of replicate Cf measurements in the 
QA sample (a pooled faecal sample with concentrations similar to the real samples; Table S2 and 
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Figure S4) indicate that the short-term variability is not largely attributable to analytical error. Rather, 
short-term variability is, perhaps, attributable to variability in meal composition and the digestive 
process on the scale of hours/meals. Short-term variability can be reduced by pooling samples over 
longer period of time. In previous studies with adults, faeces samples were pooled over 3 days, and 
the inter-individual variability in Kfb was smaller than in this study. or instance, the CV of Kfb for 
PCB153 was 44% for adults, while it was 70% for infants/toddlers.(Moser and McLachlan, 2001).  
 
Although the intra-individual variability observed in individuals who provided samples 5 months 
apart could be due to the short-term variability discussed above, it is also possible that it was partly 
due to changes occurring over a longer time period. Long-term intra-individual variability was 
observed in our previous study, where Kfb of PCB153, BDE  47 and p,p’-DDE in a single infant 
decreased by more than an order of magnitude between the age of 4 months and 12 months. It was 
hypothesized that the change in diet during weaning was a major contributing factor to this decrease 
(Chen et al. 2006). In the current study, the mean Kfb values of p,p
’-DDE declined slightly with age 
(Figure S5), but no significant trends with age were found for the other studied chemicals. 
Meanwhile, the mean Kfb was lower for the weaned group but the difference was not significant 
(Figure S6). There is a good agreement between Kfb for participants that were aged >8 months in this 
study and the earlier study (Figure S7). Variability in Kfb could possibly be reduced by focusing on 
toddlers with a narrow age range and more clearly defined weaning status.  
 
5.4.3 Sources of inter-individual variability in Kfb 
The ICC analysis indicates that some of the variability in Kfb is due to inter-individual differences. 
To assess sources of inter-individual variability in Kfb values, a mechanistic understanding of the 
contaminant excretion process can be helpful. Moser and McLachlan (2001) proposed that 
gastrointestinal exchange of persistent lipophilic organic pollutants (4.5 < Kow < 7.5) can be viewed 
as two processes that are operating simultaneously: absorption of the contaminants from the diet, and 
excretion of the contaminants from the body’s reservoirs via the faeces. They hypothesized that 
during dietary lipid absorption in the upper part of the intestine, the lipid absorbed into the intestinal 
wall increases the lipid content locally, diluting the POP concentrations there and resulting in a net 
diffusive uptake of POPs from the lumen (gut contents). The absorbed lipids are transported from the 
intestinal wall into the lymph and blood, and with time the lipid content in the intestinal wall returns 
to its original state. In parallel the gut contents move down the intestinal tract to the lower small 
intestine and large intestine, where there is a much slower exchange rate of lipophilic chemicals 
between the intestinal wall and the lumen. Although there is a POP diffusion gradient from the 
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intestinal wall into the lumen here, the low exchange rate of lipophilic chemicals in the lower 
intestinal tract prevents a significant mass transfer of POPs from occurring. The POP content of the 
faeces is thus determined by a quasi-partitioning equilibrium that is established in a transient state 
between the lumen and a fat-flushed intestinal wall during food digestion in the upper small intestine. 
This has been dubbed the “fat-flush” theory.   
 
Another mechanistic model of contaminant exchange in the gut focuses on enterohepatic circulation. 
In this model digestive tract elimination of POPs is not due to a diffusive process, but rather to biliary 
excretion. POPs are excreted as metabolites in bile to the upper intestine. Once in the lumen the 
metabolites are broken down and the chemical reverts to its lipophilic self. This chemical is then 
reabsorbed in the intestine, and then back to the liver where it converted to the metabolite which is 
then excreted via bile and so on (Jandacek and Tso 2007; Jandacek et al. 2014). Based on this theory, 
faecal excretion of POPs is also expected to increase with increasing tissue levels. However, the 
factors that can influence the Kfb values would be different. We employ these two hypotheses in the 
discussion of the results below.  
 
Based on the “fat-flush” theory, inter-individual variability in Kfb could be caused by several variables 
such as: a) the partitioning capacity of the gut contents at the time/location in the upper gut when 
equilibrium occurs; b) the extent of the fat flush, i.e. how much are the POPs in the wall of the small 
intestine diluted by recently absorbed dietary lipids at the time/location of equilibrium and c) the 
extent of the reduction of the dry weight of the gut content between the time/location of equilibration 
and excretion of the faeces. According to the “enterohepatic circulation” theory, it is conceivable that 
microbial processes affect the enterohepatic circulation and thereby the Kfb of some POPs (Meijer et 
al. 2006; Snedeker and Hay 2012). For instance, microbial change would result in slowing down the 
breakdown of metabolites so that some of the breakdown occurs too late for the re-release POP to be 
reabsorbed.  
 
Although this study was not designed to investigate the sources of inter-individual variability, our 
results provide some evidence that microflora composition does not have a strong influence on Kfb. 
Two participants (No. 15 and 23) had taken antibiotics shortly before the sampling time point. 
Although this likely strongly affected the gut microflora, the Kfb values were similar to both the values 
from the second sampling of the same participants and to the values of the other participants (with 
one exception: participant No. 15 had a markedly lower Kfb for p, p
’- DDE). Considering the sources 
of variability suggested by the fat-flush theory, standardizing the diet could be a possibility to reduce 
the effect of variables a) and b). However, this may not be easy, especially with infants/toddlers.  
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Previously, as the first study published for this technique for small children, Sahlström et al (2015) 
investigated the feasibility of feaces for biomonitoring of PBDEs in toddlers. Tri-decBDEs were 
determined in faeces from 22 toddlers (one sample per toddler) and results compared to matched 
serum samples (one sample per toddler). In contrast, Sahlstrom focused more on developing linear 
regression models for estimation of ln transformed Cb from ln transformed Cf.  A similarly 
considerable range of variations in Kfb was observed, e.g. with a factor of 7.5 for BDE47 and 38 for 
BDE 207 in terms of the quotient of 95% percentile and 5% percentile. However, the authors did not 
further discuss its reasons and its indications for the scope of the technique.  
 
In summary, this work is among the first studies that provide insight into the potential of faeces for 
biomonitoring POPs in infants and toddlers.  With participants that were not recruited from a random 
population of infants and toddlers, this study is an addition to the basis of utilizing faeces. The 
presence of strong correlations between Cf and Cb demonstrate the promise of this technique for p, 
p’- DDE and several PCB congeners. The considerable variability in Kfb indications that there are 
limits to the technique as we applied it. However, our analysis of the sources of variability suggest 
that there are ways to improve the precision and make faeces a more powerful biomonitoring tool.  
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Summary 
It has been postulated that a wide range of POPs in the faeces of adults is mainly a result of 
proportional exchange of the POPs from the body’s reservoir into the intestine. Based on this 
postulation, this thesis investigated the relationship between the POP concentrations in faeces and the 
body burden (assessed via breast milk and blood samples) in infants/toddlers, aiming to discover an 
alternative non-invasive method for characterizing the early-childhood body burden of POPs.  
The paucity of existing data on exposure of POPs in early childhood and validation of the method for 
measuring POPs in faeces were addressed in preliminary studies. The similarity of POP profiles 
observed between the existing blood data and the collected faeces samples (Chapter 2) held promise 
for the viability of faecal analysis as an early-exposure biomonitoring tool. Subsequently, matched 
breast milk and faecal samples from 10 mother-child pairs were obtained and analyzed with the 
distribution of individual exposure levels of infants/toddlers and the correlation between exposure 
and faecal concentrations being investigated for the first time (Chapter 3). Concentrations of 
individual chemicals varied typically between 1 and 2 orders of magnitude within all maternal milk 
samples. This variation was reflected in the concentrations found in the faeces. This range was much 
greater than the uncertainty in the concentration measurement, indicating that faeces provides a good 
basis for assessing the classification of exposures and the possible relationships between different 
bio-matrices.  
The intra- and inter-individual variability of the faeces:blood concentration ratio Kfb are the main 
concerns regarding the practical use of faeces as an alternative matrix for assessing the body burden 
of POPs. During infancy, the intestinal transit time, composition of diet, and absorption rate of 
intestinal food are all quite different from adults. With the advantage of the easy accessibility of 
faeces, a longitudinal study on the change of concentrations of three typical POPs (derived from 
Chapter 3) in faeces from one infant was carried out (Chapter 4). This study demonstrated the intra-
individual variability of Kfb. The monthly variations in POP concentrations in an infant’s faeces over 
the first year of life was compared to modelled blood concentrations, enabling the complete profile 
of Kfb for the first year of life to be shown for the first time. While the sampling size (of one infant) 
is an inherent limitation in this part of the study, the methodology of the study warrants application 
in future studies in a larger group of infants.  
As indicated in Chapter 4, it is crucial to take Kfb variability into consideration when applying 
biomonitoring techniques that utilize faecal samples from infants. The variability in Kfb values in 
infants was found to be less marked once breastfeeding has ceased. With this result in mind, in order 
to further investigate the reliability of the approach using convenient faecal samples as a non-invasive 
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matrix to determine body burden of POPs in infants/toddlers, the relationship between the 
concentrations of chemicals in matched plasma and faecal samples from 20 infants/toddlers from 
Australia was assessed in Chapter 5.  
 
Concluding remarks 
A range of POPs could be detected and measured in faeces 
Faeces excretion seems to be responsible for a large part of the overall elimination of selected POPs 
in infants. The excretion based half-lives of p,p’-DDE, PCB 153 and PBDE 47 obtained by the one-
compartment model from Chapter 4 (data not shown) were quite close to the empirical half-lives in 
adults (derived from subjects who had been accidentally exposed to high levels of POPs and estimated 
by a one-compartment kinetic model with first-order elimination from lipids). The role of faeces as a 
major excretion pathway for POPs has also been suggested in adults.  
Even as the most available matrix from the human body, faeces is seldom used in POP biomonitoring. 
Undoubtedly, efforts to explore this matrix are likely to have been inhibited by its physical properties 
(appearance and odour) and hygiene risks. In addition, the complexity of faeces in terms of chemical 
analysis has further hindered the progress of related research. Notwithstanding, advances in sample-
preparation techniques may facilitate a more widespread use of this matrix. A one-step 
extraction/clean-up method for the determination of POPs in faeces was developed and adopted in 
Chapters 4 and 5. This method was first developed for and applied to soil studies, but has been 
modified successfully for faeces. It provides numerous advantages over traditional methods (used in 
Chapters 2 and 3) including reduced solvent consumption and analysis time, minimal sample 
contamination and high sample throughput. However, the scope of the application of this methods is 
restricted to acid-resistant chemicals only. The development of more advanced methods covering 
acid-sensitive chemicals would be needed in order to include a more comprehensive suite of 
chemicals in such biomonitoring programs.  
 
Faecal concentrations of POPs predict the infants/toddlers body budren  
In Chapter 3, a monotonic correlation for a range of POPs was found between human milk and infant 
faeces; two possible mechanisms are postulated. The first mechanism is that a portion of the ingested 
chemical is excreted in the faeces without having been absorbed systemically, and that the 
concentration in the milk is a good surrogate for the infant’s ingestion of the chemical. The second 
mechanism is that the chemical concentration in the faeces is controlled by the chemical concentration 
in the body, and that the concentration in the milk is a good surrogate for the concentration in the 
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body of the infant during the time of breastfeeding. A mixture of these two mechanisms may also 
operate depending upon the specific chemical and the influence of exposure matrices (food, dust, air 
or other matrix).   
Further elucidation of these two mechanisms was achieved in Chapter 4. After comparing dietary 
intake and faecal excretion on a mass basis at around the time of weaning, faecal excretion was seen 
to gradually increase while dietary intake decreased substantially. After weaning, dietary intake 
increased again while faecal excretion gradually declined (Figure S4, Chapter 4). This clearly 
contradicts with the hypothesis that the level of POPs in the faeces of the infant is, in contrast to 
adults, directly governed by the level in the diet. These data favours the hypothesis that faecal 
excretion of POPs is not primarily governed by dietary intake. A small contribution of dietary intake 
of POPs to faecal excretion cannot be ruled out, but the overall pattern does not support this as the 
predominant factor.  
In another supportive case from Chapter 5, statistically significant correlations (Pearson correlation 
coefficient r >0.74, P<0.05) between plasma and faeces were found regarding the concentrations of 
five of the chemicals detected in both matrices (p,p’-DDE, PCB 118, 138, 153 and 180). For p,p’-
DDE and PCBs, the linear regressions (R2 ranged from 0.55 to 0.72) in our study were comparable 
with the predictive power of the toxicokinetic models (R2 ranged from 0.39 to 0.83) by Verner et al 
(2013).  
At present, the analysis of faeces seems to provide little improvement over the use of models such as 
the one of Verner et al. (2013). However, this study is among the first studies on measuring Kfb in 
infants/toddlers. It is clear that with a better understanding of absorption and desorption of POPs for 
predicting Cb from Cf  can substantially improve and provide a more direct (infant specific) and 
certain estimate of infant exposure. Furthermore, one can envisage a combination of the two 
approaches where faeces sampling and analysis could be applied to a (limited) subpopulation as a 
validation tool. 
 
Faeces:blood concentration ratios of POPs (Kfb) vary both inter- and intra- individually and vary 
among chemicals 
Although faecal concentrations of POPs in infants/toddlers were highly predicted by their body 
burden, where there was a narrow distribution of concentrations (of HCB, for example) in plasma 
samples irrespective of participants, the faecal concentrations were not sensitive enough for exposure 
classification (low vs. high). 
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Both the inter- and intra- individual variation were demonstrated in the faeces:blood concentration 
ratios of POPs (Kfb). In Chapter 4, Kfb differed significantly (P<0.0001) between the period before 
and after weaning, and observed changes in Kfb are far greater than the uncertainty in the estimated 
Kfb. In Chapter 5, a cross-sectional dataset of infants/toddlers was used to test whether the POP 
concentrations in matched blood and faeces samples were correlated with each other. Due to the 
varying number of samples that were collected from each participant, one pair of plasma and faecal 
samples from every individual was randomly chosen to form the cross-sectional dataset. Cf values 
from the two successively collected samples were utilized to further investigate sources of the 
variations in Kfb values. As a result, the variation in Kfb was considerable (quotient of 95% percentile 
and 5% percentile from 5.2-11). Between 5% and 50% of this variation was attributed to short term 
variability between successive bowel movements. This variability could be reduced by pooling faeces 
samples over several days. Some of the remaining variability was attributed to longer term intra-
individual variability, which was consistent with previously reported observations of a decrease in 
Kfb during weaning. 
 
 
Study Limitations 
There are a number of limitations in this study. The key limitation lies with obtaining concentration 
of POPs in blood (i.e. Cb) for infants and toddlers. In Chapter 3 I related the concentrations in faeces 
(i.e. Cf) to the concentrations in breast milk (i.e. Cm) to circumvent this, where Cm data from 10 
mothers were used as a proxy of Cb. In Chapter 4 I modelled an infants’ blood concentration over a 
12 month period and compared the modelled Cb to measured Cf in monthly pooled faeces samples 
from the infant. Last but not least in Chapter 5, I finally obtained blood samples from 20 
infants/toddlers collected in most cases on two occasions which were then analysed in arguably one 
of the leading laboratories in the world for chemical analysis. This resulted in a limited amount of Cb 
values and a comparatively large amount of censored data. In the end I only have sufficient Cb values 
for 14 chemicals in 20 children.  
 
With the limited measured Cb values my study could not provide much needed understanding on the 
factors that affect the partitioning of POPs between blood and faeces. This also limits the use of the 
Kfb values including extrapolation to other chemicals that are for example only detectable in the 
infants’ faeces but not in the blood. As outlined above my thesis can provide only limited insight into 
this matter since only some chemicals with high persistence and a limited Kow range (i.e. ~10
5- ~108) 
and size were evaluated.  It is clear that our method is not really relevant to evaluated chemicals that 
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are metabolised and excreted via urine such as phthalates, bisphenols, organophosphate flame 
retardants or various types of pesticides. The limitation lies with the chemical being metabolically 
modified through enzymes in the liver where the metabolite (i.e. glucuronide or sulfonate of the 
chemicals) are excreted through the urine.  Faeces analysis is also not applicable (as outlined above 
too) for chemicals with extremely high hydrophobicity (Log Kow >7.5) and /or relatively large in size. 
The work from McLachlan’s team suggested that exchange between blood and faeces is very slow 
and thus the excreted fraction is related primarily to remaining chemicals in the faeces not being 
resorbed. Hence I can speculate that analysis of faeces is most useful for persistent chemicals with a 
log Kow range roughly from 4-7 (i.e. typical to the properties of PCBs and most other POPs except 
the perfluorinated chemicals). There may be exceptions and refinements to this, however these 
require further evaluation which I highlighted in my section on future directions.  
 
While recognising the limitations it is important to point out that there are many constraints to this 
type of study. It is for example difficult to justify studies that require collection of infant/toddlers 
blood with no obvious benefit to the child. Ethically there are many constraints which limit sample 
numbers and recruitment of participants to such a study. The limitations associated with the detection 
of chemicals in the small volume of blood that can be collected was to a degree surprising. All the 
above highlight not only the limitation of the study but also the need to find a surrogate method that 
allows an accurate and reliable estimate of Cb for infants and toddlers.  
 
 
 
Future research 
Overall this study demonstrated that relatively little is known about factors that affect the partitioning 
of POPs between the blood and faeces. Such knowledge will be required and taken into account if 
systematic sampling and analysis of faeces is considered as a tool for measuring the body burden of 
the respective chemicals of interest (i.e. POPs).  
 
Smarter recruitment 
Recognising that the limitations with ethics and recruitment cannot be overcome easily, resolutions 
should be found for large studies that rely on collection of sufficient blood from small children. The 
limitation could potentially be overcome through smarter recruitment. For example, it is known that 
levels of brominated flame retardants are higher in North America; thus it would be easier to study 
these chemicals in infants from there. Similarly, PCB levels are higher in certain countries in Europe. 
Another option would be to preselect babies through first collecting and analysing the breast milk of 
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the mother, then focusing on recruitment of infants that are expected to have higher levels of particular 
chemicals of interest. Another area for future research relates to combining this type of study with 
more comprehensive modelling approaches.  
 
Identifying the major sorption capacity of faeces 
To explain why it is more reliable to express results on a dry weight basis compared to a lipid basis 
(as shown in Chapter 5), laboratory measurements of partition coefficients between faeces and other 
compartments may be needed. Using passive sampling techniques such as silicon and relating this to 
the chemical activity in blood to measure the chemical activity in faeces could be one approach. 
Moser and McLachlan (2002) suggested that lipid accounts for only a relative small part of the 
sorption capacity of faeces in adults. This seems also to be the case for infants/toddlers, as we found 
that reproducibility of two successively collected faecal samples was higher when POP 
concentrations in faeces were presented on a dry-weight basis instead of lipid-weight.  
 
Identifying the interaction between POPs and gut microbiota 
As discussed in Chapter 4, changes associated with the physiological development of the 
gastrointestinal system might contribute to changes in the partitioning properties of the faeces, as 
might changes in the bacterial flora (Wall et al., 2009).  The bacterial flora change over the first few 
months of breastfeeding and subsequently with the introduction of solid foods (Wall et al., 2009; 
Nejrup et al., 2015).  Recent studies have also found that POPs modify gut microbiota (Choi et al., 
2013; Zhang et al., 2015). 
 
Identify the effect of the digestibility of the food on variations in Kfb 
It is widely accepted that fibre and certain other constituents (such as animal oil) of solid food 
contribute to the development of the digestive ability of the infant. Our results suggest that these 
changes decrease the sorption capacity of the faeces for the chemicals studied (Chapter 4).  
 
In summary, this work is among the first studies that provide insight in the role of faeces in POP 
biomonitoring for infants and toddlers. The data reported here can allow back-extrapolation of 
concentrations in blood from the concentrations in faecal samples in epidemiological studies for 
exposure-outcome analysis for several POPs, but can also be further optimized and expanded. These 
results are, therefore, not only a useful addition to existing knowledge, but provide new perspectives 
to assess body burden of POPs for infants and toddlers 
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Instruction for Sampling Faeces 
 
1. Lay one layer of liner (made from corn starch) to the nappy right before putting the nappy on 
2. After baby’s bowel movement, take the nappy off, tip over the faeces into the foil sheet 
(ideally without getting the portion in contact with the liner) and discard the liner 
3. Fold the foil sheet and place it in the plastic bag. Write the name and data of collection on the 
bag 
4. Place the plastic bag in the plastic bottle and screw the lid 
5. Wrap the bottle in a plastic bag and then store the bottle in the freezer 
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Table S1 General characteristics of the mothers (average ± standard deviation (median)) from 
Sydney and Brisbane who participated in this study  
Donors’ characteristics 
(abbreviationsa) 
Primaparous donors  Secundiparous donors 
% in total number of donors  80 20 
Mother’s age at sampling, year 32.5 ± 1.6 (32) 37 ± 1 (37) 
Mother’s BMIa before pregnancy, kg 21.7 ± 3.3 (20.9) 21.5 ± 1.8 (21.5) 
% of underweight (BMI<18.5) 0 0 
% of normal weight (18.5<BMI<24.9) 87.5 100 
% of overweight (25.0<BMI<29.9) 12.5 0 
% of obese (BMI 30) 0 0 
mother body mass increaseb 
             normal weight (18.5<BMI<24.9) 
 
14.6 ± 3 (15) 
 
13 ± 1 (13) 
             overweight (25.0<BMI<29.9) 3  
Area of residence during last 5 years, %   
                                     urban/suburban 100 100 
                                              rural 0 0 
Previous area of residence, %   
                                     urban/suburban 100 100 
                                              rural 0 0 
Mother’s dietary habits, % 
                                                             mixed diet 
  vegetarian with consumption of milk and eggs 
                                                 strictly vegetarian 
 
87.5 
12.5 
0 
 
100 
0 
0 
   
Mother’s average consumption of fish, seafood, 
% 
  
                                                 never 0 0 
                                      < 1 per week 25 0 
                                        1 per week 
                                        2 per week 
                                      > 2 per week 
37.5 
12.5 
25 
50 
50 
0 
Mother’s average consumption of milk and 
dairy products, % 
  
                                                 never 0 0 
                                      < 1 per week 0 0 
                                        1 per week 
                                        2 per week 
                                      > 2 per week 
0 
0 
100 
0 
0 
100 
Smoking habits 
                                     Never smoke 
                                         Ex-smoker 
                                              Smoker 
 
100 
0 
0 
 
50 
50 
0 
Hours spend at  computer before childbirth, 
hrs/day 
 
6.8 ± 2.2 (8) 
 
3.3 ± 0.75 (3.3) 
Hours spend at computer after childbirth, 
hrs/day 
 
1.25 ± 0.75 (1) 
 
1 ± 0.5 (1) 
Air condition use at home, hrs/day 0 0 
Floor at home, % 
                                     wall to wall carpet 
 
37.5 
 
50 
                                         hardwood floors 25 50 
      hardwood floors with some carpets 25 0 
                    tiles other than in bathroom 12.5 0 
                 Plastic flooring (Vinyl flooring) 0 0 
                            Laminated floating floor 0 0 
Hours travelling in car, hrs/day 0.76 ± 0.78 (0.5) 0 ± 0 (0) 
Occupational history, %   
                                             office worker 75 0 
                          other than office worker 25 100 
Breast milk fat, %(of fresh weight) 3.1 ± 1.2 (3.1) 2.9 ± 0.2 (2.9) 
a body mass index (BMI) was calculated as follows: BMI=[mass(kg)]/[height(cm)]2 
b mother mass increase was calculated as: mother mass before delivery – mother mass before pregnancy 
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Table S2 General characteristics of the infants from Sydney and Brisbane who participated in this 
study (average ± standard deviation (median)) 
Donors’ characteristics (abbreviationsa) First child Second child 
% in total number of donors  80 20 
% of boys 62.5 100 
Child’s age at faeces sampling, month 5.8 ± 1.6 (6.5) 8 ± 2 (8) 
Child’s mass at birth (kg) 3.5 ± 0.3 (3.5) 3.2 ± 0.43 (3.2) 
Child’s mass at faeces sampling 7.5 ± 0.6 (7.5) 8.9 ± 1.3 (8.9) 
Rate of child mass increase per montha, 
%/month 
 
0.21 ± 0.06 (0.2) 
 
0.23 ± 0.05 (0.23) 
Child’s height at birth (cm) 51.1 ± 1.5 (51.5) 53 ± 2 (53) 
Child’s height at faeces sampling 66.9 ± 2.8 (67.5) 73 ± 6 (73) 
Rate of child height increase per monthb, 
%/month 
 
0.06 ±0.02 (0.05) 
 
0.05 ± 0.004 (0.05) 
Child’s food prior to the faeces sampling, %   
                                                        pure breast fed 12.5 0 
                                   breast fed and  formula fed 37.5 0 
               Breast feeding, formula and solid food 50 100 
Faeces lipid, % (of dry weight) 17.4 ± 5.6 (17.5) 23 ± 0 (23) 
a percentage of child mass increase was calculated as percentage relative to the child’s mass at birth: (child mass at 
sampling – child mass at birth)/ child mass at birth/ child age at the sampling  
b rate of child height increase per week was calculated as percentage relative to the child height at birth: (child height at 
sampling- child height at the birth)/ child height at the birth/ child age at the sampling × 100 
 
 
 
 
Table S3 Method recoveries (mean ± SD, in %) of 13C-labeled surrogate standards in laboratory 
blanks, breast milk and faeces 
Analyte internal standard (IS) 
Blank 
N=3 
Breast Milk 
N=3 
Faeces  
N=10 
PCB28 13C-PCB28 81 ± 11 70 ± 25 73 ± 22 
PCB52 13C-PCB52 87 ± 9.2 65 ± 23 83± 21 
PCB101 13C-PCB101 79 ± 14 58 ± 13 69 ± 16 
PCB118 13C-PCB118 77 ± 12 61± 28 77 ± 25 
PCB153 13C-PCB153 84 ± 8.7 66 ± 21 74 ± 15 
PCB138 13C-PCB138 91 ± 20 76 ± 19 95 ± 17 
PCB180 13C-PCB180 80 ± 16 66 ± 27 77± 23 
PBDE47 13C-PBDE47 73± 14 69 ± 18 62 ± 13 
PBDE99 13C-PBDE99 66 ± 9.8 71 ± 4.5 66 ± 13 
PBDE100 13C-PBDE100 81 ± 11 58 ± 28 60 ± 11 
PBDE153 13C-PBDE153 62 ± 14 53 ± 18 51 ± 18 
PBDE154 13C-PBDE154 59 ± 10 62 ± 23 56 ± 13 
PeCB 13C-PeCB 75 ± 15 65 ± 23 70 ± 18 
HCB 13C-HCB 80 ± 7.3 75 ± 23 76 ± 14 
heptachlor 13C-heptachlor 67 ± 17 67 ± 12 72 ± 12 
heptachlor epoxide B 13C-heptachlor epoxide B 78 ± 25 88 ± 26 73 ± 35 
heptachlor epoxide A 13C-heptachlor epoxide A 69 ± 19 83 ± 15 71 ± 11 
mirex 13C- heptachlor 71 ± 26 68 ± 36 75 ± 21 
pp-DDE 13C-pp-DDE 64 ± 23 60 ± 18 64 ± 28 
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Table S4 Quantity of target compounds in diaper liners (duplicate experiment) (ng/sample) 
Analyte 
Experiment 
1 
Experiment 
2 
The method of measuring the target 
compounds in liners was: 
1. One liner was put into a pre-cleaned 
bottle, and a 2:1 (V:V) mixture of hexane: 
acetone was added until the liner was 
submerged; 
2. The bottle was closed and put on a shaker 
for 24 hours; 
3. The extract was blown down to 2 ml and 
then filtered; 
4.  The filtered extract was blown down to 
25 ul to be analysed on HRGC/HRMS. 
 
PCB28 0.04 0.01 
PCB52 0.01 0.02 
PCB101 0.03 0.01 
PCB118 0.05 0.02 
PCB153 0.09 0.03 
PCB138 0.02 0.02 
PCB180 0.05 0.02 
PBDE47 0.05 0.03 
PBDE99 <0.01 0.02 
PBDE100 <0.01 <0.01 
PBDE153 <0.01 <0.01 
PBDE154 <0.01 < 0.01 
PeCB 0.1 0.1 
HCB <0.01 0.03 
heptachlor 0.04 <0.01 
heptachlor epoxide B <0.01 <0.01 
heptachlor epoxide A <0.01 <0.01 
mirex 0.01 <0.01 
pp-DDE 0.06 0.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 131 
 
Table S5 Concentration (ng/g lipid) of selected POPs in breast milk of 10 mothers (mean ± STD1 
(RSD2)) 
Analyte 
Pair 1 Pair 23 Pair 3 Pair 4 Pair 5 Pair 63 Pair 7 Pair 8 Pair 9 
Pair 
103 
milk milk milk milk milk milk milk milk milk milk 
PCB28 2.1 
0.73 ± 
0.11 
(15%) 
0.53 <0.24 1.1 
0.56 ± 
0.08 
(14%) 
1.1 <0.08 <0.26 <0.21 
PCB52 0.42 
0.33 ± 
0.04 
(12%) 
<0.041 0.03 <0.14 0.16-0.54 0.46 <0.04 <0.03 <0.34 
PCB101 0.20 0.3-0.73 <0.023 <0.28 0.12 0.20-0.53 0.36 <0.021 <0.0053 0.02  
PCB118 0.80 
1.7 ± 0.24 
(14%) 
0.71 0.12 0.85 
5.9 ± 0.2 
(3%) 
2 0.2 0.3 
0.56 ± 
0.05 (8%) 
PCB138 5.0 
4.5 ± 0.38 
(9%) 
8.8 0.77 4.3 
26 ± 3.0 
(11%) 
9.7 2.0 4.1 
5.1 ± 0.44 
(4%) 
PCB153 6.3 
6.1 ± 0.55 
(9%) 
12 1.3 4.2 
24 ± 1.8 
(8%) 
15 4.2 6.4 
7 ± 0.31 
(4%) 
PCB180 4.0 
2.9 ± 0.24 
(8%) 
6.3 0.56 2.0 
21 ± 2.1 
(11%) 
13 3.7 2.7 
3.3 ± 0.15 
(5%) 
BDE47 6.4 
0.93 ± 
0.05 (5%) 
0.96 0.76 2.9 
8.5 ± 
1.3(15%) 
1.1 0.27 2.4 
8.7 ± 1.3 
(16%) 
BDE99 1.1 
0.33 ± 
0.06 
(18%) 
0.07 0.26 0.09 
2.2 ± 0.28 
(13%) 
0.19 0.31-0.59 0.65 
1.1 ± 0.17 
(16%) 
BDE100 0.56 0.27-0.57 0.47 0.38 0.12 
1.8 ± 0.17 
(10%) 
0.57 0.09 1.6 
0.74 ± 
0.15 
(20%) 
BDE153 2.6 
0.4 ± 0.09 
(23%) 
1.9 0.48 1.5 0.1 0.21 2.5 1.6 
3.9 ± 
0.41(10%) 
BDE154 <1.4 <0.094 <0.72 <0.34 <0.17 <0.16 <0.24 <1.9 <0.84 <0.067 
PeCB 0.55 0.47 0.28 0.36 <0.48 0.35 0.91 <0.14 0.5 
0.42 ± 
0.08 
(19%)  
HCB 4.7 
2.0 ± 0.13 
(7.0%) 
6.6 3.2 7.5 
5.9 ± 0.23 
(4%) 
3.2 2.6 4.3 
8.9 ± 0.4 
(4%) 
heptachlor <0.049 0.36-0.86 <0.02 0.25 <0.32 <0.02 0.45-0.93 <0.23 <0.56 <0.43 
heptachlor 
epoxide B 
1.9 0.48 0.98 <0.27 3.7 
0.4 ± 0.01 
(23%) 
0.4 <0.50 1.6 
2.9 ± 0.35 
(12%) 
heptachlor 
epoxide A 
<1.5 <0.33 <1.8 <1.2 <1.1 <0.51 <0.46 <2.3 <1.3 <1.7 
mirex 0.19 <0.27 0.04 0.03 <0.10 
0.4 ± 0.02 
(5%) 
2 0.56 <0.040 <0.19 
pp-DDE 90 
140 ± 4.4 
(3.0%) 
18 41 28 
230 ± 7.9 
(3%) 
100 9.0 210 
62 ± 11 
(18%) 
 mLOD-mLOQ 
 <mLOD 
1:  standard deviation 
2:  relative standard deviation 
3: data are means of two replicates 
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Table S6 Concentration (ng/g lipid) of selected POPs in faeces of 10 infants (mean ± STD1 (RSD2)) 
Analyte 
Pair 1 Pair 2 Pair 3 Pair 4 Pair 5 Pair 6 Pair 7 Pair 8 Pair 9 Pair 10 
Faeces Faeces Faeces Faeces Faeces Faeces Faeces Faeces Faeces Faeces 
PCB28 
0.59 ± 
0.14 
(24%) 
0.55 ± 
0.04 (8%) 
1.7 ± 0.4 
(24%) 
0.11 
1 ± 0.13 
(27%) 
2.4 ± 0.2 
(7%) 
1.2 ± 0.32 
(27%) 
0.39 ± 
0.12 
(29%) 
0.24 ± 
0.05 
(20%) 
0.15 
PCB52 0.05-0.13 0.17 0.07-0.36 0.14 
0.09 ± 
0.02 
(22%) 
3.5 ± 0.02 
(4%) 
0.19 
0.059-
0.13 
0.44 ± 
0.11 
(25%) 
0.12 
PCB101 0.12 
0.074-
0.20 
<0.13 0.2 <0.05 
2.5 ± 0.46 
(18%) 
0.23 ± 
0.07 
(30%) 
<0.06 
0.33 ± 0.1 
(30%) 
0.068-
0.19 
PCB118 
0.16 ± 
0.04 
(23%) 
0.2 ± 0.01 
(5%) 
0.15-0.40 
0.34 ± 0.1 
(29%) 
0.55 ± 
0.04 (7%) 
3.5 ± 0.86 
(24%) 
0.27 ± 
0.08 
(30%) 
0.073-
0.15 
0.74 ± 
0.17 
(22%) 
0.94 ± 
0.05 (5%) 
PCB138 
0.26 ± 
0.08 
(30%) 
0.48 ± 
0.12 
(24%) 
2.3 ± 0.65 
(29%) 
0.38 ± 
0.07 
(18%) 
1.0 ± 0.3 
(29%) 
8.7 ± 1.5 
(17%) 
2.9 ± 0.6 
(21%) 
1.2 ± 0.31 
(27%) 
2 ± 0.47 
(23%) 
1.9 ± 
0.22(11%) 
PCB153 
0.44 ± 
0.02 (3%) 
0.79 ± 
0.13 
(16%) 
2.4 ± 0.46 
(20%) 
0.47 ± 
0.04 (9%) 
0.86 ± 
0.25 
(29%) 
12 ± 0.59 
(5%) 
3.1 ± 0.31 
(10%) 
0.67 ± 
0.19 
(28%) 
0.76 ± 
0.13 
(17%) 
2.8 ± 0.26 
(10%) 
PCB180 
0.18 ± 
0.02 (9%) 
0.29 ± 
0.07 
(23%) 
2.3 ± 0.57 
(24%) 
0.4 ± 0.07 
(18%) 
0.45 ± 
0.08 
(18%) 
10 ± 0.9 
(9%) 
3.2 ± 0.38 
(12%) 
0.51 ± 
0.09 
(17%) 
0.2 ± 0.05 
(25%) 
2.5 ± 0.46 
(19%) 
BDE47 
4.9 ± 1.5 
(30%) 
0.9 ± 0.18 
(20%) 
0.76 ± 0.2 
(26 %) 
1.1 ± 0.33 
(30%) 
2.2 ± 0.5 
(23%) 
15± 6.7 
(27%) 
1.5 ± 0.51 
(34%) 
0.34 ± 
0.09 
(26%) 
2.4 ± 0.45 
(18%) 
9.8 ± 0.35 
(4%) 
BDE99 
0.83 ± 
0.27 
(33%) 
0.079-
0.18 
0.14-0.23 
0.38 ± 
0.12 
(31%) 
0.08 
3.7 ± 1.1 
(28%) 
0.15 
0.081-
0.18 
0.085 
1.5 ± 0.14 
(9%) 
BDE100 
0.57 ± 
0.11 
(19%) 
0.23 
0.42 ± 0.1 
(23%) 
0.11 0.15 
5.8 ± 1.5 
(25%) 
0.56 ± 0.2 
(35%) 
0.08 
0.079-
0.17 
<0.13 
BDE153 
2.1 ± 0.55 
(27%) 
0.099-
0.24 
2.6 ± 0.72 
(27%) 
0.39 
1.2 ± 0.31 
(26%) 
0.079-
0.16 
0.25 ± 
0.05 
(18%) 
2.25 
±0.03 
(16%) 
0.94 
1.7 ± 0.3 
(18%) 
BDE154 <0.087 <0.11 <0.20 <0.09 <0.07 <0.087 <0.11 <0.094 <0.090 <0.010 
PeCB 
1.6 ± 0.47 
(30%) 
1.43 ± 
0.14 (9%) 
0.33-0.65 0.31 
0.56 ± 0.1 
(18%) 
0.33 ± 
0.06 
(17%) 
0.38 ± 
0.08 
(21%) 
0.16-0.32 
2 ± 0.53 
(26%) 
0.27 
HCB 
1.3 ± 0.2 
(15%) 
0.43 ± 
0.15 
(35%) 
0.79 ± 
0.13 
(16%) 
0.86 ± 0.1 
(12%) 
2.8 ± 0.3 
(11%) 
0.75 ± 
0.21 
(28%) 
0.85 ± 
0.06 (7%) 
3.5 ± 0.5 
(14%) 
0.36 ± 
0.11 
(31%) 
1.5 ± 0.4 
(26%) 
heptachlor 
0.17 ± 
0.04 
(24%) 
<0.068 <0.12 
0.11 ± 
0.14 
(19%) 
0.2 ± 0.41 
(10%) 
<0.055 <0.07 
0.14 ± 
0.41 
(29%) 
0.25 ± 
0.56 
(22%) 
0.11 ± 
0.13 
(31%) 
heptachlor 
epoxide B 
1.5 ± 0.3 
(21%) 
<0.02 
0.04 ± 
0.01 
(33%) 
0.06 ± 
0.01 (9%) 
1.7 ± 0.11 
(7%) 
0.06 ± 
0.01 
(17%) 
0.1 ± 0.02 
(16%) 
0.72 ± 
0.17 
(24%) 
0.04 ± 
0.01 
(25%) 
0.12 ± 
0.03 
(25%) 
heptachlor 
epoxide A 
<0.03 <0.087 <0.068 <0.032 <0.026 <0.03 <0.04 <0.03 <0.031 <0.034 
mirex 
0.03 ± 
0.01 
(20%) 
<0.08 0.26 
0.04 ± 
0.06 
(14%) 
<0.06 <0.067 
0.69 ± 
0.06 (8%) 
0.28 ± 
0.08 
(29%) 
0.14 0.13 
pp-DDE 
4 ± 0.98 
(24%) 
21 ± 1.1 
(5%) 
9.3 ± 2.5 
(27%) 
26 ± 3.7 
(14%) 
7.1 ± 0.58 
(8%) 
30 ± 2.3 
(7%) 
25 ± 1.1 
(4%) 
5.7 ± 0.44 
(8%) 
41 ± 6.1 
(15%) 
16 ± 2.5 
(16%) 
mLOD-mLOQ 
<mLOD 
1:  standard deviation 
2:  relative standard deviation 
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Table S7 Diet information for each infant and the method of calculating the breast feeding length 
Infants Age (at sampling time) Diet history Breast feeding length* 
Pair 1 10 months 
10 months breast fed 
5 months solid fed (Mixed diet) 
 
5+0.8×2+0.5×2+0.3×1 =7.9 
Pair 2 7 months 
7 months breast fed 
3 months solid fed (Mixed diet)  
4+0.8×2+0.5×1=6.1 
Pair 3 5 months 
5 month breast fed  
Just started on solids food and strictly 
vegetarian when sampling 
4+0.8= 4.8 
Pair 4 4 months Breast fed (Pure) 4 
Pair 5 6 months Breast fed, just started solid food 5+0.8= 5.8 
Pair 6 3 months Breast fed (pure) 3 
Pair 7 6 months 
Breast fed and formula from birth to about 4 
months.  2 months mixed breast and formula 
fed 
4×0.8+0.8× 0.5× 2= 4 
Pair 8 6 months 
6 month breast fed  
2 months of a combination of breast feeding 
and formula/solid foods  
4+0.8 ×0.5×2= 4.8 
Pair9 8 months 
8 months breast fed  
2 months of solid food fed 
5+ 0.8×2+0.5=7.1 
Pair10 6 months Breast fed, just started solid food 5+0.8=5.8 
*When calculating the breastfeeding time (months), we used 1 month for each month with solely breastfeeding while we 
used 0.8 month for each month with both breast feeding and formula feeding before solid food introduction and 0.5 month 
for after introduction (after consulting the corresponding mothers). Further, 0.8 month was assigned to each month during 
the first two months after solid food introduced (0.8× 0.5 month for a combination with formula feeding), 0.5 month to 
the each month during the second two months after solid food was introduced (0.5×0.5 month for a combination with 
formula feeding), 0.3 month to each month during the third two months after solid food introduced (0.3×0.5 month for a 
combination with formula feeding). 
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Table S8 Ratios of the concentrations (in ng/g lipid) of selected POPs in faeces and breast milk (RFM) 
(only the mother/infant pairs that have concentrations above mLOQs are included) 
Analyte Pair 1 Pair 2 Pair 3 Pair 4 Pair 5 Pair 6 Pair 7 Pair 8 Pair 9 Pair 10 
PCB28 0.28 0.79 3.2 -- 0.92 4.2 1.1 -- -- -- 
PCB52 -- 0.5 -- 4.8 -- -- 0.40 -- -- - 
PCB101 0.58 -- -- -- -- -- 0.64 -- -- -- 
PCB118 0.19 0.12 -- 2.8 0.65 0.59 0.14 -- 2.5 1.7 
PCB138 0.052 0.11 0.26 0.49 0.24 0.33 0.30 0.56 0.49 0.37 
PCB153 0.069 0.13 0.20 0.36 0.21 0.48 0.21 0.16 0.12 0.41 
PCB180 0.044 0.099 0.37 0.71 0.23 0.48 0.24 0.14 0.075 0.74 
BDE47 0.77 0.97 0.79 1.4 0.76 1.8 1.4 1.3 1.1 1.1 
BDE99 0.75 -- -- 1.4 0.78 1.7 0.79 -- 0.13 1.3 
BDE100 1.0 -- 0.88 0.29 0.96 3.2 0.97 0.89 -- -- 
BDE153 0.79 -- 1.4 0.80 0.79 -- 1.2 0.9 0.58 0.43 
BDE154 -- -- -- -- -- -- -- -- -- -- 
PeCB 2.8 3.0 -- 0.86 -- 0.93 0.42 -- 4 0.64 
HCB 0.28 0.22 0.12 0.27 0.37 0.13 0.27 1.4 0.084 0.17 
heptachlor -- -- -- 3.4 -- -- -- -- -- -- 
heptachlor 
epoxide B 
0.78 -- 0.038 -- 0.45 0.15 0.24 -- 0.024 0.041 
heptachlor 
epoxide A 
-- -- -- -- -- -- -- -- -- -- 
mirex 0.13 -- 1.3 1.2 -- -- 0.34 0.5 -- -- 
pp-DDE 0.044 0.16 0.52 0.62 0.25 0.13 0.24 0.63 0.20 0.25 
median 0.24 0.13 0.45 0.71 0.45 0.41 0.27 0.71 0.17 0.37 
   PCB 52, PCB101, BDE 154, heptachlor, heptachlor epoxide A are not discussed further due to lack of the detection 
frequency 
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Fig. S1 Rfm for each compound with a detection frequency ≥ 50%, shown for each mother/infant pair 
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Instrument method 
 
Samples were analysed using a Thermo TRACE 1310 gas chromatograph coupled to a Thermo DFS 
high resolution mass spectrometer (HRGC-HRMS). Injection of each sample was in splitless mode 
and the temperatures for the injection port, transfer line and source were maintained at 250, 280 and 
280 °C, respectively. A DB5-MS column (30 m x 0.25 mm x 0.25 µm, J&W Scientific) was used 
with helium as the carrier gas at a constant flow of 1 ml/min. The oven temperature program was: 80 
°C held for 2 min, then raised by 20 °C min-1 to 180 °C and held for 0.5 min before being ramped to 
290 °C at 10 °C min-1, then held for 8 min. The HRMS was operated in electron impact--multiple ion 
detection (EI-MID) mode and resolution was set to ≥10,000 (10% valley definition). Quality 
assurance for the faecal and breast milk samples is outlined in Table S1.  
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Table S1 Quality assurance for faecal sample and breast milk sample analysis 
Faeces mLOQ1 One pooled faecal sample for reference2 (n=4) 
Duplicates of all 
samples in this study 
(n=22) 
 
 
(ng/ g lipid) 
Recovery of internal 
standrard3 (%) 
Mean ± SD4 
Concentration CV5 
(%) 
Concentration 
average CV (%) 
PCB153 0.049 92 ± 12 23 10 
         BDE47 0.086  77 ± 24 23 14 
pp-DDE 0.025 83 ± 17 12 9.7 
Lipid content (CV) -- 4.5% -- 
    
Breast milk mLOQ1 Breast milk samples for reference6 (n=3) 
Duplicate of the 
sample in this study 
 (ng/ g lipid) 
Recovery of internal 
standard (%) 
Mean ± SD 
Concentration CV (%) Concentration CV (%) 
PCB153 0.04 66 ± 21 7 20 
         BDE47 0.05  69 ± 18 12 21 
pp-DDE 0.05 60 ± 18 8 4.7 
Lipid content (CV) -- 7.1% -- 
1: mLOQ: method limit of quantification, which was defined as the mean values of the concentration in blank samples 
(lipid content of 10% was assumed) plus 10 times its standard deviation 
2: One pooled faecal sample was made by combining selected remaining samples. During each batch, it was analysed 
as a reference material 
3: Internal standards used: 13C-PCB153, 13C-BDE47 and 13C-pp-DDE 
4: SD: standard deviation  
5: CV: coefficient variation 
6: Three breast milk samples were analysed to assess reproducibility in the previous study with the same analytical 
method (Chen et al., 2015)  
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Figure S1 The process for one-step extraction and clean-up of a faeces sample  
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Figure S2 Conceptual representation of the model 
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Parameterization of the model 
1. Weight data 3.55, 4.5, 5.29, 6.00, 7.3, 8.25, 9.30, 10.9 and 11.4 kg at Day 14, 39, 69, 108, 133, 175, 269, 373, respectively, were 
provided by the infant’s doctor. Weight for other days was calculated by linear interpolation.  
2. Body Lipid Fraction data at Day 8, 65 and 120 were obtained from the Table 2 in the study of Schmelzle and Fusch (Schmelzle 
and Fusch, 2002). Data for Day 180, 270 and 365 were obtained from the Table 2 in the study by Butte et al (2000). Data for all other 
days were linearly interpolated between two data obtained from references. Table below shows the data from references. 
 t1 t2 t3 t4 t5 t6 
Age (d) 8 65 120 180 270 365 
%BF 
(average±SD) 
13.3 ± 4.3* 24.5 ± 5.8 31.2 ± 6.6 29.1 ± 4.7 25.7 ± 5.2 25.6 ± 4.0 
 
3. Breast milk intake was calculated as a function of both infant age and infant body weight using an algorithm found in (Arcus-Arth 
et al., 2005) and modified in (Verner et al., 2009a): 
                      (1) 
where is the age of the infant in years and intake is in liters per day per kilogram of infant body weight. This equation was applied 
up until Day 126. There was good agreement between the (monthly averaged) breast milk ingestion (ml/d) predicted by the equation 
and recorded in the parents’ feeding diary (see Table below).  
 Month 1 (ml) Month 2 (ml) Month 3 (ml) Month 4 (ml) 
Values from equation  586 684 726 741 
Values from diary    ~600 ~650 ~700 ~750 
 
According to the parents’ feeding diary, weaning began on Day 126 and continued to Day 189. During this period breast milk ingestion 
was assumed to decrease linearly from 600 ml/d to 100 ml/d. From Day 190 onwards breast milk ingestion was 0.  
4. Lipid content of breast milk was calculated using a logarithmic function optimized on breast milk lipid fraction data from (Bitman 
et al., 1983) for the first 42 days and from (Arcus-Arth et al., 2005) for the period 3- 12 months: 
                     (2) 
where  represents the mass fraction of lipid in milk, and the infant age in years (although the breast milk collected for 
analysis had a lipid content of 3%, the samples were collected at the beginning of each feeding when lipid content is typically low). 
5. Chemical concentration in solid food. Refer to Table S2.  
6. Excretion of faecal dry mass (in g dry weight per kg body weight and day) was taken from the study of Sievers et al. (1993): 0.6 
for the first 17 days, 0.7 (for Day 35, 0.13 for Day 57 and Day 85, and 0.3 for Day 113. On Day 161, 6 weeks after starting weaning 
and just before the introduction of solid food, the value from Sievers et al. for formula fed infants was used (0.8). From Day 114 until 
the introduction of solid food, 0.8 from Siever et al. (1993) was used. From Day 220 (5 weeks after weaning) onwards, the daily 
excretion of faecal dry mass was set equal to 0.08 times the daily intake of food dry mass in accordance with (Schlummer et al., 1998). 
The excretion of faecal dry mass for all other days up until Day 220 was calculated using linear interpolation. 
7. Lipid content of faeces and POP concentrations in faeces were based on the measurements in this study. Each measured value 
was assigned to the middle dates of the corresponding sampling period, while the values for other days were calculated using linear 
interpolation. 
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Table S2 Model variables, their parameterization, and the parameter uncertainty used in the model 
uncertainty analysis 
Variables Sub-variables Estimated values Uncertainty References 
Cmilk 
PCB153 13 ng/g lipid 2.5 ng/g lipid Measured 
BDE 47 1.4 ng/g lipid 0.3 ng/g lipid Measured 
p,p’-DDE 96 ng/g lipid 4.5 ng/g lipid Measured 
Qmilk (fat 
intake via 
breastmilk) 
Fresh weight of 
breastmilk intake                        
0.038 L/kg body 
weight/d 
(Verner et al., 2009a) 
Breastmilk lipid 
content   
0.0032 (Verner et al., 2009a) 
Qsolid food (fat 
intake via solid 
food) 
Dry weight of 
solid food 
See Parameterization 20% (CV)1 Diary 
Solid food lipid 
content  
See Parameterization 20% (CV)1 (Fernandes et al., 2012) 
Qdust (For 
BDE47) 
Dust 0.03 g dw/d 50% (CV)1 
(Wu et al., 2007; Watkins 
et al., 2011; Ali et al., 
2014) 
Cfaeces 
PCB 153 
See Table 3 
19% (CV) Measured; Table 3 
BDE47 32% (CV) Measured; Table 3 
p,p’-DDE 16% (CV) Measured; Table 3 
Qfaeces (fat 
excreted via 
faeces) 
Fresh weight of 
faeces excreted 
See Parameterization 
0.6 g dw/kg 
bodyweight/d was used 
for month 2 -4 2 
(Sievers et al., 1993); 
dairy 
Lipid of faeces See Table 3 17% (CV) Measured 
 
Mt(body lipid 
mass) 
Body weight See Parameterization 50 g 3 Measured 
 
Lipid fraction of 
body weight 
 
See Parameterization point 2 
 
0.066 
 
(Schmelzle and Fusch, 
2002) 
Csolid food 
(Concentration 
in solid food) 
(PCB 153) 
Formula 0.26 ng/g lipid 0.065 ng/g lipid 
(Fernandes et al., 2012) 
Bread 0.08 ng/g lipid 0.028 ng/g lipid 
Cereals & Grains 0.03 ng/g lipid 0.47 ng/g lipid 
Fruits 0.59 ng/g lipid 0.42 ng/g lipid 
Vegetables 0.42 ng/g lipid 0.22 ng/g lipid 
Protein (chicken) 0.09 ng/g lipid 0.03 ng/g lipid 
Protein (tuna) 9.26 ng/g lipid 2.2 ng/g lipid 
Dairy (cheese) 0.34 ng/g lipid 0.082 ng/g lipid 
Dust  Not applicable Not applicable 
Csolid food 
(Concentration 
in solid food) 
(BDE 47) 
Formula 0.091 ng/g lipid 0.032 ng/g lipid 
(Wu et al., 2007; Watkins 
et al., 2011; Fernandes et 
al., 2012; Ali et al., 2014) 
Bread 0.13 ng/g lipid 0.072 ng/g lipid 
Cereals & Grains 0.067 ng/g lipid 0.041 ng/g lipid 
Fruits 0.58 ng/g lipid 0.45 ng/g lipid 
Vegetables 0.53 ng/g lipid 0.23 ng/g lipid 
Protein (chicken) 0.073 ng/g lipid 0.02 ng/g lipid 
Protein (tuna) 1.443 ng/g lipid 0.16 ng/g lipid 
Dairy (cheese) 0.099 ng/g lipid 0.015 ng/g lipid 
Dust  70 ng/g dw 50% (CV)1 
Csolid food 
(Concentration 
in solid food) 
(p,p’-DDE) 
Formula 0.058 ng/g lipid 0.029 ng/g lipid 
(Kannan et al., 1994; 
Defra, 2012; FDA, 2012) 
Bread 0.24 ng/g lipid 0.12 ng/g lipid 
Cereals & Grains 0.24 ng/g lipid 0.12 ng/g lipid 
Fruits 0.13 ng/g lipid 0.065 ng/g lipid 
Vegetables 11 ng/g lipid 5.5 ng/g lipid 
Protein (chicken) 0.34 ng/g lipid 0.17 ng/g lipid 
Protein (tuna) 15 ng/g lipid 7.5g/g lipid 
Dairy (cheese) 0.058 ng/g lipid 0.029 ng/g lipid 
Dust  Not applicable Not applicable 
1: Arbitrary assumption. CV: coefficient of variation.    2: The strong dip in Qfaeces during months 2-4 in the model was 
not documented in the parents’ diary, so a scenario without this dip was used for the uncertainty analysis.   3: Given the 
uncertainty in urine and bowel content at the time of weighing, 50 g is a reasonable estimate of uncertainty. 
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Figure S3 Results of the model uncertainty analysis 
Percentage change of the area under the curve (AUC) of Cblood caused by changing one variable from 
default to default + variable uncertainty while other variables stayed unchanged. 
 
The uncertainty analysis was carried out by assessing the impact of estimated uncertainty of each 
variable on area under the curve (AUC) of model predicted blood concentration of PCB 153, BDE 
47 and p,p-DDE in infants for the first year of life. Figure S3 is a graphical representation of the 
uncertainty analysis that we performed.  
 
Variables’ abbreviations: Cmilk = lipid based concentration in breast milk; BM (fresh weight) = fresh 
weight of breast milk consumed in gram per day; Lipid content of BM = lipid content of breast milk; 
Solid food (dry weight) = solid food dry weight consumed in gram per day; Lipid from solid food = 
Lipid consumed from solid food in gram per day; Csolid food = POP concentration in solid food; 
Cfaeces = POP concentration in faecal samples; Lipid content of faeces = Lipid content of faecal 
samples; Faeces (dry weight) = dry weight of faeces excreted in gram per day; Body weight: weight 
of the infant; Lipid content of body = lipid content of body of the infant; Dust (dry weight)= dry 
weight of dust consumed in gram per day; Cdust= POP concentration in dust.  
The results show that the variables related to the ingestion of breast milk (Cmilk, BM and Lipid 
content of BM) and the lipid content of the body of the infant have the largest influences on predicted 
lipid adjusted blood concentration in the infant.  
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Figure S4 Comparison of the dietary intake and faecal excretion of: A) Lipids; B) PCB153; C) 
BDE47; D) p,p’-DDE   
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Table S1 Inclusion/exclusion criteria for “OMPAC” study and for this study. 
Inclusion criteria 
of this study 
Inclusion 
criteria of 
“OMPAC” 
study 
Participants who meet all of the following criteria are eligible for enrolment: 
1. Children of either sex, aged 3-20 months old whose biological mother, 
father, or sibling has a history of asthma and/or atopy (defined as SPT 
reactivity to one or more allergen, food allergy, atopic dermatitis or 
allergic rhinitis).  
2. Participants who, in the opinion of the investigator, are able to comply 
with the protocol for its duration 
3. Written informed consent signed and dated by parent/legal guardian 
according to local regulations 
 
4. Written informed consent signed and dated by parent/legal guardian 
according to local regulations for plasma and faecal sample analysis for 
persistent organic pollutants 
Exclusion criteria 
of this study 
Exclusion 
criteria of 
“OMPAC’ 
study 
Participants who meet any of these criteria are not eligible for enrolment: 
1. Children born after less than 36 weeks gestation 
2. Children who have been diagnosed with asthma 
3. Children who have chronic pulmonary disease or other chronic disease 
(other than atopic dermatitis, food allergy, or chronic rhinitis) requiring 
therapy 
4. Participation in another randomized controlled trial within the 3 
months preceding inclusion in this study 
5. Children who have previously received OM-85 or other 
immunostimulants or immunosuppressive drugs including cyclosporine 
 6. Children who have failed to provide either plasma or faecal samples* 
*: Participants that failed to provide plasma sample of more than 0.3 ml or faecal sample of more than 1 g dry weight 
were excluded for that particular sampling time. 
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Table S2 Quality assurance for plasma and faecal sample analysis. 
Plasma 
Internal standard 
 (IS) 
LOD1(ng/g lipid) (n=33)) Sample Recovery  (n=33) 
mean ± SD2 Mean ± SD 
p,p’-DDE 13C- p,p’-DDE 8.2 ± 6.9 81 ± 14 
HCB 13C-HCB 8.2 ± 6.9 74 ± 20 
b-HCH 13C-b-HCH 8.2 ± 6.9 73 ± 20 
y-HCH 13C-y-HCH 8.2 ± 6.9 72 ± 21 
PCB28 13C-PCB28 1.6 ± 1.4 79 ± 16 
PCB118 13C-PCB118 1.6 ± 1.4 81 ± 14 
PCB138 13C-PCB138 1.6 ± 1.4 84 ± 12 
PCB153 13C-PCB153 1.6 ± 1.4 81 ± 14 
PCB180 13C-PCB180 1.6 ± 1.4 84 ± 12 
PBDE47 13C-PBDE47 4.0 ±  1.8 86 ± 11 
PBDE99 13C-PBDE99 1.6 ± 1.4 88 ± 9.1 
PBDE100 13C-PBDE100 1.6 ± 1.4 87 ± 10 
PBDE153 13C-PBDE153 2.2 ± 1.8 93 ± 8.7 
PBDE154 13C-PBDE154 1.6 ± 1.4 86 ± 10 
     
Faeces 
Internal standard  
(IS) 
LOQ3(ng/g lipid) (n=33) 
LOQ3(ng/g dry weight) 
(n=33) 
Recovery of internal 
standards (%) (n=33) 
Replicate analyses of a 
pooled faecal sample (dry-
weight based) 
(n=4) 
mean ± SD Mean ± SD Mean (CV4[%)) 
p,p’-DDE 13C- p,p’-DDE 0.36 ± 0.20 0.036 ± 0.0014 81 ± 12 1.0 (7.2) 
HCB 13C-HCB 0.34 ± 0.23 0.035 ± 0.018 75 ± 14 0.11 (9.1) 
b-HCH 13C-b-HCH 0.11 ± 0.077 0.011 ± 0.0061 67 ± 20 0.25 (16) 
y-HCH 13C-y-HCH 0.29 ± 0.17 0.028 ± 0.019 61 ± 12 0.021 (11) 
PCB28 13C-PCB28 0.68 ± 0.39 0.070 ± 0.028 71 ± 19 0.03 (4.6) 
PCB118 13C-PCB118 0.18 ± 0.18 0.019 ± 0.016 79 ± 16 0.024(9.3) 
PCB138 13C-PCB138 0.22 ± 0.20 0.022 ± 0.017 78 ± 18 0.037 (13) 
PCB153 13C-PCB153 0.37 ± 0.25 0.038 ± 0.020 82 ± 17 0.056 (16) 
PCB180 13C-PCB180 0.41 ± 0.24 0.042 ± 0.017 76 ± 12 0.029 (8.5) 
PBDE47 13C-PBDE47 0.47 ± 0.31 0.046 ± 0.024 71 ± 14 0.12 (8.4) 
PBDE99 13C-PBDE99 0.16 ± 0.15 0.016 ± 0.012 72 ± 19  0.032 (25) 
PBDE100 13C-PBDE100 0.52 ± 0.37 0.052 ± 0.029 66 ± 19 --5 
PBDE153 13C-PBDE153 0.24 ± 0.15 0.023 ± 0.011 67 ± 19 0.016 (28) 
PBDE154 13C-PBDE154 0.09 ± 0.053 0.0088 ± 0.0036 69 ± 18 --5 
1: LOD: limit of quantification used for plasma samples. It was calculated by dividing the method limit of detection (mLOD) with the sample amount 
for each individual sample. mLOD was defined as three times the standard deviation of blank samples or the instrumental detection limit (lowest 
standard confirmed to have a signal to nose ratio greater than three), whichever was larger. 
2: SD: standard deviation 
3: LOQ: limit of quantification used for faecal samples. It was calculated by dividing the method limit of quantification (mLOQ) with the sample 
amount for each individual sample. mLOQ was defined as the sum of the mean blank and 10 times the standard deviation of blank samples.  
4. CV: coefficient of variation 
5. --: not calculated due to data < LOD.  
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Table S3 Comparison between dry-weight based and lipid-weight based concentrations of PCB 153, p,p’-DDE, HCB and BDE47 in 
replicate faeces samples. The selection of samples for replicate analysis was based on the amount of faeces collected. The code in the 
column “No.” indicates the participant number (first number) and the sampling occasion number (second number). 
pp'-
DDE 
Dry-weight based 
(ng/g dw) 
Lipid-weight based 
(ng/g lipid) HCB 
Dry-weight based 
(ng/g dw) 
Lipid-weight based 
(ng/g lipid) 
No.  
Value 
1 
Value 
2 
% 
difference 
Value 
1 
Value 
2 
% 
difference  
Value 
1 
Value 
2 
% 
difference 
Value 
1 
Value 
2 
% 
difference 
2-2 -- -- -- -- -- --  -- -- --  --  -- -- 
3-2 0.88 0.99 12 4.4 6.0 30  0.077 0.15 64 0.47 0.76 47 
5-1 0.23 0.15 43 1.3 0.65 64  0.034 0.037 8 0.20 0.17 15 
8-1 12 16 28 55 80 38  0.064 0.045 35 0.29 0.22 25 
8-2 8.3 6.0 32 40 31 24  0.005 0.003 50 0.02 0.02 45 
10-2 0.56 0.63 11 5.1 5.7 11  0.074 0.086 14 0.68 0.78 13 
15-2 0.37 0.20 61 5.2 1.8 100  0.033 0.014 78 0.47 0.13 110 
16-2 0.67 1.1 48 7.3 11 42  0.17 0.19 16 1.8 2.0 8.2 
20-1 1.3 3.0 80 11 41 120  0.09 0.10 12 1.2 0.86 33 
22-1 0.97 0.46 72 8.1 5.6 36  0.11 0.13 15 0.93 1.6 53 
mean -- -- 43 -- -- 52  -- -- 32 -- -- 39 
PCB 
118 
Dry-weight based 
       (ng/g dw) 
  Lipid-weight based 
          (ng/g lipid) 
PCB 
138 
Dry-weight based 
(ng/g dw) 
Lipid-weight based 
(ng/g lipid) 
No.  
Value 
1 
Value 
2 
% 
difference 
Value 
1 
Value 
2 
% 
difference  
Value 
1 
Value 
2 
% 
difference 
Value 
1 
Value 
2 
% 
difference 
2-2 0.055 0.092 50 0.28 0.65 80  0.090 0.062 37 0.64 0.31 68 
3-2 0.13 0.14 0.7 0.81 0.67 19  0.21 0.25 19 1.3 1.3 0 
5-1 0.004 0.002 67 0.023 0.01 86  0.005 0.004 22 0.029 0.018 45 
8-1 0.33 0.16 68 1.5 0.80 60  0.19 0.30 42 0.88 1.5 51 
8-2 0.21 0.12 52 0.99 0.63 45  0.44 0.23 61 2.1 1.2 54 
10-2 0.011 0.017 43 0.10 0.16 45  0.023 0.008 97 0.21 0.076 94 
15-2 0.035 0.036 2.8 0.50 0.32 45  0.038 0.052 31 0.55 0.46 17 
16-2 0.15 0.078 65 1.5 0.85 59  0.10 0.10 3.9 1.1 1.1 2.9 
20-1 0.063 0.035 57 0.53 0.47 11  0.066 0.058 13 0.56 0.79 35 
22-1 0.037 0.017 74 0.31 0.21 39  0.053 0.025 72 0.44 0.32 33 
mean   48   49    40   40 
PCB 
153 
Dry-weight based 
(ng/g dw) 
Lipid-weight based 
(ng/g lipid) BDE47 
Dry-weight based 
(ng/g dw) 
Lipid-weight based 
(ng/g lipid) 
No.  
Value 
1 
Value 
2 
% 
difference 
Value 
1 
Value 
2 
% 
difference  
Value 
1 
Value 
2 
% 
difference 
Value 
1 
Value 
2 
% 
difference 
2-2 0.10 0.064 46 0.72 0.32 77  0.90 0.20 130 6.4 1.0 150 
3-2 0.19 0.21 11 1.1 1.0 8.3  0.51 0.75 38 3.1 3.8 19 
5-1 0.006 0.004 51 0.037 0.017 72  0.044 0.02 76 0.28 0.11 90 
8-1 0.39 0.33 17 1.8 1.6 7.0  0.26 0.40 44 1.2 2.0 53 
8-2 0.37 0.27 33 1.8 1.4 24  0.092 0.049 60 0.44 0.26 51 
10-2 0.022 0.015 36 0.21 0.14 39  0.11 0.11 9.1 0.98 1.1 11 
15-2 0.040 0.056 33 0.57 0.49 15  0.45 0.56 22 6.4 4.9 26 
16-2 0.16 0.082 63 1.7 0.83 70  2.8 1.1 86 30 11 91 
20-1 0.064 0.091 35 0.55 1.2 77  0.54 0.53 1.0 7.3 4.5 48 
22-1 0.056 0.021 89 0.47 0.26 55  0.068 0.058 16 0.57 0.72 23 
mean -- -- 41 -- -- 44  -- -- 48 -- -- 56 
--: Data under LOQ 
                                 : Participants were still breastfed.  
%difference =
|𝑉𝑎𝑙𝑢𝑒 1−𝑉𝑎𝑙𝑢𝑒 2|
(value 1+value 2)
2
 × 100 
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Table S4 POP concentrations (ng/g lipid) in plasma from individual infants/toddlers. The code indicates the participant 
number (first number) and the sampling occasion number (second number).  
Code 
Lipid 
(mg) 
 p,p’-
DDE 
HCB 
B-
HCH 
Y-
HCH 
 PCB 
28 
PCB 
118 
PCB 
138 
PCB 
153 
PCB 
180 
BDE 
47 
 BDE 
99 
 BDE 
100 
BDE 
153 
BDE 
154 
1_1 3.3 80 9.8 5.4 5.4 1.1 1.1 1.1 1.1 1.1 7.1 1.1 2.3 9.4 1.1 
1_2 2 60 9.2 9.2 9.2 1.8 1.8 1.8 1.8 1.8 4.4 1.8 1.8 7.5 1.8 
2_1 5.2 14 3.5 3.5 3.5 0.70 0.70 0.70 0.70 0.70 1.7 0.7 0.7 1.1 0.7 
2_2 5 19 3.6 3.6 3.6 0.71 0.71 0.71 0.71 0.71 1.8 0.71 0.71 1.1 0.71 
3_1 2.5 140 21 7.1 7.1 1.4 5.2 8.4 11 3.9 3.5 1.4 1.4 2.2 1.4 
3_2 5.3 130 20 3.4 3.4 0.68 4.0 8.1 9.6 3.3 1.7 0.68 0.68 4.8 0.68 
5_1 4.9 24 3.7 3.7 3.7 0.71 0.71 0.71 0.71 0.71 1.8 0.71 0.71 1.1 0.71 
5_2 4 27 4.5 4.5 4.5 0.92 0.92 0.92 0.92 0.92 2.2 0.92 0.92 1.4 0.92 
8_1 3.6 3400 7.7 5.1 5.1 0.99 12 31 31 8.7 2.5 0.99 0.99 1.6 0.99 
8_2 2.9 2800 6.3 6.3 6.3 1.3 11 26 26 7.1 3.1 1.3 1.3 2.0 1.3 
9 2.4 96 7.8 7.8 7.8 1.6 1.6 1.6 1.6 1.6 3.8 1.6 1.6 2.4 1.6 
10_1 0.8 70 23 23 23 4.7 4.7 4.7 4.7 4.76 11 4.7 4.7 7.1 4.7 
10_2 2.8 78 6.4 6.4 6.4 1.3 1.3 2.1 2.5 1.3 3.1 1.3 1.3 2.0 1.3 
11 3.5 35 5.2 5.2 5.2 1.1 1.1 2.6 3 1.1 2.6 1.1 1.1 1.6 1.1 
12_1 5.9 94 7.0 3.1 3.1 0.62 0.96 1.8 2.3 0.93 1.5 0.62 0.62 1.6 0.62 
12_2 3 170 13 5.9 5.9 1.2 2.4 4 4.7 2.5 2.9 1.2 1.8 1.8 1.2 
15_1 5 240 11 6.6 3.6 0.71 1.3 2.5 2.9 1.6 3.2 0.71 1.2 1.1 0.71 
15_2 8.7 160 8.2 4.6 2.1 0.42 0.68 1.8 2 1 0.99 0.42 0.71 0.64 0.42 
16_2 4.8 150 28 15 3.8 1.5 3.6 4.0 3.9 1.7 3.9 0.78 1.2 1.1 0.78 
17_1 3 64 6.1 6.1 6.1 1.2 1.2 1.2 1.2 1.2 3.0 1.2 1.2 1.9 1.2 
17_2 3.4 51 5.3 5.3 5.3 1.1 1.1 1.1 1.6 1.1 2.6 1.1 1.1 1.1 1.1 
18 5 120 6.7 3.7 3.7 0.71 0.71 2.8 4.3 2.7 1.8 0.71 0.71 1.5 0.71 
20_1 0.8 120 24  24 24 4.8 4.8 4.8 4.8 4.8 12 4.8 4.8 4.8 4.8 
20_2 3.4 120 13 5.4 5.4 1.1 2.6 3.4 3.7 2.4 2.6 1.1 1.1 3.2 1.1 
22_1 6.1 97 14 4.5 3.0 1.8 2.6 3.0 3.6 1.7 3.4 0.59 0.9 4.0 0.59 
22_2 4 100 15 4.6 4.6 1.7 2.7 3.3 4.0 1.7 2.3 0.92 0.92 3.2 0.92 
23_1 6.6 9.6 2.8 2.8 2.8 0.55 0.55 0.55 0.55 0.55 1.3 0.55 0.55 0.55 0.55 
23_2 5.1 10 3.6 3.6 3.6 0.71 0.71 0.71 0.71 0.71 1.8 0.71 0.71 0.71 0.71 
24 5 70 6.5 3.7 3.7 1.9 1.6 1.8 1.9 0.71 1.8 0.71 0.71 0.71 0.71 
25_1 3.3 670 16 12 5.5 2.2 5.4 7.0 10 6.3 2.7 1.1 1.1 4.5 1.1 
25_2 5.4 760 19 10 3.4 1.9 5.1 8.3 11 6.6 1.6 0.67 1.4 4.2 0.67 
26 7.8 190 12 4.5 2.3 0.47 1.5 4.3 6.0 3.4 1.1 0.47 0.47 2.3 0.47 
27_1 4.3 84 13 6.7 4.2 0.85 5.6 27 42 20 2.1 0.85 0.85 1.4 0.85 
DF* -- 
100
% 
55% 24% 0% 18% 52% 61% 64% 52% 12% 0% 21% 36% 0% 
                       : Data under LOD, LOD/(2)1/2 was used 
DF*: detection frequency above LOD. 
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Table S5 POP concentrations (ng/g dry weight) in faeces from individual infants/toddlers. The code indicates the 
participant number (first number) and the sampling occasion number (second number). 
 
Sample 
amount 
(g) 
 p,p’-DDE HCB B-HCH Y-HCH 
 PCB 
28 
PCB 
118 
PCB 
138 
PCB 
153 
PCB 
180 
BDE 47 
 BDE 
99 
 BDE 
100 
BDE 153 
BDE 
154 
1_1 0.59 0.43 0.006 0.009 0.006 0.017 0.013 0.01 0.036 0.010 0.35 0.01 0.015 0.0041 0.0018 
1_2 0.48 0.30 0.013 0.054 0.0084 0.013 0.067 0.029 0.060 0.009 0.52 0.062 0.0077 0.0091 0.0022 
2_1 0.52 0.031 0.015 0.0021 0.008 0.008 0.049 0.030 0.042 0.012 0.40 0.01 0.017 0.024 0.0021 
2_2 0.59 0.0094 0.006 0.0020 0.006 0.032 0.074 0.076 0.082 0.016 0.55 0.012 0.0071 0.044 0.0019 
3_1 0.70 1.7 0.025 0.0015 0.004 0.005 0.21 0.31 0.30 0.056 0.40 0.01 0.013 0.018 0.0015 
3_2 0.87 0.93 0.11 0.0012 0.008 0.020 0.13 0.23 0.20 0.020 0.63 0.054 0.015 0.045 0.0012 
5_1 0.92 0.19 0.036 0.0074 0.005 0.005 0.0034 0.0028 0.005 0.006 0.03 0.014 0.0067 0.0031 0.0012 
5_2 0.19 0.014 0.01 0.003 0.004 0.006 0.003 0.001 0.002 0.003 0.02 0.005 0.0048 0.0013 0.0006 
8_1 0.59 14 0.054 0.030 0.030 0.072 0.24 0.25 0.36 0.029 0.33 0.025 0.012 0.015 0.0022 
8_2 0.77 7.0 0.02 0.007 0.005 0.008 0.16 0.34 0.32 0.026 0.07 0.023 0.0087 0.0091 0.0014 
9 0.81 0.86 0.10 0.044 0.0049 0.052 0.059 0.040 0.061 0.0077 0.51 0.068 0.032 0.0007 0.0013 
10_1 0.49 0.42 0.034 0.066 0.003 0.020 0.048 0.023 0.033 0.010 0.37 0.029 0.0052 0.0067 0.0022 
10_2 0.99 0.59 0.080 0.005 0.0055 0.012 0.014 0.016 0.018 0.006 0.11 0.030 0.0090 0.0041 0.0011 
11 0.92 0.56 0.025 0.0012 0.015 0.020 0.039 0.045 0.059 0.0084 0.01 0.001 0.0097 0.0027 0.0012 
12_1 0.56 0.88 0.34 0.0019 0.006 0.018 0.048 0.003 0.052 0.011 0.05 0.002 0.016 0.37 0.0019 
12_2 0.29 2.9 0.21 0.0037 0.011 0.035 0.097 0.099 0.14 0.039 0.67 0.004 0.031 0.56 0.0037 
15_1 0.56 0.79 0.034 0.0019 0.0084 0.006 0.052 0.054 0.059 0.006 0.53 0.002 0.016 0.0043 0.0019 
15_2 0.81 0.28 0.016 0.0014 0.004 0.029 0.036 0.045 0.048 0.006 0.50 0.046 0.0087 0.0028 0.0013 
16 0.30 0.88 0.18 0.15 0.022 0.022 0.12 0.10 0.12 0.021 1.9 0.24 0.14 0.025 0.0049 
17_1 0.54 0.59 0.066 0.083 0.029 0.15 0.018 0.018 0.025 0.0091 0.20 0.0049 0.0047 0.0061 0.0020 
17_2 0.52 0.32 0.098 0.005 0.008 0.41 0.015 0.021 0.020 0.006 0.29 0.002 0.017 0.0047 0.0020 
18 0.45 1.1 0.15 0.037 0.031 0.033 0.015 0.023 0.035 0.020 0.24 0.022 0.0056 0.0076 0.0024 
20_1 0.47 2.0 0.088 0.15 0.014 0.045 0.049 0.062 0.078 0.041 0.53 0.097 0.075 0.11 0.0023 
20_2 0.57 0.58 0.14 0.13 0.004 0.12 0.28 0.14 0.27 0.007 0.11 0.032 0.021 0.09 0.0025 
22_1 0.61 0.71 0.12 0.0018 0.011 0.024 0.027 0.039 0.039 0.014 0.042 0.007 0.015 0.0050 0.0018 
22_2 0.90 0.50 0.02 0.0012 0.006 0.016 0.017 0.020 0.021 0.005 0.05 0.001 0.0099 0.0046 0.0012 
23_1 0.77 0.15 0.051 0.0014 0.015 0.13 0.0045 0.0049 0.0077 0.008 0.08 0.001 0.012 0.0032 0.0014 
23_2 0.45 0.097 0.086 0.25 0.025 0.022 0.017 0.017 0.035 0.022 0.11 0.012 0.0057 0.0043 0.0024 
24 0.53 0.23 0.13 0.0020 0.004 0.010 0.0050 0.0049 0.007 0.011 0.03 0.002 0.017 0.004 0.0020 
25_1 0.60 6.8 0.047 0.18 0.025 0.020 0.21 0.16 0.38 0.26 0.71 0.099 0.054 0.29 0.0018 
25_2 0.52 9.2 0.081 0.12 0.008 0.023 0.27 0.46 0.57 0.52 0.85 0.16 0.14 0.43 0.0020 
26 0.45 1.5 0.12 0.36 0.035 0.041 0.033 0.041 0.078 0.053 0.18 0.033 0.0035 0.0045 0.0015 
27_1 0.85 0.90 0.077 0.0012 0.017 0.062 0.27 1.4 2.1 0.83 0.20 0.024 0.01 0.0057 0.0012 
DF* -- 88% 70% 39% 21% 21% 79% 67% 73% 18% 88% 48% 15% 24% 0% 
                     : Data between LOD and LOQ, (LOD+LOQ)/2 is shown 
             : Data under LOQ, LOD/(2)1/2 was used  
DF*: detection frequency above LOQ. 
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Table S6 Kfb for each participant at each sampling time for selected POPs (The code indicates the participant number 
(first number) and the sampling occasion number (second number)). 
 
 DDE HCB PCB 118 PCB 138 PCB 153 
1_1 -- -- -- -- -- 
1_2 0.005 -- -- -- -- 
2_1 -- -- -- -- -- 
2_2 -- -- -- -- -- 
3_1 0.012 -- 0.040 0.037 0.027 
3_2 0.0072 0.0055 0.033 0.028 0.021 
5_1 0.0079 -- -- -- -- 
5_2 -- -- -- -- -- 
8_1 0.004 0.007 0.020 0.008 0.012 
8_2 0.0025 -- 0.015 0.013 0.012 
9 0.0089 -- -- -- -- 
10_1 0.006 -- -- -- -- 
10_2 0.0076 -- -- 0.008 0.007 
11 0.016 -- -- 0.018 0.020 
12_1 0.0094 0.049 0.050 -- 0.023 
12_2 0.017 0.016 0.040 0.025 0.030 
15_1 0.0033 0.003 0.040 0.022 0.020 
15_2 0.0018 -- 0.053 0.025 0.024 
16 0.006 0.006 0.033 0.025 0.031 
17_1 0.0092 -- -- -- -- 
17_2 0.0063 -- -- -- -- 
18 0.0095 0.023 -- -- -- 
20_1 0.017 -- -- -- -- 
20_2 0.0048 0.011 0.11 0.041 0.073 
22_1 0.0073 0.009 0.010 0.013 0.011 
22_2 0.005 -- 0.006 0.006 0.005 
23_1 0.016 -- -- -- -- 
23_2 0.0097 -- -- -- -- 
24 0.003 0.020 -- -- -- 
25_1 0.010 0.029 0.039 0.023 0.038 
25_2 0.012 0.0043 0.053 0.055 0.052 
26 0.008 0.010 0.022 0.010 0.013 
27_1 0.011 0.006 0.048 0.052 0.050 
Mean 0.0086 0.012 0.038 0.024 0.026 
Standard deviation 0.0047 0.012 0.024 0.015 0.018 
Median 0.0079 0.0078 0.039 0.023 0.022 
25% Percentile 0.0018 0.0052 0.0063 0.0061 0.012 
75% Percentile 0.010 0.017 0.050 0.033 0.033 
Results in adults*  
(n) 
-- 4 4 5 5 
Mean -- 0.024 0.023 0.018 0.016 
Std. Deviation -- 0.005 0.013 0.008 0.007 
CV -- 21% 57% 44% 44% 
                   a: Reference: (Moser and McLachlan, 2001) 
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Table S7 A summary of POP concentrations in plasma (ng/g lipid) and faeces (ng/g dw) for a cross-sectional dataset. The 
code indicates the participant number (first number) and the sampling occasion number (second number). 
Plasma data 
 
Lipid 
(mg) 
p,p’-DDE HCB B-HCH Y-HCH 
PCB 
28 
PCB 
118 
PCB 
138 
PCB 
153 
PCB 
180 
BDE 47 
BDE 
99 
BDE 
100 
BDE 153 
BDE 
154 
1_1 3.3 80 9.8 5.4 5.4 1.1 1.1 1.1 1.1 1.1 7.1 1.1 2.3 9.4 1.1 
2_1 5.2 14 3.5 3.5 3.5 0.7 0.7 0.7 0.7 0.7 1.7 0.7 0.7 1.1 0.7 
3_2 5.3 130 20 3.4 3.4 0.68 4.0 8.1 9.6 3.3 1.7 0.68 0.68 4.8 0.68 
5_1 4.9 24 3.7 3.7 3.7 0.71 0.71 0.71 0.71 0.71 1.8 0.71 0.71 1.1 0.71 
8_1 3.6 3400 7.7 5.1 5.1 0.99 12 31 31 8.7 2.5 0.99 0.99 1.6 0.99 
9 2.4 96 7.8 7.8 7.8 1.6 1.6 1.6 1.6 1.6 3.8 1.6 1.6 2.4 1.6 
10_2 2.8 78 6.4 6.4 6.4 1.3 1.3 2.1 2.5 1.3 3.1 1.3 1.3 2.0 1.3 
11 3.5 35 5.2 5.2 5.2 1.1 1.1 2.6 3 1.1 2.6 1.1 1.1 1.6 1.1 
12_2 3 170 13 5.9 5.9 1.2 2.4 4 4.7 2.5 2.9 1.2 1.8 1.8 1.2 
15_1 5 240 11 6.6 3.6 0.71 1.3 2.5 2.9 1.6 3.2 0.71 1.2 1.1 0.71 
16 4.8 150 28 15 3.8 1.5 3.6 4.0 3.9 1.7 3.9 0.78 1.2 1.1 0.78 
17_2 3.4 51 5.3 5.3 5.3 1.1 1.1 1.1 1.6 1.1 2.6 1.1 1.1 1.1 1.1 
18 5 120 6.7 3.7 3.7 0.71 0.71 2.8 4.3 2.7 1.8 0.71 0.71 1.5 0.71 
20_2 3.4 120 13 5.4 5.4 1.1 2.6 3.4 3.7 2.4 2.6 1.1 1.1 3.2 1.1 
22_1 6.1 97 14 4.5 3.0 1.8 2.6 3.0 3.6 1.7 3.4 0.59 0.9 4.0 0.59 
23_2 5.1 10 3.6 3.6 3.6 0.71 0.71 0.71 0.71 0.71 1.8 0.71 0.71 0.71 0.71 
24 5 70 6.5 3.7 3.7 1.9 1.6 1.8 1.9 0.71 1.8 0.71 0.71 0.71 0.71 
25_1 3.3 670 16 12 5.5 2.2 5.4 7.0 10 6.3 2.7 1.1 1.1 4.5 1.1 
26 7.8 190 12 4.5 2.3 0.47 1.5 4.3 6.0 3.4 1.1 0.47 0.47 2.3 0.47 
27_1 4.3 84 13 6.7 4.2 0.85 5.6 27 42 20 2.1 0.85 0.85 1.4 0.85 
DFa -- 100% 65% 30% 0% 20% 55% 70% 75% 55% 20% 0% 20% 40% 0% 
Faeces data 
 
Sample 
amount 
(g) 
p,p’-DDE HCB B-HCH Y-HCH 
PCB 
28 
PCB 
118 
PCB 
138 
PCB 
153 
PCB 
180 
BDE 47 
BDE 
99 
BDE 
100 
BDE 153 
BDE 
154 
1_1 0.59 0.43 0.006 0.009 0.006 0.017 0.013 0.01 0.036 0.010 0.35 0.01 0.015 0.0041 0.0018 
2_1 0.52 0.031 0.015 0.0021 0.008 0.008 0.049 0.030 0.042 0.012 0.40 0.01 0.017 0.024 0.0021 
3_2 0.87 0.93 0.11 0.0012 0.008 0.020 0.13 0.23 0.20 0.020 0.63 0.054 0.015 0.045 0.0012 
5_1 0.92 0.19 0.036 0.0074 0.005 0.005 0.0034 0.0028 0.005 0.006 0.03 0.014 0.0067 0.0031 0.0012 
8_1 0.59 14 0.054 0.030 0.030 0.072 0.24 0.25 0.36 0.029 0.33 0.025 0.012 0.015 0.0022 
9 0.81 0.86 0.10 0.044 0.0049 0.052 0.059 0.040 0.061 0.0077 0.51 0.068 0.032 0.0007 0.0013 
10_2 0.99 0.59 0.080 0.005 0.0055 0.012 0.014 0.016 0.018 0.006 0.11 0.030 0.0090 0.0041 0.0011 
11 0.92 0.56 0.025 0.0012 0.015 0.020 0.039 0.045 0.059 0.0084 0.01 0.001 0.0097 0.0027 0.0012 
12_2 0.29 2.9 0.21 0.0037 0.011 0.035 0.097 0.099 0.14 0.039 0.67 0.004 0.031 0.56 0.0037 
15_1 0.56 0.79 0.034 0.0019 0.0084 0.006 0.052 0.054 0.059 0.006 0.53 0.002 0.016 0.0043 0.0019 
16 0.30 0.88 0.18 0.15 0.022 0.022 0.12 0.10 0.12 0.021 1.9 0.24 0.14 0.025 0.0049 
17_2 0.52 0.32 0.098 0.005 0.008 0.41 0.015 0.021 0.020 0.006 0.29 0.002 0.017 0.0047 0.0020 
18 0.45 1.1 0.15 0.037 0.031 0.033 0.015 0.023 0.035 0.020 0.24 0.022 0.0056 0.0076 0.0024 
20_2 0.57 0.58 0.14 0.13 0.004 0.12 0.28 0.14 0.27 0.007 0.11 0.032 0.021 0.09 0.0025 
22_1 0.61 0.71 0.12 0.0018 0.011 0.024 0.027 0.039 0.039 0.014 0.042 0.007 0.015 0.0050 0.0018 
23_2 0.45 0.097 0.086 0.25 0.025 0.022 0.017 0.017 0.035 0.022 0.11 0.012 0.0057 0.0043 0.0024 
24 0.53 0.23 0.13 0.0020 0.004 0.010 0.0050 0.0049 0.007 0.011 0.03 0.002 0.017 0.004 0.0020 
25_1 0.60 6.8 0.047 0.18 0.025 0.020 0.21 0.16 0.38 0.26 0.71 0.099 0.054 0.29 0.0018 
26 0.45 1.5 0.12 0.36 0.035 0.041 0.033 0.041 0.078 0.053 0.18 0.033 0.0035 0.0045 0.0015 
27_1 0.85 0.90 0.077 0.0012 0.017 0.062 0.27 1.4 2.1 0.83 0.20 0.024 0.01 0.0057 0.0012 
DF -- 90% 90% 40% 30% 30% 80% 75% 75% 20% 90% 45% 15% 20% 0% 
                     :Data between LOD and LOQ, (LOD+LOQ)/2 is shown 
             : Data under LOQ,  LOD/(2)1/2 was used  
DFa: detection frequency 
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Table S8 Information about the study participants.  
Participant 
NO. 
 
Age (in 
months) 
when 
sampled 
(number 
of 
samples) 
Feeding status How long spent/day (h) 
 
Age (in months) 
when weaned  
 
Breast-fed more than 
50% of the total food 
when sampled(YES/NO) 
 
Length of 
breast 
feeding 
(months)* 
Description of 
solid food 
On 
floor 
In 
car 
With 
air 
con 
01 
 
19(2) -- NO 12 Mixed diet 4 2 0 
24(2) 20 -- 13 Mixed diet 3 3 0 
02 
 
16(2) 4 -- 3 
Mixed diet 
9 1 0 
21(2) 4 -- 3 9 1 0 
03 
 
16(2) 12 -- 6 
Mixed diet 
10 0.5 0.5 
21(2) 12 -- 6 5 1 -- 
05 
 
20(2) 8 -- 6 
Mixed diet 
11 1 4 
24(1) 8 -- 6 11 1 0 
08 
 
15(2) 10 -- 5 
Mixed diet 
8 1 0 
19(2) 10 -- 5 4 0.5 0 
09 
 
16(1) -- NO 11 Mixed diet 12 0.5 0 
--                  -- -- -- -- -- -- -- 
10 
 
20(2) 5 -- 4.5 
Mixed diet 
10 1 0 
24(2) 5 -- 4.5 4 1 0 
11 
 
15(1) 2 -- 2 -- 10 0 0 
-- -- -- -- -- -- -- -- 
12 
 
4.7(2) 
-- YES 4 Mainly 
carbohydrate 
1 0.5 8 
9.6(2) 
-- NO 7 
Mainly protein 8 0.5 8 
15 
 
8.6(2) -- NO 6.3 -- 8 1 1 
13(2) 12 -- 8 Mixed diet 8 1 2 
16 
-- -- -- -- -- -- -- -- 
14(2) -- NO 10 -- 6 1 4.3 
17 
 
8.9(2) 0.5 -- 0.25 
-- 
10 1 0 
14(2) 0.5 -- 0.25 7 1 -- 
18 
 
8.2(2) -- NO 6.6 -- 8 0 8 
-- -- -- -- --    
20 
 
8.9(2) -- NO 7 
-- 
8 2 4 
13(1) -- NO 8.5 3 0.5 2 
22 
 
8.3(2) -- YES 7.7 Mixed diet 5 0.5 1 
13(2) 9 -- 10 Mixed diet 6 1 3 
23 
 
8.9(2) 1 -- 0.5 Mixed diet 7 1 0 
14(1) 1 -- 0.5 Mixed diet -- -- 0 
24 
-- -- --  
-- 
-- -- -- 
11(2) -- NO 7.5 8 1 0 
25 
 
7.8(2) 
-- YES 5.9 Mainly 
carbohydrate 
6 1 < 1 
14(1) -- NO 9 Mixed diet 6 1 2 
26 
 
-- -- --  -- -- -- -- 
9.6(2) -- NO 6.8 -- 5 1 0 
27 
 
5.6(2) -- YES 5  2 0.5 10 
-- -- -- -- -- -- -- -- 
                     : Participants who were being weaned. 
                    :  Participants who were weaned in between the two sampling time points. 
                    :  Participants who were weaned. 
                     : Results used in the cross-sectional dataset 
*Breast feeding length: When calculating the breastfeeding time (months), we used 1 month for each month with solely 
breastfeeding while we used 0.5 months for any other month when the participant was partially breastfed.  
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Table S9 Information about the mothers (average ± standard deviation (median)) in this study.  
Participants’ characteristics (abbreviationsa) Primaparous 
participants
  
Secundiparous 
participants 
Information not provided 
 
Number of participants 14 4 2 
% of total number of participants  70 20 10 
Mother’s age at sampling, year 31 ± 4.9 (31) 34 ± 2.9 (32) -- 
Mother’s BMIa before pregnancy, kg 23 ± 3.1 (23) 28 ± 4.8 (30) -- 
                   % of underweight (BMI<18.5) 7 0 -- 
                   % of normal weight (18.5<BMI<24.9) 67 25 -- 
                   % of overweight (25.0<BMI<29.9) 26 0 -- 
                   % of obese (BMI ≥30) 0 75 -- 
mother body mass increaseb, kg 
        under weight (BMI<18.5) 
 
2 ± 0 (2) 
 
0 
 
-- 
        normal weight (18.5<BMI<24.9) 2.3 ± 1.2 (2) 8 -- 
        overweight (25.0<BMI<29.9) 2 ± 1.2 (2) 0 -- 
        obese (BMI ≥30) 0 3 ± 1 -- 
Region during last 5 years, %    
                                        Oceania 100 100 -- 
                                          Europe 0 0 -- 
                                        America  0 0 -- 
                                              Asia 0 0 -- 
                                            Africa 0 0 -- 
Previous Region, %    
                                        Oceania 81 100 -- 
                                          Europe 13 0 -- 
                                        America  0 0 -- 
                                              Asia 6 0 -- 
                                            Africa 0 0 - 
Birth Region, %    
                                        Oceania 75 100 -- 
                                          Europe 6 0 -- 
                                        America  0 0 -- 
                                              Asia 19 0 -- 
                                            Africa 0 0 -- 
Mother’s dietary habits, % 
                                                                mixed diet 
  vegetarian with consumption of milk and eggs 
                                                    strictly vegetarian 
 
100 
0 
0 
 
67 
33 
 
-- 
-- 
-- 
Eat anything in own garden, %    
                                             Yes 0 33 -- 
                                             No 100 67 -- 
Mother’s frequency of consumption of fish, seafood, %    
                                   never 5 33 -- 
                                   < 1 time per week 67 67 -- 
                                  1 time per week 28 0 -- 
                                   2 times per week 0 0 -- 
                                   > 2 times per week 0 0 -- 
Mother’s frequency of consumption of milk and dairy 
products, % 
   
                                   never 0 0 -- 
                                   < 1 servingC per day 0 0 -- 
                                   1-3 servings per day 100 100 -- 
                                   >  3 servings per day 0 0 -- 
Place of work,     
                                        indoors 53 67 -- 
                                        outdoors 0 0 -- 
                                        both 47 33 -- 
Time spent at  computer at work, hrs/week 20 ± 11 (20) 20 ± 15 (16) -- 
a body mass index (BMI) was calculated as follows: BMI=[mass(kg)]/[height(cm)]2 
b mother mass increase was calculated as: mother mass right after delivery – mother mass before pregnancy 
C1 serve = 250 ml milk, 200 g yoghurt, or 30 g of cheese 
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Table S10 Pearson’ correlation coefficients between log-transformed faecal dry-weight based concentrations and plasma 
lipid-weight based concentrations for selected POPs 
*
Only volunteers that had POP concentrations above the LOD in plasma and the LOQ in faeces were included.  
 
 
 
 
 
 
 
 
 
Table S11 Equation parameters for estimating POP concentrations in faeces from measured plasma concentrations from 
infants/toddlers using linear regression 
Chemicals 
Y-intercept (b) Slope (k) 
 
r2  
 
P1 
 
n 
Best-fit values ± SE Best-fit values ± SE 
p,p’-DDE -1.9 ± 0.24 0.86± 0.12 0.77 <0.05 18 
HCB2 -1.2± 0.46 
 
0.19 ± 0.41 
0.022 0.65 13 
PCB 118 -1.5 ± 0.20 
 
1.0 ± 0.33 
0.55 <0.05 10 
PCB 138 -1.8 ± 0.18 
 
1.1 ± 0.22 
0.73 <0.05 12 
PCB 153 -1.8 ± 0.20 
 
1.2 ± 0.20 
0.73 <0.05 12 
1: when P<0.05, the slope is significantly non-zero 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 R P n* 
p,p’-DDE 0.88 <0.05 18 
HCB 0.12 0.72 12 
PCB118 0.74 <0.05 10 
PCB138 0.85 <0.05 12 
PCB153 0.86 <0.05 12 
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Figure S1 Concentrations of POPs in plasma from the current study and a study of pooled samples collected in 2006-07 
(Toms et al., 2009) 
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Figure S2 Concentrations of DDE, HCB, PCB118, PCB138 and PCB153 in plasma for participants at each sampling time 
plotted against their age (only data >LOD are shown) 
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Figure S3 Concentrations of DDE, HCB, PCB118, PCB138 and PCB153 in faeces for participants at each sampling time 
plotted against their age (only data >LOQ are shown) 
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Figure S4 Comparison between the mean Cf value (error bar represents standard deviation) of the replicates (n=4) of a 
pooled faecal sample and the value of the two consecutive faecal samples (from the participant that had the highest 
percentage difference between the two consecutive samples). The data from participant 20 at the first sampling time point, 
participant 15 at the second sampling time point, participant 22 at the first sampling time point, participant 10 at the 
second sampling time point, participant 22 at the first sampling time point and participant 2 at the second sampling time 
were used here for p,p’-DDE, HCB, PCB118, PCB138, PCB153 and PBDE 47, respectively (Data source: Table S2 and 
S3).   
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Figure S5 Mean Kfb of p,p’-DDE, HCB, PCB118, PCB138 and PCB153 plotted against the age of the participants.  
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Figure S6 Comparison of Kfb of DDE, HCB, PCB118, PCB138 and PCB153 for participants who were sampled during 
weaning against participants who were sampled after weaning. 
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Figure S7 Panels a and b: Kfb ((g lipid)/(g dw)) for p,p’-DDE and PCB153 for a single infant over 1 year from Chen et 
al. (2015); the dotted lines show the uncertainty bounds. Panels c through j: Kfb for the participants in this study plotted 
against age at the time of sampling for selected POPs (black symbols represent samples collected post-weaning, green 
symbols represent samples collected during weaning, and red symbols indicate that weaning occurred between first and 
second samples; the lines connect two sampling points from the same individual). 
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